A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1767 guidelines that have been superceded.

Academy for Chiropractic Education

1. Manual medicine guidelines for musculoskeletal injuries. (NGC-4054)
   • Braddock EJ, Greenlee J, Hammer RE, Johnson SF, Martello MJ, O'Connell MR, Rinzler R, Swanson MR, Tain L, Vogel JA, Walsh G. Manual medicine guidelines for musculoskeletal injuries. California: Academy for Chiropractic Education; 2004 Dec 1. 25 p. [39 references]

   CURRENT NGC SUMMARY: Manual medicine guidelines for musculoskeletal injuries. (NGC-5626)

Academy of Ambulatory Foot and Ankle Surgery

1. Hallux abductovalgus. (NGC-1563)
   • Academy of Ambulatory Foot and Ankle Surgery. Hallux abductovalgus. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 21 p. [50 references]

   CURRENT NGC SUMMARY: Hallux abductovalgus. (NGC-3240)

2. Hallux limitus and hallux rigidus. (NGC-1567)
   • Academy of Ambulatory Foot and Ankle Surgery. Hallux limitus & hallux rigidus. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 12 p. [3 references]

   CURRENT NGC SUMMARY: Hallux limitus and hallux rigidus. (NGC-3244)

3. Hammertoe syndrome. (NGC-1565)
   • Academy of Ambulatory Foot and Ankle Surgery. Hammertoe syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 23 p. [31 references]

   CURRENT NGC SUMMARY: Hammertoe syndrome. (NGC-3242)

4. Heel spur syndrome. (NGC-1568)
   • Academy of Ambulatory Foot and Ankle Surgery. Heel spur syndrome. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 12 p. [14 references]

   CURRENT NGC SUMMARY: Heel spur syndrome. (NGC-3245)

5. Ingrown toenails. (NGC-1564)
   • Academy of Ambulatory Foot and Ankle Surgery. Ingrown toenails. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 20 p. [30 references]

   CURRENT NGC SUMMARY: Ingrown toenails. (NGC-3241)

6. Intermetatarsal neuroma. (NGC-1566)
   • Academy of Ambulatory Foot and Ankle Surgery. Intermetatarsal neuroma. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 17 p. [15 references]

   CURRENT NGC SUMMARY: Intermetatarsal neuroma. (NGC-3243)

7. Metatarsalgia/intractable plantar keratosis/Tailor's bunion. (NGC-1569)
   • Academy of Ambulatory Foot and Ankle Surgery. Metatarsalgia/intractable plantar keratosis/Tailor's bunion. Philadelphia (PA): Academy of Ambulatory Foot and Ankle Surgery; 2000. 13 p. [26 references]

   CURRENT NGC SUMMARY: Metatarsalgia/intractable plantar keratosis/Tailor's bunion. (NGC-3246)

Allergic Rhinitis and its Impact on Asthma Workshop Group

1. Allergic rhinitis and its impact on asthma. (NGC-2647)
   • Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 Nov;108(5):S147-334. [2776 references]

   CURRENT NGC SUMMARY: Allergic rhinitis and its impact on asthma. (NGC-6274)

Alzheimer's Association

1. Dementia care practice recommendations for assisted living residences and nursing homes. (NGC-4493)
   • Alzheimer's Association. Dementia care practice recommendations for assisted living residences and nursing homes. Chicago (IL): Alzheimer's Association; 2005. 15 p. [90 references]

   CURRENT NGC SUMMARY: Dementia care practice recommendations for assisted living residences and nursing homes. (NGC-5562)

American Academy of Allergy, Asthma and Immunology

1. The diagnosis and management of anaphylaxis. (NGC-0673)
   • Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis. J Allergy Clin Immunol 1998 Jun;101(6 Pt 2):S465-S528. [337 references]

   CURRENT NGC SUMMARY: The diagnosis and management of anaphylaxis: an updated practice parameter. (NGC-4211)

American Academy of Child and Adolescent Psychiatry

1. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. (NGC-0320)
   • Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):69S-84S. [161 references]

   CURRENT NGC SUMMARY: Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. (NGC-5512)

2. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. (NGC-0319)
   • Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):157S-177S. [120 references]

   CURRENT NGC SUMMARY: Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. (NGC-5511)

3. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. (NGC-0757)
   • American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998 Oct;37(10 Suppl):63S-83S. [231 references] PubMed

   CURRENT NGC SUMMARY: Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. (NGC-5924)

4. Practice parameters for the assessment and treatment of children and adolescents with substance use disorders. (NGC-0316)
   • Practice parameters for the assessment and treatment of children and adolescents with substance abuse disorders. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):140S-56S. [99 references]

   CURRENT NGC SUMMARY: Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. (NGC-4076)

5. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. (NGC-0323)
   • Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997 Oct;36(10 Suppl):85S-121S. [396 references]

   CURRENT NGC SUMMARY: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. (NGC-5912)

American Academy of Family Physicians

1. Summary of recommendations for clinical preventive services. (NGC-5335)
   • American Academy of Family Physicians (AAFP). Summary of recommendations for clinical preventive services. Revision 6.2. Leawood (KS): American Academy of Family Physicians (AAFP); 2006 Aug. 15 p.

   CURRENT NGC SUMMARY: Summary of recommendations for clinical preventive services. (NGC-6077)

2. Trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. (NGC-0440)
   • Trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. Am Fam Physician 1995 Nov 1;52(6):1763-5. [60 references]

   CURRENT NGC SUMMARY: Trial of labor after cesarean (TOLAC), formerly trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. (NGC-4454)

American Academy of Neurology

1. Assessment: prevention of post-lumbar puncture headaches. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (NGC-2041)
   • Evans RW, Armon C, Frohman EM, Goodin DS. Assessment: prevention of post-lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2000 Oct 10;55(7):909-14. [52 references]

   CURRENT NGC SUMMARY: (1) Assessment: prevention of post-lumbar puncture headaches. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (2) Addendum to assessment: prevention of post-lumbar puncture headaches. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. (NGC-4514)

American Academy of Ophthalmology

1. Age-related macular degeneration. Limited revision. (NGC-4573)
   • Retina Panel, Preferred Practice Patterns Committee. Age-related macular degeneration. San Francisco (CA): American Academy of Ophthalmology (AAO); 2005. 30 p. [107 references]

   CURRENT NGC SUMMARY: Age-related macular degeneration. Limited revision. (NGC-5358)

2. Amblyopia. (NGC-2772)
   • American Academy of Ophthalmology Pediatric Ophthalmology Panel. Amblyopia. San Francisco (CA): American Academy of Ophthalmology; 2002 Oct. 25 p. [113 references]

   CURRENT NGC SUMMARY: Amblyopia. (NGC-6055)

3. Bacterial keratitis. (NGC-1882)
   • American Academy of Ophthalmology (AAO). Bacterial keratitis. San Francisco (CA): American Academy of Ophthalmology (AAO); 2000 Sep. 25 p. [50 references]

   CURRENT NGC SUMMARY: Bacterial keratitis. (NGC-4574)

4. Blepharitis. (NGC-0738)
   • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Cornea/External Disease Panel. Blepharitis. San Francisco (CA): American Academy of Ophthalmology (AAO); 1998. 16 p. [27 references]

   CURRENT NGC SUMMARY: Blepharitis. (NGC-3279)

5. Cataract in the adult eye. (NGC-2313)
   • American Academy of Ophthalmology (AAO), Anterior Segment Panel. Cataract in the adult eye. San Francisco (CA): American Academy of Ophthalmology (AAO); 2001. 62 p. [301 references]

   CURRENT NGC SUMMARY: Cataract in the adult eye. (NGC-5357)

6. Comprehensive adult medical eye evaluation. (NGC-1884)
   • American Academy of Ophthalmology (AAO). Comprehensive adult medical eye evaluation. San Francisco (CA): American Academy of Ophthalmology (AAO); 2000 Sep. 18 p. (Preferred practice pattern). [78 references]

   CURRENT NGC SUMMARY: Comprehensive adult medical eye evaluation. (NGC-4575)

7. Conjunctivitis. (NGC-0894)
   • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Cornea/External Disease. Conjunctivitis. San Francisco (CA): American Academy of Ophthalmology (AAO) ; 1998. 24 p. [33 references]

   CURRENT NGC SUMMARY: Conjunctivitis. (NGC-3280)

8. Diabetic retinopathy. (NGC-0741)
   • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Retina Panel. Diabetic retinopathy. San Francisco (CA): American Academy of Ophthalmology (AAO) ; 1998. 32 p. [60 references]

   CURRENT NGC SUMMARY: Diabetic retinopathy. (NGC-3276)

9. Dry eye syndrome. (NGC-0739)
   • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Cornea/External Disease Panel. Dry eye syndrome. San Francisco (CA): American Academy of Ophthalmology (AAO); 1998. 18 p. [29 references]

   CURRENT NGC SUMMARY: Dry eye syndrome. (NGC-3281)

10. Esotropia and exotropia. (NGC-2770)
    • American Academy of Ophthalmology Pediatric Ophthalmology Panel. Esotropia and exotropia. San Francisco (CA): American Academy of Ophthalmology; 2002 Oct. 30 p. [118 references]

    CURRENT NGC SUMMARY: Esotropia and exotropia. (NGC-6056)

11. Management of posterior vitreous detachment, retinal breaks, and lattice degeneration. (NGC-0742)
    • American Academy of Ophthalmology (AAO), Preferred Practice Patterns Committee, Retina Panel. Management of posterior vitreous detachment, retinal breaks, and lattice degeneration. San Francisco (CA): American Academy of Ophthalmology (AAO) ; 1998. 24 p. [82 references]

    CURRENT NGC SUMMARY: Posterior vitreous detachment, retinal breaks, and lattice degeneration. (NGC-3277)

12. Pediatric eye evaluations. (NGC-2769)
    • American Academy of Ophthalmology Pediatric Ophthalmology Panel. Pediatric eye evaluations. San Francisco (CA): American Academy of Ophthalmology; 2002 Oct. 22 p. [36 references]

    CURRENT NGC SUMMARY: Pediatric eye evaluations: I. Screening. II. Comprehensive ophthalmic evaluation. (NGC-6057)

13. Primary angle closure. (NGC-1774)
    • American Academy of Ophthalmology (AAO). Primary angle closure. San Francisco (CA): American Academy of Ophthalmology (AAO); 2000. 20 p. [53 references]

    CURRENT NGC SUMMARY: Primary angle closure. (NGC-4576)

14. Primary open-angle glaucoma suspect. (NGC-2773)
    • American Academy of Ophthalmology Glaucoma Panel. Primary open-angle glaucoma suspect. San Francisco (CA): American Academy of Ophthalmology; 2002 Oct. 26 p. [80 references]

    CURRENT NGC SUMMARY: Primary open-angle glaucoma suspect. (NGC-4577)

15. Primary open-angle glaucoma. Limited revision. (NGC-3282)
    • American Academy of Ophthalmology Glaucoma Panel, Preferred Practice Patterns Committee. Primary open-angle glaucoma. Limited revision. San Francisco (CA): American Academy of Ophthalmology (AAO); 2003. 37 p. [148 references]

    CURRENT NGC SUMMARY: Primary open-angle glaucoma. (NGC-4578)

16. Refractive errors. (NGC-2771)
    • American Academy of Ophthalmology Refractive Errors Panel. Refractive errors. San Francisco (CA): American Academy of Ophthalmology; 2002. 53 p. [297 references]

    CURRENT NGC SUMMARY: Refractive errors and refractive surgery. (NGC-6058)

17. Vision rehabilitation for adults. (NGC-5356)
    • American Academy of Ophthalmology (AAO). Vision rehabilitation for adults. Preferred practice pattern. San Francisco (CA): American Academy of Ophthalmology (AAO); 2006. 31 p. [42 references]

    CURRENT NGC SUMMARY: Vision rehabilitation for adults. (NGC-6059)

American Academy of Orthopaedic Surgeons

1. Clinical guideline on knee pain. (NGC-0933)
   • American Academy of Orthopaedic Surgeons. Clinical guideline on knee pain. Rosemont (IL): American Academy of Orthopaedic Surgeons; 1996. 12 p. [102 references]

   CURRENT NGC SUMMARY: AAOS clinical guideline on osteoarthritis of the knee. (NGC-3069)

American Academy of Pediatric Dentistry

1. Clinical guideline on behavior guidance for the pediatric dental patient. (NGC-4438)
   • American Academy of Pediatric Dentistry (AAPD). Clinical guideline on behavior guidance for the pediatric dental patient. Chicago (IL): American Academy of Pediatric Dentistry (AAPD); 2005. 12 p. [57 references]

   CURRENT NGC SUMMARY: Guideline on behavior guidance for the pediatric dental patient. (NGC-5689)

2. Clinical guideline on management of acute dental trauma. (NGC-4033)
   • American Academy of Pediatric Dentistry. Clinical guideline on management of acute dental trauma. Chicago (IL): American Academy of Pediatric Dentistry; 2004. 8 p. [45 references]

   CURRENT NGC SUMMARY: Clinical guideline on management of acute dental trauma. (NGC-6230)

3. Clinical guideline on periodicity of examination, preventive dental services, anticipatory guidance, and oral treatment for children. (NGC-4025)
   • American Academy of Pediatric Dentistry. Clinical guideline on periodicity of examination, preventive dental services, anticipatory guidance, and oral treatment for children. Chicago (IL): American Academy of Pediatric Dentistry; 2003. 3 p. [24 references]

   CURRENT NGC SUMMARY: Clinical guideline on periodicity of examination, preventive dental services, anticipatory guidance, and oral treatment for infants, children, and adolescents. (NGC-6231)

4. Clinical guideline on the role of dental prophylaxis in pediatric dentistry. (NGC-4026)
   • American Academy of Pediatric Dentistry. Clinical guideline on the role of dental prophylaxis in pediatric dentistry. Chicago (IL): American Academy of Pediatric Dentistry; 2003. 3 p. [29 references]

   CURRENT NGC SUMMARY: Clinical guideline on the role of dental prophylaxis in pediatric dentistry. (NGC-6232)

American Academy of Pediatrics

1. (1) Distinguishing sudden infant death syndrome from child abuse fatalities; (2) Distinguishing sudden infant death syndrome from child abuse fatalities (Addendum). (NGC-1989)
   • American Academy of Pediatrics: Distinguishing sudden infant death syndrome from child abuse fatalities. Committee on Child Abuse and Neglect. Pediatrics 2001 Feb;107(2):437-41. [70 references]

   CURRENT NGC SUMMARY: Distinguishing sudden infant death syndrome from child abuse fatalities. (NGC-5073)

2. (1) Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. (2) Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: addendum. (NGC-1001)
   • American Academy of Pediatrics (AAP). Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 1992 Jun;89(6 Pt 1):1110-5. [44 references] PubMed
   
   
   
   • Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: addendum. Pediatrics 2002 Oct;110(4):836-8. [9 references] PubMed

   CURRENT NGC SUMMARY: Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update. (NGC-5437)

3. Breastfeeding and the use of human milk. (NGC-1039)
   • American Academy of Pediatrics. Breastfeeding and the use of human milk. American Academy of Pediatrics. Work Group on Breastfeeding. Pediatrics 1997 Dec;100(6):1035-9. [111 references] PubMed

   CURRENT NGC SUMMARY: Breastfeeding and the use of human milk. (NGC-4072)

4. Changing concepts of sudden infant death syndrome: implications for infant sleeping environment and sleep position. (NGC-1994)
   • American Academy of Pediatrics, Task Force on Infant Sleep Position and Sudden Infant Death Syndrome. Changing concepts of sudden infant death syndrome: implications for infant sleeping environment and sleep position. American Academy of Pediatrics. Task Force on Infant Sleep Position and Sudden Infant Death Syndrome. Pediatrics 2000 Mar;105(3 Pt 1):650-6. [120 references]

   CURRENT NGC SUMMARY: The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. (NGC-4580)

5. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. (NGC-0081)
   • American Academy of Pediatrics. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics 1994 Oct;94(4 Pt 1):558-65. [31 references] PubMed

   CURRENT NGC SUMMARY: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (NGC-3716)

6. Prevention and management of pain and stress in the neonate. (NGC-1823)
   • American Academy of Pediatrics. Prevention and management of pain and stress in the neonate. American Academy of Pediatrics. Committee on Fetus and Newborn. Committee on Drugs. Section on Anesthesiology. Section on Surgery. Canadian Paediatric Society. Fetus and Newborn Committee. Pediatrics 2000 Feb;105(2):454-61. [110 references]

   CURRENT NGC SUMMARY: Prevention and management of pain in the neonate: an update. (NGC-5353)

7. Prevention of influenza: recommendations for influenza immunization of children, 2006–2007. (NGC-5581)
   • American Academy of Pediatrics Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2006-2007. Pediatrics 2007 Apr;119(4):846-51. PubMed

   CURRENT NGC SUMMARY: Prevention of influenza: recommendations for influenza immunization of children, 2007-2008. (NGC-6412)

8. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. (NGC-0919)
   • American Academy of Pediatrics (AAP). Prevention of rotavirus disease: guidelines for use of rotavirus vaccine (RE9840). American Academy of Pediatrics. Pediatrics 1998 Dec;102(6):1483-91. [73 references] PubMed

   CURRENT NGC SUMMARY: Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. (NGC-5438)

9. Recommended childhood and adolescent immunization schedule: United States, 2006. (NGC-4760)
   • American Academy of Pediatrics, Committee on Infectious Disease. Recommended childhood and adolescent immunization schedule--United States, 2006. Pediatrics 2006 Jan;117(1):239-40. PubMed
   
   
   
   • Centers for Disease Control and Prevention (CDC). Recommended childhood and adolescent immunization schedule -- United States, 2006. MMWR Morb Mortal Wkly Rep 2006 Jan 6;54(51&52):Q1-4. [5 references]

   CURRENT NGC SUMMARY: Recommended immunization schedules for children and adolescents: United States, 2007. (NGC-5439)

10. Screening examination of premature infants for retinopathy of prematurity. (NGC-2841)
    • Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2001 Sep;108(3):809-11. [10 references] PubMed

    CURRENT NGC SUMMARY: Screening examination of premature infants for retinopathy of prematurity. (NGC-4846)

11. Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. (NGC-1003)
    • American Academy of Pediatrics (AAP). Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. Committee on Injury and Poison Prevention. Pediatrics 1996 May;97(5):761-3. [11 references] PubMed

    CURRENT NGC SUMMARY: Selecting and using the most appropriate car safety seats for growing children: guidelines for counseling parents. (NGC-2408)

American Academy of Sleep Medicine

1. Practice parameters for the indications for polysomnography and related procedures. (NGC-0902)
   • Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997 Jun;20(6):406-22. [12 references] PubMed

   CURRENT NGC SUMMARY: Practice parameters for the indications for polysomnography and related procedures: an update for 2005. (NGC-4545)

2. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. (NGC-3033)
   • Littner M, Kushida CA, Anderson WM, Bailey D, Berry RB, Davila DG, Hirshkowitz M, Kapen S, Kramer M, Loube D, Wise M, Johnson SF. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 2003 May;26(3):337-41. [3 references] PubMed

   CURRENT NGC SUMMARY: Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. (NGC-5607)

3. Practice parameters for the treatment of narcolepsy: an update for 2000. (NGC-2159)
   • Littner M, Johnson SF, McCall WV, Anderson WM, Davila D, Hartse SK, Kushida CA, Wise MS, Hirshkowitz M, Woodson BT. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep 2001 Jun 15;24(4):451-66. [58 references] PubMed

   CURRENT NGC SUMMARY: Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. (NGC-6234)

4. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. (NGC-0900)
   • American Sleep Disorders Association. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep - Europe 1995 Jul;18(6):511-3. [3 references] PubMed

   CURRENT NGC SUMMARY: Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. (NGC-4852)

5. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. (NGC-2407)
   • Standards of Practice Committee. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea. Sleep 2002;25(2):143-7. [29 references]

   CURRENT NGC SUMMARY: Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. (NGC-6313)

6. Practice parameters for the use of polysomnography in the evaluation of insomnia. (NGC-0898)
   • American Sleep Disorders Association. Practice parameters for the use of polysomnography in the evaluation of insomnia. Sleep - Europe 1995 Jan;18(1):55-7. [2 references] PubMed

   CURRENT NGC SUMMARY: Practice parameters for using polysomnography to evaluate insomnia: an update. (NGC-3292)

American Association for Respiratory Care

1. Application of continuous positive airway pressure to neonates via nasal prongs or nasopharyngeal tube. (NGC-0362)
   • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Application of continuous positive airway pressure to neonates via nasal prongs or nasopharyngeal tube. Respir Care 1994 Aug;39(8):817-23. [64 references]

   CURRENT NGC SUMMARY: Application of continuous positive airway pressure to neonates via nasal prongs, nasopharyngeal tube, or nasal mask — 2004 revision & update. (NGC-4085)

2. Bland aerosol administration. (NGC-0359)
   • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Bland aerosol administration. Respir Care 1993 Nov;38(11):1196-200. [20 references]

   CURRENT NGC SUMMARY: Bland aerosol administration: 2003 revision and update. (NGC-2978)

3. Capnography/capnometry during mechanical ventilation. (NGC-0378)
   • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Capnography/capnometry during mechanical ventilation. Respir Care 1995 Dec;40(12):1321-4. [41 references]

   CURRENT NGC SUMMARY: Capnography/capnometry during mechanical ventilation: 2003 revision and update. (NGC-2980)

4. Fiberoptic bronchoscopy assisting. (NGC-0360)
   • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Fiberoptic bronchoscopy assisting. Respir Care 1993 Dec;38(12):1173-8. [33 references]

   CURRENT NGC SUMMARY: Bronchoscopy assisting—2007 revision & update. (NGC-5573)

5. Intermittent positive pressure breathing. (NGC-0361)
   • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Intermittent positive pressure breathing. Respir Care 1993 Dec;38(12):1189-95. [66 references]

   CURRENT NGC SUMMARY: Intermittent positive pressure breathing: 2003 revision and update. (NGC-2979)

6. Metabolic measurement using indirect calorimetry during mechanical ventilation. (NGC-0368)
   • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Metabolic measurement using indirect calorimetry during mechanical ventilation. Respir Care 1994 Dec;39(12):1170-5. [57 references]

   CURRENT NGC SUMMARY: Metabolic measurement using indirect calorimetry during mechanical ventilation — 2004 revision & update. (NGC-4084)

7. Nasotracheal suctioning (NGC-0341)
   • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Nasotracheal suctioning. Respir Care 1992 Aug;37(8):898-901. [36 references]

   CURRENT NGC SUMMARY: Nasotracheal suctioning — 2004 revision & update. (NGC-4083)

8. Removal of the endotracheal tube. (NGC-0994)
   • American Association for Respiratory Care (AARC). Removal of the endotracheal tube. Respir Care 1999 Jan;44(1):85-90. [78 references]

   CURRENT NGC SUMMARY: Removal of the endotracheal tube—2007 revision & update. (NGC-5574)

9. Resuscitation in acute care hospitals. (NGC-0358)
   • American Association for Respirator Care (AARC). AARC clinical practice guideline. Resuscitation in acute care hospitals. Respir Care 1993 Dec;38(12):1179-88. [129 references]

   CURRENT NGC SUMMARY: Resuscitation and defibrillation in the health care setting — 2004 revision & update. (NGC-4081)

10. Transcutaneous blood gas monitoring for neonatal & pediatric patients. (NGC-0369)
    • American Association for Respiratory Care (AARC). AARC clinical practice guideline. Transcutaneous blood gas monitoring for neonatal & pediatric patients. Respir Care 1994 Dec;39(12):1176-9. [25 references]

    CURRENT NGC SUMMARY: Transcutaneous blood gas monitoring for neonatal & pediatric patients — 2004 revision & update. (NGC-4082)

American Association for the Study of Liver Diseases

1. Chronic hepatitis B. (NGC-3589)
   • Lok AS, McMahon BJ. Chronic hepatitis B. Alexandria (VA): American Association for the Study of Liver Diseases; 2004. 25 p. [234 references]

   CURRENT NGC SUMMARY: (1) Chronic hepatitis B. (2) Corrections to AASLD guidelines on chronic hepatitis B. (NGC-5652)

2. Liver transplantation. (NGC-2675)
   • Carithers RL Jr. Liver transplantation. American Association for the Study of Liver Diseases. Liver Transpl 2000 Jan;6(1):122-35. [141 references] PubMed

   CURRENT NGC SUMMARY: AASLD practice guidelines: evaluation of the patient for liver transplantation. (NGC-4333)

3. Management of adult patients with ascites caused by cirrhosis. (NGC-2676)
   • Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998 Jan;27(1):264-72. [78 references] PubMed

   CURRENT NGC SUMMARY: Management of adult patients with ascites due to cirrhosis. (NGC-3590)

American Association of Clinical Endocrinologists

1. AACE clinical practice guidelines for growth hormone use in adults and children. (NGC-0455)
   • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for growth hormone use in adults and children. Endocr Pract 1998 May-Jun;4(3):165-73. [12 references]
   
   
   
   • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for growth hormone use in adults and children. Jacksonville (FL): AACE; 1998. 17 p. [12 references]

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update. (NGC-2952)

2. AACE clinical practice guidelines for the evaluation and treatment of male sexual dysfunction. (NGC-0554)
   • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology. AACE clinical practice guidelines for the evaluation and treatment of male sexual dysfunction. Endocr Pract 1998 Jul-Aug;4(4):219-35. [69 references]

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update. (NGC-2951)

3. AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. (NGC-0457)
   • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. Jacksonville (FL): AACE; 1996. 26 p. (AACE clinical guidelines; no. 1996). [33 references]
   
   
   
   • American Association of Clinical Endocrinologists (AACE). AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. Endocr Pract 1996 Mar-Apr;2(2):155-71. [33 references]

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. (NGC-3185)

4. AACE medical guidelines for clinical practice for management of menopause. (NGC-1364)
   • American Association of Clinical Endocrinologists. AACE medical guidelines for clinical practice for management of menopause. 1999 Nov-Dec. 12 p. [62 references]

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. (NGC-5039)

5. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management--2002 update. (NGC-2398)
   • American Association of Clinical Endocrinologists, American College of Endocrinology. Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management--2002 update. Endocr Pract 2002 Jan-Feb;8(Suppl 1):40-82. [96 references]

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Screening and diagnosis. (NGC-5851)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Prevention of type 2 diabetes mellitus. (NGC-5852)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Glycemic management. (NGC-5853)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Hypertension management. (NGC-5854)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Lipid management. (NGC-5855)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Nutrition and diabetes. (NGC-5856)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Microvascular complications. (NGC-5857)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Diabetes and pregnancy. (NGC-5858)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Diabetes management in the hospital setting. (NGC-5859)

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Patient safety in diabetes care. (NGC-5860)

American Cancer Society

1. ACS guidelines for breast cancer screening: update 2003. (NGC-2971)
   • Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP 3rd, Foster RS Jr, Hendrick E, Eyre HJ, Sener S. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003 May-Jun;53(3):141-69. [184 references] PubMed

   CURRENT NGC SUMMARY: (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). (NGC-6083)

2. ACS prostate cancer screening guideline: update 1997. (NGC-0923)
   • von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N. American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin 1997 Sep-Oct;47(5):261-4. PubMed

   CURRENT NGC SUMMARY: Recommendations from the American Cancer Society Workshop on Early Prostate Cancer Detection, May 4-6, 2000 and ACS guideline on testing for early prostate cancer detection: update 2001. In: American Cancer Society guidelines for the early detection of cancer. (NGC-1973)

3. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. (NGC-2757)
   • Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams A, Gansler T, Thun M. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2002 Mar-Apr;52(2):92-119. [86 references] PubMed

   CURRENT NGC SUMMARY: American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. (NGC-6082)

American College of Cardiology Foundation

1. (1) ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). (2) ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. (NGC-4880)
   • American College of Cardiology Foundation (ACCF), American Heart Association (AHA). ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to Update the 1996 Guidelines). Bethesda (MD): American College of Cardiology Foundation; 2002. 58 p. [390 references]
   
   
   
   • Fleisher LA, Beckman JA, Freeman WK, Brown KA, Froeclich JB, Calkins H, Kasper EK, Chaikof E, Kersten JR, Fleischmann KE, Riegel B. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation on noncardiac surgery: focused update on perioperative beta-blocker therapy. A report of the American College of Cardiology/American Heart Association Task Force on Practice [trunc]. J Am Coll Cardiol 2006;47:1-12. [25 references]

   CURRENT NGC SUMMARY: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. (NGC-5963)

2. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). (NGC-2416)
   • American College of Cardiology Foundation, American Heart Association. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Bethesda (MD): American College of Cardiology Foundation (ACCF); 2002 Mar. 95 p. [552 references]

   CURRENT NGC SUMMARY: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-Elevation myocardial infarction. (NGC-5906)

3. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). (NGC-1347)
   • American College of Cardiology, American Heart Association, Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gott JP, Herrmann HC, Marlow RA, Nugent WC, O'Connor GT, Orszulak TA, Rieselbach RE, Winters WL, Yusuf S, Gibbons RJ, Alpert JS, Eagle KA, Garson A Jr, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA Guidelines for coronary artery bypass graft surgery. J Am Coll Cardiol 1999 Oct;34(4):1262-347. [753 references] PubMed

   CURRENT NGC SUMMARY: ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). (NGC-3768)

4. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). (NGC-0032)
   • Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD, et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Committee on Clinical Application of Echocardiography. Circulation 1997 Mar 18;95(6):1686-744. [514 references]

   CURRENT NGC SUMMARY: ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography). (NGC-3138)

5. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). (NGC-2340)
   • Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Bethesda (MD): American College of Cardiology Foundation (ACCF); 2001 Sep. 56 p. [573 references]

   CURRENT NGC SUMMARY: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). (NGC-4463)

6. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 guidelines for the Management of Acute Myocardial Infarction). (NGC-3734)
   • Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the Am Coll of Cardiol/Am Heart Assoc Task Force on Practice Guidelines (Committee to revise the 1999 guidelines). Bethesda (MD): American College of Cardiology, American Heart Association; 2004. 211 p. [1398 references]

   CURRENT NGC SUMMARY: (1) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 guidelines for the Management of Acute Myocardial Infarction). (2) 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on (NGC-6289)

7. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). (NGC-2194)
   • American College of Cardiology, American Heart Association, European Society of of Cardiology. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 2001 Oct;38:1266i-lxx. [580 references]
   
   
   
   • Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the ESC Committee for Practice Guidelines and Policy [trunc]. Eur Heart J 2001 Oct;22(20):1852-923. [580 references] PubMed

   CURRENT NGC SUMMARY: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). (NGC-5176)

8. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (NGC-2665)
   • ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. Bethesda (MD): American College of Cardiology Foundation; 2002. 48 p. [447 references]

   CURRENT NGC SUMMARY: ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). (NGC-6498)

9. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 guidelines for percutaneous coronary intervention). (NGC-4670)
   • Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Assoc Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 guidelines for PCI). Bethesda (MD): American College of Cardiology Foundation (ACCF); 2005. 122 p. [926 references]

   CURRENT NGC SUMMARY: (1) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 guidelines for percutaneous coronary intervention). (2) 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (NGC-6290)

10. Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Radionuclide Imaging). (NGC-0031)
    • Guidelines for the clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging). J Nucl Cardiol 1995 Mar;2(2 Pt 1):172-92. [274 references]
    
    
    
    • Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, O'Rourke RA, Parisi AF, Verani MS. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging). J Am Coll Cardiol 1995 Feb;25(2):521-47. [274 references] PubMed
    
    
    
    • Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ, Orourke RA, Parisi AF, Verani MS, Cheitlin MD, et al. Guidelines for clinical use of cardiac radionuclide imaging - a report of the American Heart Association American College of Cardiology task force on assessment of diagnostic and therapeutic cardiovascular procedures, committee on radionuclide imaging. Circulation 1995 Feb 15;91(4):1278-303. [274 references]

    CURRENT NGC SUMMARY: ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). (NGC-3137)

11. Management of patients with valvular heart disease. (NGC-1024)
    • American College of Cardiology (ACC), American Heart Association (AHA), Task Force on Practice Guidelines, (Committee on Management of Patients with Valvular Heart Disease). ACC/AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998 Nov;32(5):1486-588. [737 references] PubMed

    CURRENT NGC SUMMARY: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). (NGC-5067)

American College of Chest Physicians

1. Antithrombotic agents in coronary artery disease. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1955)
   • Cairns JA, Theroux P, Lewis HD Jr, Ezekowitz M, Meade TW. Antithrombotic agents in coronary artery disease. Chest 2001 Jan;119(1 Suppl):228S-252S. [154 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3883)

2. Antithrombotic and thrombolytic therapy for ischemic stroke. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1959)
   • Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001 Jan;119(1 Suppl):300S-320S. [160 references] PubMed

   CURRENT NGC SUMMARY: Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3882)

3. Antithrombotic therapy for venous thromboembolic disease. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1951)
   • Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 2001 Jan;119(1 Suppl):176S-193S. [263 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3879)

4. Antithrombotic therapy in atrial fibrillation. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1952)
   • Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001 Jan;119(1 Suppl):194S-206S. [103 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3880)

5. Antithrombotic therapy in children. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1961)
   • Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 2001 Jan;119(1 Suppl):344S-370S. [350 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3889)

6. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1960)
   • Popma JJ, Ohman EM, Weitz J, Lincoff AM, Harrington RA, Berger P. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest 2001 Jan;119(1 Suppl):321S-336S. [134 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3885)

7. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1954)
   • Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001 Jan;119(1 Suppl):220S-227S. [58 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy in valvular heart disease -- native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3881)

8. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1957)
   • Stein PD, Dalen JE, Goldman S, Theroux P. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 2001 Jan;119(1 Suppl):278S-282S. [42 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3886)

9. Antithrombotic therapy in peripheral arterial occlusive disease. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1958)
   • Jackson MR, Clagett GP. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 2001 Jan;119(1 Suppl):283S-299S. [207 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3887)

10. Antithrombotic therapy in valvular heart disease. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1953)
    • Salem DN, Daudelin HD, Levine HJ, Pauker SG, Eckman MH, Riff J. Antithrombotic therapy in valvular heart disease. Chest 2001 Jan;119(1 Suppl):207S-219S. [151 references]

    CURRENT NGC SUMMARY: Antithrombotic therapy in valvular heart disease -- native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3881)

11. Chemotherapeutic management of stage IV non-small cell lung cancer. (NGC-2875)
    • Socinski MA, Morris DE, Masters GA, Lilenbaum R. Chemotherapeutic management of stage IV non-small cell lung cancer. Chest 2003 Jan;123(1 Suppl):226S-43S. [92 references] PubMed

    CURRENT NGC SUMMARY: Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5937)

12. Diagnosis of lung cancer: the guidelines. (NGC-2867)
    • Rivera MP, Detterbeck F, Mehta AC. Diagnosis of lung cancer: the guidelines. Chest 2003 Jan;123(1 Suppl):129S-36S. [35 references] PubMed

    CURRENT NGC SUMMARY: Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5930)

13. End-of-life care in patients with lung cancer. (NGC-2880)
    • Griffin JP, Nelson JE, Koch KA, Niell HB, Ackerman TF, Thompson M, Cole FH Jr. End-of-life care in patients with lung cancer. Chest 2003 Jan;123(1 Suppl):312S-31S. [152 references] PubMed

    CURRENT NGC SUMMARY: Palliative care consultation, quality-of-life measurements, and bereavement for end-of-life care in patients with lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5942)

14. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. (NGC-2878)
    • Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 2003 Jan;123(1 Suppl):272S-83S. [91 references] PubMed

    CURRENT NGC SUMMARY: Follow-up and surveillance of the lung cancer patient following curative-intent therapy: ACCP evidence-based clinical practice guideline. (2nd Edition) (NGC-5940)

15. Guidelines on treatment of stage IIIB non-small cell lung cancer. (NGC-2874)
    • Jett JR, Scott WJ, Rivera MP, Sause WT. Guidelines on treatment of stage IIIB non-small cell lung cancer. Chest 2003 Jan;123(1 Suppl):221S-5S. [25 references] PubMed

    CURRENT NGC SUMMARY: Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5936)

16. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. (NGC-2865)
    • Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003 Jan;123(1 Suppl):97S-104S. [54 references] PubMed

    CURRENT NGC SUMMARY: Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines. (2nd Edition) (NGC-5928)

17. Intravenous thrombolysis in acute myocardial infarctions. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1956)
    • Ohman EM, Harrington RA, Cannon CP, Agnelli G, Cairns JA, Kennedy JW. Intravenous thrombolysis in acute myocardial infarction. Chest 2001 Jan;119(1 Suppl):253S-277S. [188 references]

    CURRENT NGC SUMMARY: Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3884)

18. Lung cancer prevention: the guidelines. (NGC-2862)
    • Dragnev KH, Stover D, Dmitrovsky E. Lung cancer prevention: the guidelines. Chest 2003 Jan;123(1 Suppl):60S-71S. [81 references] PubMed

    CURRENT NGC SUMMARY: Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5925)

19. Lung cancer. Invasive staging: the guidelines. (NGC-2869)
    • Detterbeck FC, DeCamp MM Jr, Kohman LJ, Silvestri GA. Lung cancer. Invasive staging: the guidelines. Chest 2003 Jan;123(1 Suppl):167S-75S. [29 references] PubMed

    CURRENT NGC SUMMARY: Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5932)

20. Lung cancer. Palliative care. (NGC-2879)
    • Kvale PA, Simoff M, Prakash UB. Lung cancer. Palliative care. Chest 2003 Jan;123(1 Suppl):284S-311S. [216 references] PubMed

    CURRENT NGC SUMMARY: Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5941)

21. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. (NGC-3737)
    • Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004 Jul;126(1 Suppl):35S-62S. [191 references] PubMed

    CURRENT NGC SUMMARY: (1) Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. (2) 2007 addendum. (NGC-5762)

22. Presentations of lung cancer with special treatment considerations. (NGC-2876)
    • Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS. Presentations of lung cancer with special treatment considerations. Chest 2003 Jan;123(1 Suppl):244S-58S. [56 references] PubMed

    CURRENT NGC SUMMARY: Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5938)

23. Prevention of venous thromboembolism. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1950)
    • Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB. Prevention of venous thromboembolism. Chest 2001 Jan;119(1 Suppl):132S-175S. [630 references] PubMed

    CURRENT NGC SUMMARY: Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3878)

24. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. (NGC-1228)
    • Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. Chest 1997 Nov 5;112(5):1363-96. [185 references] PubMed

    CURRENT NGC SUMMARY: Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. (NGC-5669)

25. Screening for lung cancer: the guidelines. (NGC-2863)
    • Bach PB, Niewoehner DE, Black WC, American College of Chest Physicians. Screening for lung cancer: the guidelines. Chest 2003 Jan;123(1 Suppl):83S-8S. [19 references] PubMed

    CURRENT NGC SUMMARY: Screening for lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5926)

26. Small cell lung cancer. (NGC-2877)
    • Simon GR, Wagner H. Small cell lung cancer. Chest 2003 Jan;123(1 Suppl):259S-71S. [103 references] PubMed

    CURRENT NGC SUMMARY: Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5939)

27. The noninvasive staging of non-small cell lung cancer: the guidelines. (NGC-2868)
    • Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003 Jan;123(1 Suppl):147S-56S. [70 references] PubMed

    CURRENT NGC SUMMARY: The noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines. (2nd Edition) (NGC-5931)

28. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. (NGC-2866)
    • Beckles MA, Spiro SG, Colice GL, Rudd RM. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003 Jan;123(1 Suppl):105S-14S. [69 references] PubMed

    CURRENT NGC SUMMARY: The physiologic evaluation of patients with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines. (2nd Edition) (NGC-5929)

29. The solitary pulmonary nodule. (NGC-2864)
    • Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD. The solitary pulmonary nodule. Chest 2003 Jan;123(1 Suppl):89S-96S. [55 references] PubMed

    CURRENT NGC SUMMARY: Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5927)

30. Treatment of early stage non-small cell lung cancer. (NGC-2870)
    • Mathur PN, Edell E, Sutedja T, Vergnon JM. Treatment of early stage non-small cell lung cancer. Chest 2003 Jan;123(1 Suppl):176S-80S. [36 references] PubMed

    CURRENT NGC SUMMARY: Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5933)

31. Treatment of stage I non-small cell lung carcinoma. (NGC-2871)
    • Smythe WR. Treatment of stage I non-small cell lung carcinoma. Chest 2003 Jan;123(1 Suppl):181S-7S. [48 references] PubMed

    CURRENT NGC SUMMARY: Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5934)

32. Treatment of stage II non-small cell lung cancer. (NGC-2872)
    • Scott WJ, Howington J, Movsas B. Treatment of stage II non-small cell lung cancer. Chest 2003 Jan;123(1 Suppl):188S-201S. [52 references] PubMed

    CURRENT NGC SUMMARY: Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5934)

33. Treatment of stage IIIA non-small cell lung cancer. (NGC-2873)
    • Robinson LA, Wagner H Jr, Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest 2003 Jan;123(1 Suppl):202S-20S. [109 references] PubMed

    CURRENT NGC SUMMARY: Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines. (2nd Edition) (NGC-5935)

34. Use of antithrombotic agents during pregnancy. In: Sixth ACCP Consensus Conference on Antithrombotic Therapy. (NGC-1949)
    • Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001 Jan;119(1 Suppl):122S-131S. [80 references]

    CURRENT NGC SUMMARY: Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (NGC-3888)

American College of Emergency Physicians

1. Clinical policy: critical issues in the evaluation and management of patients presenting with syncope. (NGC-2525)
   • American College of Emergency Physicians (ACEP). Clinical policy: critical issues in the evaluation and management of patients presenting with syncope. Ann Emerg Med 2001 Jun;37(6):771-6. [27 references] PubMed

   CURRENT NGC SUMMARY: Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. (NGC-5584)

American College of Foot and Ankle Surgeons

1. Diabetic foot disorders: a clinical practice guideline. (NGC-2118)
   • Frykberg RG, Armstrong DG, Giurini J, Edwards A, Kravette M, Kravitz S, Ross C, Stavosky J, Stuck R, Vanore J. Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg 2000;39(5 Suppl):S1-60. [248 references] PubMed

   CURRENT NGC SUMMARY: Diabetic foot disorders: a clinical practice guideline. (NGC-5270)

American College of Obstetricians and Gynecologists

1. AACE clinical practice guidelines for the diagnosis and management of thyroid nodules. (NGC-0050)
   • American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE). AACE clinical practice guidelines for the diagnosis and management of thyroid nodules. Jacksonville (FL): AACE; 1996. 16 p. (AACE clinical guidelines; no. 1996). [16 references]

   CURRENT NGC SUMMARY: American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. (NGC-4869)

2. Antibiotic prophylaxis for gynecologic procedures. (NGC-3111)
   • American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Jan. 9 p. (ACOG practice bulletin; no. 23). [38 references]

   CURRENT NGC SUMMARY: Antibiotic prophylaxis for gynecologic procedures. (NGC-5696)

3. Emergency oral contraception. (NGC-3113)
   • American College of Obstetricians and Gynecologists (ACOG). Emergency oral contraception. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Mar. 8 p. (ACOG practice bulletin; no. 25). [48 references]

   CURRENT NGC SUMMARY: Emergency contraception. (NGC-4882)

4. Management of herpes in pregnancy. (NGC-3096)
   • American College of Obstetricians and Gynecologists (ACOG). Management of herpes in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1999 Oct. 10 p. (ACOG practice bulletin; no. 8). [50 references]

   CURRENT NGC SUMMARY: Management of herpes in pregnancy. (NGC-5948)

5. Management of postterm pregnancy. (NGC-0392)
   • American College of Obstetricians and Gynecologists (ACOG). Management of postterm pregnancy. Washington (DC): American College of Obstetricians and Gynecologists; 1997 Oct. 6 p. (ACOG practice patterns; no. 6). [21 references]

   CURRENT NGC SUMMARY: Management of postterm pregnancy. (NGC-5697)

6. Medical management of abortion. (NGC-3114)
   • American College of Obstetricians and Gynecologists (ACOG). Medical management of abortion. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Apr. 13 p. (ACOG practice bulletin; no. 26). [89 references]

   CURRENT NGC SUMMARY: Medical management of abortion. (NGC-4875)

7. Medical management of tubal pregnancy. (NGC-3091)
   • American College of Obstetricians and Gynecologists (ACOG). Medical management of tubal pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1998 Dec. 7 p. (ACOG practice bulletin; no. 3). [31 references]

   CURRENT NGC SUMMARY: Medical management of ectopic pregnancy. (NGC-6533)

8. Pelvic organ prolapse. (NGC-5699)
   • American College of Obstetricians and Gynecologists (ACOG). Pelvic organ prolapse. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2007 Feb. 13 p. (ACOG practice bulletin; no. 79). [82 references]

   CURRENT NGC SUMMARY: Pelvic organ prolapse. (NGC-6532)

9. Premature rupture of membranes. (NGC-3090)
   • American College of Obstetricians and Gynecologists (ACOG). Premature rupture of membranes. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1998 Jun. 10 p. (ACOG practice bulletin; no. 1). [70 references]

   CURRENT NGC SUMMARY: Premature rupture of membranes. (NGC-5695)

10. Prevention of deep vein thrombosis and pulmonary embolism. (NGC-3109)
    • American College of Obstetricians and Gynecologists (ACOG). Prevention of deep vein thrombosis and pulmonary embolism. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Oct. 10 p. (ACOG practice bulletin; no. 21). [65 references]

    CURRENT NGC SUMMARY: Prevention of deep vein thrombosis and pulmonary embolism. (NGC-5947)

11. Prophylactic oophorectomy. (NGC-3095)
    • American College of Obstetricians and Gynecologists (ACOG). Prophylactic oophorectomy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 1999 Sep. 7 p. (ACOG practice bulletin; no. 7). [33 references]

    CURRENT NGC SUMMARY: Elective and risk-reducing salpingo-oophorectomy. (NGC-6287)

12. The use of hormonal contraception in women with coexisting medical conditions. (NGC-3106)
    • American College of Obstetricians and Gynecologists (ACOG). The use of hormonal contraception in women with coexisting medical conditions. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2000 Jul. 14 p. (ACOG practice bulletin; no. 18). [92 references]

    CURRENT NGC SUMMARY: Use of hormonal contraception in women with coexisting medical conditions. (NGC-5704)

American College of Occupational and Environmental Medicine

1. Elbow complaints. (NGC-4753)
   • Elbow complaints. Elk Grove Village (IL): American College of Occupational and Environmental Medicine (ACOEM); 2004. 25 p. [28 references]

   CURRENT NGC SUMMARY: Elbow disorders. (NGC-5681)

2. Low back complaints. (NGC-4755)
   • Low back complaints. Elk Grove Village (IL): American College of Occupational and Environmental Medicine (ACOEM); 2004. 41 p. [154 references]

   CURRENT NGC SUMMARY: Low back disorders. (NGC-6456)

American College of Preventive Medicine

1. Childhood immunizations. (NGC-0560)
   • Patel R, Kinsinger L. Childhood immunizations: American College of Preventive Medicine practice policy. Am J Prev Med 1997 Mar-Apr;13(2):74-7. [21 references] PubMed

   CURRENT NGC SUMMARY: Childhood immunizations. (NGC-3164)

2. Screening for prostate cancer in American men. (NGC-0555)
   • Ferrini R, Woolf SH. American College of Preventive Medicine Practice Policy: screening for prostate cancer in American men. Am J Prev Med 1998 Jul;15(1):81-4. [43 references]

   CURRENT NGC SUMMARY: Screening for prostate cancer in U.S. men: ACPM position statement on preventive practice. (NGC-6394)

American College of Radiology

1. ACR Appropriateness Criteria™ for acute hand and wrist trauma. (NGC-2488)
   • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Acute hand and wrist trauma. Reston (VA): American College of Radiology (ACR); 2001. 7 p. (ACR appropriateness criteria). [27 references]

   CURRENT NGC SUMMARY: Acute hand and wrist trauma. (NGC-4607)

2. ACR Appropriateness Criteria™ for acute pancreatitis. (NGC-2483)
   • American College of Radiology (ACR), Expert Panel on Gastrointestinal Imaging. Acute pancreatitis. Reston (VA): American College of Radiology (ACR); 2001. 5 p. (ACR appropriateness criteria). [29 references]

   CURRENT NGC SUMMARY: Acute pancreatitis. (NGC-5114)

3. ACR Appropriateness Criteria™ for acute trauma to the knee. (NGC-2487)
   • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Acute trauma to the knee. Reston (VA): American College of Radiology (ACR); 2001. 8 p. (ACR appropriateness criteria). [92 references]

   CURRENT NGC SUMMARY: Acute trauma to the knee. (NGC-4606)

4. ACR Appropriateness Criteria™ for imaging evaluation of patients with acute abdominal pain and fever. (NGC-2484)
   • American College of Radiology (ACR), Expert Panel on Gastrointestinal Imaging. Imaging evaluation of patients with acute abdominal pain and fever. Reston (VA): American College of Radiology (ACR); 2001. 4 p. (ACR appropriateness criteria). [28 references]

   CURRENT NGC SUMMARY: Acute abdominal pain and fever or suspected abdominal abscess. (NGC-5138)

5. ACR Appropriateness Criteria™ for imaging in acute pyelonephritis. (NGC-2491)
   • American College of Radiology (ACR), Expert Panel on Urologic Imaging. Imaging in acute pyelonephritis. Reston (VA): American College of Radiology (ACR); 2001. 4 p. (ACR appropriateness criteria). [17 references]

   CURRENT NGC SUMMARY: Acute pyelonephritis. (NGC-4609)

6. ACR Appropriateness Criteria™ for imaging recommendations for patients with dysphagia. (NGC-2485)
   • American College of Radiology (ACR), Expert Panel on Gastrointestinal Imaging. Imaging recommendations for patients with dysphagia. Reston (VA): American College of Radiology (ACR); 2001. 6 p. (ACR appropriateness criteria). [32 references]

   CURRENT NGC SUMMARY: Dysphagia. (NGC-4604)

7. ACR Appropriateness Criteria™ for radiologic investigation of causes of renal failure. (NGC-2497)
   • American College of Radiology (ACR), Expert Panel on Urologic Imaging. Radiologic investigation of causes of renal failure. Reston (VA): American College of Radiology (ACR); 2001. 8 p. (ACR appropriateness criteria). [51 references]

   CURRENT NGC SUMMARY: Renal failure. (NGC-4615)

8. ACR Appropriateness Criteria™ for radiologic investigation of patients with hematuria. (NGC-2493)
   • American College of Radiology (ACR), Expert Panel on Urologic Imaging. Radiologic investigation of patients with hematuria. Reston (VA): American College of Radiology (ACR); 2001. 5 p. (ACR appropriateness criteria). [22 references]

   CURRENT NGC SUMMARY: Hematuria. (NGC-4611)

9. ACR Appropriateness Criteria™ for recurrent lower urinary tract infections in women. (NGC-2490)
   • American College of Radiology (ACR), Expert Panel on Urologic Imaging. Recurrent lower urinary tract infections in women. Reston (VA): American College of Radiology (ACR); 2001. 6 p. (ACR appropriateness criteria). [30 references]

   CURRENT NGC SUMMARY: Recurrent lower urinary tract infections in women. (NGC-4608)

10. ACR Appropriateness Criteria® for anal cancer. (NGC-2779)
    • American College of Radiology (ACR), Expert Panel on Radiation Oncology-Rectal/Anal Cancer. Anal cancer. Reston (VA): American College of Radiology (ACR); 2002. 11 p. (ACR appropriateness criteria). [31 references]

    CURRENT NGC SUMMARY: Anal cancer. (NGC-6008)

11. ACR Appropriateness Criteria® for appropriate imaging work-up of palpable breast masses. (NGC-3858)
    • American College of Radiology (ACR), Expert Panel on Women's Imaging-Breast Work Group. Appropriate imaging work-up of palpable breast masses. Reston (VA): American College of Radiology (ACR); 2003. 4 p. (ACR appropriateness criteria). [28 references]

    CURRENT NGC SUMMARY: Palpable breast masses. (NGC-5560)

12. ACR Appropriateness Criteria® for congestive heart failure. (NGC-3861)
    • American College of Radiology (ACR), Expert Panel on Thoracic Imaging. Congestive heart failure. Reston (VA): American College of Radiology (ACR); 2003. 4 p. (ACR appropriateness criteria). [18 references]

    CURRENT NGC SUMMARY: Congestive heart failure. (NGC-5125)

13. ACR Appropriateness Criteria® for follow-up examinations for bone tumors, soft-tissue tumors, and suspected metastasis post therapy. (NGC-2782)
    • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Follow-up examinations for bone tumors, soft-tissue tumors, and suspected metastasis post therapy. Reston (VA): American College of Radiology (ACR); 2002. 10 p. (ACR appropriateness criteria). [32 references]

    CURRENT NGC SUMMARY: Follow-up of malignant or aggressive musculoskeletal tumors. (NGC-5117)

14. ACR Appropriateness Criteria® for imaging evaluation of the palpable abdominal mass. (NGC-2482)
    • American College of Radiology (ACR), Expert panel on Gastrointestinal Imaging. Imaging evaluation of the palpable abdominal mass. Reston (VA): American College of Radiology (ACR); 2001. 2 p. (ACR appropriateness criteria). [8 references]

    CURRENT NGC SUMMARY: Palpable abdominal mass. (NGC-5116)

15. ACR Appropriateness Criteria® for imaging work-up for stage I breast carcinoma. (NGC-2788)
    • American College of Radiology (ACR), Expert Panel on Women's Imaging-Breast Work Group. Imaging work-up for stage I breast carcinoma. Reston (VA): American College of Radiology (ACR); 2002. 4 p. (ACR appropriateness criteria). [28 references]

    CURRENT NGC SUMMARY: Stage 1 breast carcinoma. (NGC-5559)

16. ACR Appropriateness Criteria® for osteoporosis and bone mineral density. (NGC-2489)
    • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Osteoporosis and bone mineral density. Reston (VA): American College of Radiology (ACR); 2001. 17 p. (ACR appropriateness criteria). [49 references]

    CURRENT NGC SUMMARY: Osteoporosis and bone mineral density. (NGC-5990)

17. ACR Appropriateness Criteria® for suspected congenital heart disease in the adult. (NGC-2789)
    • American College of Radiology (ACR), Expert Panel on Cardiovascular Imaging. Suspected congenital heart disease in the adult. Reston (VA): American College of Radiology (ACR); 2002. 6 p. (ACR appropriateness criteria). [38 references]

    CURRENT NGC SUMMARY: Suspected congenital heart disease in the adult. (NGC-5988)

18. ACR Appropriateness Criteria™ for acute chest pain - suspected aortic dissection. (NGC-1605)
    • Gomes AS, Bettmann MA, Boxt LM, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Pagan-Marin H, Polak JF, Stanford W. Acute chest pain--suspected aortic dissection. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1-5. [28 references]

    CURRENT NGC SUMMARY: Acute chest pain - suspected aortic dissection. (NGC-4621)

19. ACR Appropriateness Criteria™ for acute chest pain--no ECG evidence of myocardial ischemia/infarction. (NGC-2480)
    • American College of Radiology (ACR), Expert Panel on Cardiovasular Imaging. Acute chest pain - no ECG evidence of myocardial ischemia/infarction. Reston (VA): American College of Radiology (ACR); 2001. 5 p. (ACR appropriateness criteria). [50 references]

    CURRENT NGC SUMMARY: Acute chest pain - no ECG or enzyme evidence of myocardial ischemia/infarction. (NGC-4770)

20. ACR Appropriateness Criteria™ for acute chest pain--suspected myocardial ischemia. (NGC-1606)
    • Stanford W, Bettmann MA, Boxt LM, Gomes AS, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Pagan-Marin H, Polak JF. Acute chest pain--suspected myocardial ischemia. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):7-13. [46 references]

    CURRENT NGC SUMMARY: Acute chest pain - suspected myocardial ischemia. (NGC-4622)

21. ACR Appropriateness Criteria™ for acute chest pain--suspected pulmonary embolism. (NGC-1607)
    • Bettmann MA, Boxt LM, Gomes AS, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Pagan-Marin H, Polak JF, Stanford W, Ashburn W. Acute chest pain--suspected pulmonary embolism. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):15-21. [55 references]

    CURRENT NGC SUMMARY: Acute chest pain—suspected pulmonary embolism. (NGC-5542)

22. ACR Appropriateness Criteria™ for acute low back pain--radiculopathy. (NGC-1667)
    • Anderson RE, Drayer BP, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Acute low back pain--radiculopathy. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):479-85. [15 references]

    CURRENT NGC SUMMARY: Low back pain. (NGC-4786)

23. ACR Appropriateness Criteria™ for acute respiratory illness in HIV-positive patients. (NGC-3859)
    • American College of Radiology (ACR), Expert Panel on Thoracic Imaging. Acute respiratory illness in HIV-positive patients. Reston (VA): American College of Radiology (ACR); 2003. 5 p. (ACR appropriateness criteria). [31 references]

    CURRENT NGC SUMMARY: Acute respiratory illness in HIV-positive patients. (NGC-4775)

24. ACR Appropriateness Criteria™ for ataxia. (NGC-1675)
    • Johnson BA, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Ataxia. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):573-8. [40 references]

    CURRENT NGC SUMMARY: Ataxia. (NGC-5547)

25. ACR Appropriateness Criteria™ for blunt chest trauma--suspected aortic injury. (NGC-1610)
    • Kelley MJ, Bettmann MA, Boxt LM, Gomes AS, Grollman J, Henkin RE, Higgins CB, Needleman L, Pagan-Marin H, Polak JF, Stanford W. Blunt chest trauma--suspected aortic injury. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):35-9. [29 references]

    CURRENT NGC SUMMARY: Blunt chest trauma - suspected aortic injury. (NGC-4623)

26. ACR Appropriateness Criteria™ for bone tumors. (NGC-1644)
    • Berquist TH, Dalinka MK, Alazraki N, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Bone tumors. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):261-4. [18 references]

    CURRENT NGC SUMMARY: Bone tumors. (NGC-4783)

27. ACR Appropriateness Criteria™ for cerebrovascular disease. (NGC-1663)
    • Masaryk T, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Cerebrovascular disease. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):415-35. [60 references]

    CURRENT NGC SUMMARY: Cerebrovascular disease. (NGC-5545)

28. ACR Appropriateness Criteria™ for chronic ankle pain. (NGC-2780)
    • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Chronic ankle pain. Reston (VA): American College of Radiology (ACR); 2002. 12 p. (ACR appropriateness criteria). [34 references]

    CURRENT NGC SUMMARY: Chronic ankle pain. (NGC-4617)

29. ACR Appropriateness Criteria™ for chronic chest pain--suspected cardiac origin. (NGC-1609)
    • Higgins CB, Bettmann MA, Boxt LM, Gomes AS, Grollman J, Henkin RE, Kelley MJ, Needleman L, Pagan-Marin H, Polak JF, Stanford W. Chronic chest pain--suspected cardiac origin. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):29-34. [23 references]

    CURRENT NGC SUMMARY: Chronic chest pain—suspected cardiac origin. (NGC-5543)

30. ACR Appropriateness Criteria™ for chronic elbow pain. (NGC-2486)
    • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Chronic elbow pain. Reston (VA): American College of Radiology (ACR); 2001. 5 p. (ACR appropriateness criteria). [29 references]

    CURRENT NGC SUMMARY: Chronic elbow pain. (NGC-4605)

31. ACR Appropriateness Criteria™ for chronic foot pain. (NGC-2781)
    • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Chronic foot pain. Reston (VA): American College of Radiology (ACR); 2002. 7 p. (ACR appropriateness criteria). [51 references]

    CURRENT NGC SUMMARY: Chronic foot pain. (NGC-4618)

32. ACR Appropriateness Criteria™ for chronic hip pain. (NGC-1661)
    • Berquist TH, Dalinka MK, Alazraki N, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Chronic hip pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):391-6.

    CURRENT NGC SUMMARY: ACR Appropriateness Criteria® for chronic hip pain. (NGC-3896)

33. ACR Appropriateness Criteria™ for chronic neck pain. (NGC-1655)
    • Daffner RH, Dalinka MK, Alazraki N, Berquist TH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Schweitzer ME, Haralson RH, McCabe JB. Chronic neck pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):345-56.

    CURRENT NGC SUMMARY: Chronic neck pain. (NGC-4629)

34. ACR Appropriateness Criteria™ for chronic wrist pain. (NGC-3895)
    • American College of Radiology (ACR), Expert Panel on Musculoskeletal Imaging. Chronic wrist pain. Reston (VA): American College of Radiology (ACR); 2003. 8 p. (ACR appropriateness criteria). [15 references]

    CURRENT NGC SUMMARY: Chronic wrist pain. (NGC-4619)

35. ACR Appropriateness Criteria™ for dementia. (NGC-1671)
    • Braffman B, Drayer BP, Anderson RE, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Dementia. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):525-33. [31 references]

    CURRENT NGC SUMMARY: Dementia and movement disorders. (NGC-6012)

36. ACR Appropriateness Criteria™ for diagnostic imaging in patients with claudication. (NGC-1614)
    • Bettmann MA, Boxt LM, Gomes AS, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Pagan-Marin H, Polak JF, Stanford W, Levin DC, Gardiner GA. Diagnostic imaging in patients with claudication. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):61-5. [44 references]

    CURRENT NGC SUMMARY: Claudication. (NGC-4624)

37. ACR Appropriateness Criteria™ for diagnostic imaging of avascular necrosis of the hip. (NGC-1642)
    • DeSmet AA, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Diagnostic imaging of avascular necrosis of the hip. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):247-54. [41 references]

    CURRENT NGC SUMMARY: Avascular necrosis of the hip. (NGC-4628)

38. ACR Appropriateness Criteria™ for epilepsy. (NGC-1665)
    • Tanenbaum L, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Masdeu JC. Epilepsy. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):459-70. [54 references]

    CURRENT NGC SUMMARY: Epilepsy. (NGC-5546)

39. ACR Appropriateness Criteria™ for evaluation of acute right lower quadrant pain. (NGC-1629)
    • Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. Evaluation of acute right lower quadrant pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):159-66. [35 references]

    CURRENT NGC SUMMARY: Right lower quadrant pain. (NGC-4780)

40. ACR Appropriateness Criteria™ for evaluation of left lower quadrant pain. (NGC-3894)
    • American College of Radiology (ACR), Expert Panel on Gastrointestinal Imaging. Evaluation of left lower quadrant pain. Reston (VA): American College of Radiology (ACR); 2003. 5 p. (ACR appropriateness criteria). [21 references]

    CURRENT NGC SUMMARY: Left lower quadrant pain. (NGC-4773)

41. ACR Appropriateness Criteria™ for evaluation of multiple gestations. (NGC-3864)
    • American College of Radiology (ACR), Expert Panel on Women's Imaging. Evaluation of multiple gestations. Reston (VA): American College of Radiology (ACR); 2001. 11 p. (ACR appropriateness criteria). [20 references]

    CURRENT NGC SUMMARY: Multiple gestations. (NGC-4777)

42. ACR Appropriateness Criteria™ for evaluation of patients with acute right upper quadrant pain. (NGC-1628)
    • Bree RL, Ralls PW, Balfe DM, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. Evaluation of patients with acute right upper quadrant pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):153-7. [13 references]

    CURRENT NGC SUMMARY: Right upper quadrant pain. (NGC-4781)

43. ACR Appropriateness Criteria™ for follow-up and retreatment of brain metastases. (NGC-1731)
    • Simpson JR, Mendenhall WM, Schupak KD, Larson D, Bloomer WD, Buckley JA, Gaspar LE, Gibbs FA, Lewin AA, Loeffler JS, Malcolm AW, Schneider JF, Shaw EG, Wharam MD Jr, Gutin PH, Rogers L, Leibel S. Follow-up and retreatment of brain metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1129-35. [32 references]

    CURRENT NGC SUMMARY: Follow-up and retreatment of brain metastases. (NGC-5554)

44. ACR Appropriateness Criteria™ for head trauma. (NGC-1670)
    • Davis PC, Drayer BP, Anderson RE, Braffman B, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Head trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):507-24. [44 references]

    CURRENT NGC SUMMARY: Head trauma. (NGC-5118)

45. ACR Appropriateness Criteria™ for hematemesis. (NGC-2783)
    • American College of Radiology (ACR), Expert Panel on Cardiovascular Imaging. Hematemesis. Reston (VA): American College of Radiology (ACR); 2002. 7 p. (ACR appropriateness criteria). [38 references]

    CURRENT NGC SUMMARY: Hematemesis. (NGC-5111)

46. ACR Appropriateness Criteria™ for imaging evaluation of suspected ankle fractures. (NGC-1640)
    • Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Imaging evaluation of suspected ankle fractures. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):239-41. [20 references]

    CURRENT NGC SUMMARY: Suspected ankle fractures. (NGC-4633)

47. ACR Appropriateness Criteria™ for imaging of blunt abdominal trauma. (NGC-1627)
    • Shuman WP, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Saini S, Greene FL, Laine LA, Lillemoe K, Berland L. Imaging of blunt abdominal trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):143-51. [77 references]

    CURRENT NGC SUMMARY: Blunt abdominal trauma. (NGC-4602)

48. ACR Appropriateness Criteria™ for imaging recommendations for patients with Crohn's disease. (NGC-2481)
    • American College of Radiology (ACR), Expert Panel on Gastrointestinal Imaging. Imaging recommendations for patients with Crohn's disease. Reston (VA): American College of Radiology (ACR); 2001. 11 p. (ACR appropriateness criteria). [32 references]

    CURRENT NGC SUMMARY: Crohn's disease. (NGC-4772)

49. ACR Appropriateness Criteria™ for imaging strategies in the initial evaluation of the jaundiced patient. (NGC-1625)
    • Balfe DM, Ralls PW, Bree RL, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K, Kidd R. Imaging strategies in the initial evaluation of the jaundiced patient. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):125-33. [27 references]

    CURRENT NGC SUMMARY: Jaundice. (NGC-4626)

50. ACR Appropriateness Criteria™ for liver lesion characterization. (NGC-2784)
    • American College of Radiology (ACR), Expert Panel on Gastrointestinal Imaging. Liver lesion characterization. Reston (VA): American College of Radiology (ACR); 2002. 8 p. (ACR appropriateness criteria). [29 references]

    CURRENT NGC SUMMARY: Liver lesion characterization. (NGC-5115)

51. ACR Appropriateness Criteria™ for metastatic bone disease. (NGC-1647)
    • el-Khoury GY, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Metastatic bone disease. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):283-93. [33 references]

    CURRENT NGC SUMMARY: Metastatic bone disease. (NGC-4630)

52. ACR Appropriateness Criteria™ for multiple brain metastases. (NGC-1730)
    • Shaw EG, Gaspar LE, Gibbs FA, Lewin AA, Wharam MD Jr, Larson D, Bloomer WD, Buckley JA, Loeffler JS, Malcolm AW, Mendenhall WM, Schneider JF, Schupak KD, Simpson JR, Gutin PH, Rogers L, Leibel S. Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1121-8. [27 references]

    CURRENT NGC SUMMARY: Multiple brain metastases. (NGC-5553)

53. ACR Appropriateness Criteria™ for myelopathy. (NGC-1669)
    • Seidenwurm D, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Tanenbaum L, Masdeu JC. Myelopathy. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):495-505. [31 references]

    CURRENT NGC SUMMARY: Myelopathy. (NGC-5119)

54. ACR Appropriateness Criteria™ for neuroendocrine imaging. (NGC-1674)
    • Seidenwurm D, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Hasso AN, Johnson BA, Masaryk T, Pomeranz SJ, Tanenbaum L, Masdeu JC. Neuroendocrine imaging. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):563-71. [36 references]

    CURRENT NGC SUMMARY: Neuroendocrine imaging. (NGC-5121)

55. ACR Appropriateness Criteria™ for non traumatic knee pain. (NGC-1651)
    • Pavlov H, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Haralson RH, McCabe JB, Sartoris D. Nontraumatic knee pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):311-20. [39 references]

    CURRENT NGC SUMMARY: Nontraumatic knee pain. (NGC-4631)

56. ACR Appropriateness Criteria™ for orbits, vision and visual loss. (NGC-1676)
    • Hasso AN, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Orbits, vision, and visual loss. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):579-87. [23 references]

    CURRENT NGC SUMMARY: Orbits, vision, and visual loss. (NGC-5122)

57. ACR Appropriateness Criteria™ for patient with suspected small bowel obstruction: imaging strategies. (NGC-1624)
    • DiSantis DJ, Ralls PW, Balfe DM, Bree RL, Glick SN, Levine MS, Megibow AJ, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. The patient with suspected small bowel obstruction: imaging strategies. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):121-4. [39 references]

    CURRENT NGC SUMMARY: Suspected small bowel obstruction. (NGC-4782)

58. ACR Appropriateness Criteria™ for pre-irradiation evaluation and management of brain metastasis. (NGC-1728)
    • Gaspar LE, Gutin PH, Rogers L, Schneider JF, Larson D, Bloomer WD, Buckley JA, Gibbs FA, Lewin AA, Loeffler JS, Malcolm AW, Mendenhall WM, Schupak KD, Shaw EG, Simpson JR, Wharam MD Jr, Leibel S. Pre-irradiation evaluation and management of brain metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1105-10. [25 references]

    CURRENT NGC SUMMARY: Pre-irradiation evaluation and management of brain metastases. (NGC-4635)

59. ACR Appropriateness Criteria™ for premature cervical dilatation. (NGC-1719)
    • Laing F, Mendelson E, Bohm-Velez M, Bree RL, Finberg H, Fishman EK, Hricak H, Sartoris D, Thurmond A, Goldstein S. Premature cervical dilatation. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun 1;215(Suppl):939-45. [24 references]

    CURRENT NGC SUMMARY: Premature cervical dilatation. (NGC-4636)

60. ACR Appropriateness Criteria™ for pulsatile abdominal mass. (NGC-1613)
    • Grollman J, Bettmann MA, Boxt LM, Gomes AS, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Pagan-Marin H, Polak JF, Stanford W. Pulsatile abdominal mass. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):55-9. [29 references]

    CURRENT NGC SUMMARY: Pulsatile abdominal mass. (NGC-4625)

61. ACR Appropriateness Criteria™ for recurrent symptoms following lower extremity angioplasty: claudication and threatened limb. (NGC-2787)
    • American College of Radiology (ACR), Expert Panel on Cardiovascular Imaging. Recurrent symptoms following lower extremity angioplasty: claudication and threatened limb. Reston (VA): American College of Radiology (ACR); 2002. 5 p. (ACR appropriateness criteria). [30 references]

    CURRENT NGC SUMMARY: Recurrent symptoms following lower extremity angioplasty. (NGC-4771)

62. ACR Appropriateness Criteria™ for recurrent symptoms following lower extremity arterial bypass surgery. (NGC-1619)
    • Hessel SJ, Levin DC, Bettmann MA, Gomes AS, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Polak JF, Stanford W, Wexler L, Abbott W, Port S. Recurrent symptoms following lower extremity arterial bypass surgery. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):89-93. [18 references]

    CURRENT NGC SUMMARY: Follow-up of lower extremity arterial bypass surgery. (NGC-4787)

63. ACR Appropriateness Criteria™ for routine admission and preoperative chest radiography. (NGC-3860)
    • American College of Radiology (ACR), Expert Panel on Thoracic Imaging. Routine admission and preoperative chest radiography. Reston (VA): American College of Radiology (ACR); 2000. 5 p. (ACR appropriateness criteria). [36 references]

    CURRENT NGC SUMMARY: Routine admission and preoperative chest radiography. (NGC-5128)

64. ACR Appropriateness Criteria™ for screening for colorectal cancer. (NGC-1639)
    • Glick SN, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Kidd R, Levine MS, Megibow AJ, Mezwa DG, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K. Screening for colorectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):231-7. [22 references] PubMed

    CURRENT NGC SUMMARY: Colorectal cancer screening. (NGC-5544)

65. ACR Appropriateness Criteria™ for shortness of breath--suspected cardiac origin. (NGC-1608)
    • Boxt LM, Bettmann MA, Gomes AS, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Needleman L, Pagan-Marin H, Polak JF, Stanford W, Wexler L. Shortness of breath--suspected cardiac origin. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):23-7. [26 references]

    CURRENT NGC SUMMARY: Shortness of breath--suspected cardiac origin. (NGC-5112)

66. ACR Appropriateness Criteria™ for shoulder trauma. (NGC-1649)
    • Newberg A, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Shoulder trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):299-302. [22 references]

    CURRENT NGC SUMMARY: Shoulder trauma. (NGC-4632)

67. ACR Appropriateness Criteria™ for sinusitis in the pediatric population. (NGC-1711)
    • McAlister WH, Parker BR, Kushner DC, Babcock DS, Cohen HL, Gelfand MJ, Hernandez RJ, Royal SA, Slovis TL, Smith WL, Strain JD, Strife JL, Kanda MB, Myer E, Decter RM, Moreland MS. Sinusitis in the pediatric population. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):811-18. [44 references]

    CURRENT NGC SUMMARY: Sinusitis--child. (NGC-5124)

68. ACR Appropriateness Criteria™ for soft tissue masses. (NGC-1643)
    • Berquist TH, Dalinka MK, Alazraki N, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Soft tissue masses. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):255-9. [22 references]

    CURRENT NGC SUMMARY: Soft tissue masses. (NGC-4784)

69. ACR Appropriateness Criteria™ for solitary brain metastasis. (NGC-1729)
    • Loeffler JS, Bloomer WD, Buckley JA, Gutin PH, Malcolm AW, Schupak KD, Larson D, Gaspar LE, Gibbs FA, Lewin AA, Mendenhall WM, Schneider JF, Shaw EG, Simpson JR, Wharam MD Jr, Rogers L, Leibel S. Solitary brain metastasis. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):1111-20. [18 references]

    CURRENT NGC SUMMARY: Single brain metastasis. (NGC-5132)

70. ACR Appropriateness Criteria™ for stress/insufficiency fractures (excluding vertebral). (NGC-1645)
    • Manaster BJ, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Goergen TG, Keats TE, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Stress/insufficiency fractures (excluding vertebral). American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):265-72. [29 references]

    CURRENT NGC SUMMARY: Stress/insufficiency fracture, including sacrum, excluding other vertebrae. (NGC-4785)

71. ACR Appropriateness Criteria™ for suspected abdominal abscess. (NGC-1631)
    • Saini S, Ralls PW, Balfe DM, Bree RL, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Shuman WP, Greene FL, Laine LA, Lillemoe K, Brown M, Berland L. Suspected abdominal abscess. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):173-9. [21 references]

    CURRENT NGC SUMMARY: Acute abdominal pain and fever or suspected abdominal abscess. (NGC-5138)

72. ACR Appropriateness Criteria™ for suspected bacterial endocarditis. (NGC-1616)
    • Higgins CB, Levin DC, Bettmann MA, Gomes AS, Grollman J, Henkin RE, Hessel SJ, Kelley MJ, Needleman L, Polak JF, Stanford W, Wexler L, Abbott W, Port S. Suspected bacterial endocarditis. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):73-7. [24 references]

    CURRENT NGC SUMMARY: Suspected bacterial endocarditis. (NGC-5113)

73. ACR Appropriateness Criteria™ for suspected liver metastases. (NGC-1637)
    • Bree RL, Greene FL, Ralls PW, Balfe DM, DiSantis DJ, Glick SN, Kidd R, Levine MS, Megibow AJ, Mezwa DG, Saini S, Shuman WP, Laine LA, Lillemoe K. Suspected liver metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):213-24. [13 references]

    CURRENT NGC SUMMARY: Suspected liver metastases. (NGC-4627)

74. ACR Appropriateness Criteria™ for suspected lower extremity deep vein thrombosis. (NGC-1612)
    • Needleman L, Polak JF, Bettmann MA, Boxt LM, Gomes AS, Grollman J, Henkin RE, Higgins CB, Kelley MJ, Pagan-Marin H, Stanford W. Suspected lower extremity deep vein thrombosis. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):49-53. [32 references]

    CURRENT NGC SUMMARY: Suspected lower extremity deep vein thrombosis. (NGC-4779)

75. ACR Appropriateness Criteria™ for the role of imaging in cancer of the cervix. (NGC-1718)
    • Hricak H, Mendelson E, Bohm-Velez M, Bree R, Finberg H, Fishman EK, Laing F, Sartoris D, Thurmond A, Goldstein S. Role of imaging in cancer of the cervix. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun 1;215(Suppl):925-30. [50 references]

    CURRENT NGC SUMMARY: Invasive cancer of the cervix. (NGC-4637)

76. ACR Appropriateness Criteria™ for unilateral upper extremity swelling and pain. (NGC-1622)
    • Polak JF, Levin DC, Bettmann MA, Gomes AS, Grollman J, Henkin RE, Hessel SJ, Higgins CB, Kelley MJ, Needleman L, Stanford W, Wexler L, Abbott W, Port S. Unilateral upper extremity swelling and pain. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):107-12. [30 references]

    CURRENT NGC SUMMARY: Suspected upper extremity deep vein thrombosis (DVT). (NGC-4795)

77. ACR Appropriateness Criteria™ for vertigo and hearing loss. (NGC-1666)
    • Hasso AN, Drayer BP, Anderson RE, Braffman B, Davis PC, Deck MD, Johnson BA, Masaryk T, Pomeranz SJ, Seidenwurm D, Tanenbaum L, Masdeu JC. Vertigo and hearing loss. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):471-8. [21 references]

    CURRENT NGC SUMMARY: Vertigo and hearing loss. (NGC-5123)

78. ACR Appropriateness Criteria™ for work-up of the solitary pulmonary nodule (SPN). (NGC-1796)
    • Henschke CI, Yankelevitz D, Westcott J, Davis SD, Fleishon H, Gefter WB, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Bode FR, Swensen SJ. Work-up of the solitary pulmonary nodule. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):607-9. [19 references]

    CURRENT NGC SUMMARY: Solitary pulmonary nodule. (NGC-4603)

79. Acute onset flank pain, suspicion of stone disease. (NGC-4610)
    • Rosenfield AT, Choyke PL, Bluth E, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Sandler C, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Acute onset flank pain, suspicion of stone disease. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 4 p. [32 references]

    CURRENT NGC SUMMARY: Acute onset flank pain, suspicion of stone disease. (NGC-5991)

80. Acute onset of scrotal pain (without trauma, without antecedent mass). (NGC-4614)
    • Older RA, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler C, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Acute onset of scrotal pain (without trauma, without antecedent mass). [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 4 p. [50 references]

    CURRENT NGC SUMMARY: Acute onset of scrotal pain (without trauma, without antecedent mass). (NGC-5992)

81. Follow-up imaging of bladder carcinoma. (NGC-4642)
    • Segal AJ, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Follow-up imaging of bladder carcinoma. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 9 p. [54 references]

    CURRENT NGC SUMMARY: Follow-up imaging of bladder carcinoma. (NGC-5993)

82. Follow-up of renal cell carcinoma. (NGC-4643)
    • Casalino DD, Choyke PL, Bluth EI, Bush WH Jr, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Follow-up of renal cell carcinoma. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 4 p. [44 references]

    CURRENT NGC SUMMARY: Follow-up of renal cell carcinoma. (NGC-5994)

83. Growth disturbances: risk of intrauterine growth restriction. (NGC-4778)
    • Zelop C, Fleischer AC, Andreotti RF, Bohm-Velez M, Horrow MM, Hricak H, Javitt MC, Thurmond A, Expert Panel on Women's Imaging. Growth disturbances: risk of intrauterine growth restriction. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 10 p. [20 references]

    CURRENT NGC SUMMARY: Growth disturbances: risk of intrauterine growth restriction. (NGC-6006)

84. Incidentally discovered adrenal mass. (NGC-4647)
    • Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Segal CM, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. The incidentally discovered adrenal mass. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 8 p. [43 references]

    CURRENT NGC SUMMARY: Incidentally discovered adrenal mass. (NGC-5995)

85. Indeterminate renal masses. (NGC-4644)
    • Francis IR, Choyke PL, Bluth E, Bush WH Jr, Casalino DD, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler C, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Indeterminate renal masses. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 7 p. [54 references]

    CURRENT NGC SUMMARY: Indeterminate renal masses. (NGC-5996)

86. Obstructive voiding symptoms secondary to prostate disease. (NGC-4612)
    • Bluth EI, Choyke PL, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Obstructive voiding symptoms secondary to prostate disease. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 4 p. [24 references]

    CURRENT NGC SUMMARY: Obstructive voiding symptoms secondary to prostate disease. (NGC-5997)

87. Post-treatment follow-up of prostate cancer. (NGC-4645)
    • Kawashima A, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kronthal AJ, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Segal AJ, Tempany CM, Resnick MI, Expert Panel on Urologic Imaging. Post-treatment follow-up of prostate cancer. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 9 p. [50 references]

    CURRENT NGC SUMMARY: Post-treatment follow-up of prostate cancer. (NGC-5998)

88. Pretreatment staging of invasive bladder cancer. (NGC-4613)
    • Jafri SZ, Shetty M, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Kawashima A, Papanicolaou N, Rosenfield AT, Sandler CM, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Pretreatment staging of invasive bladder cancer. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 8 p. [51 references]

    CURRENT NGC SUMMARY: Pretreatment staging of invasive bladder cancer. (NGC-5999)

89. Pretreatment staging prostate cancer. (NGC-4776)
    • Roach M III, Tempany C, Choyke PL, Anscher MS, Bluth EI, Kawashima A, Lee WR, Sandler CM, Vijayakumar S, Resnick MI, Vijayakumar V, Expert Panel on Radiation Oncology--Prostate Work Group (ROP) and Urologic Imaging. Pretreatment staging prostate cancer. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 11 p. [97 references]

    CURRENT NGC SUMMARY: Pretreatment staging prostate cancer. (NGC-6000)

90. Renal cell carcinoma staging. (NGC-4616)
    • Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Renal cell carcinoma staging. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 5 p. [40 references]

    CURRENT NGC SUMMARY: Renal cell carcinoma staging. (NGC-6001)

91. Renal trauma. (NGC-4634)
    • Sandler CM, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Renal trauma. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 4 p. [24 references]

    CURRENT NGC SUMMARY: Renal trauma. (NGC-6002)

92. Renovascular hypertension. (NGC-4620)
    • Jafri SZ, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Renovascular hypertension. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 7 p. [45 references]

    CURRENT NGC SUMMARY: Renovascular hypertension. (NGC-6003)

93. Staging and follow-up of ovarian cancer. (NGC-4794)
    • Javitt MC, Fleischer AC, Andreotti RF, Bohm-Velez M, Horrow MM, Hricak H, Thurmond A, Zelop C, Expert Panel on Women's Imaging. Staging and follow-up of ovarian cancer. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 4 p. [31 references]

    CURRENT NGC SUMMARY: Staging and follow-up of ovarian cancer. (NGC-6007)

94. Staging of testicular malignancy. (NGC-4646)
    • Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Papanicolaou N, Rosenfield AT, Sandler CM, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Staging of testicular malignancy. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 6 p. [57 references]

    CURRENT NGC SUMMARY: Staging of testicular malignancy. (NGC-6004)

95. Suspected lower urinary tract trauma. (NGC-4656)
    • Sandler CM, Choyke PL, Bluth EI, Bush WH, Casalino DD, Francis IR, Jafri ZH, Kawashima A, Papanicolaou N, Rosenfield AT, Segal AJ, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Suspected lower urinary tract trauma. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 8 p. [38 references]

    CURRENT NGC SUMMARY: Suspected lower urinary tract trauma. (NGC-6005)

American Diabetes Association

1. Diabetes management in correctional institutions. (NGC-5451)
   • American Diabetes Association. Diabetes management in correctional institutions. Diabetes Care 2007 Jan;30 Suppl 1:S77-84. [15 references] PubMed

   CURRENT NGC SUMMARY: Diabetes management in correctional institutions. (NGC-6286)

2. Hyperglycemic crises in patients with diabetes mellitus. (NGC-2808)
   • Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM. Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care 2003 Jan;26 Suppl 1:S109-17. [38 references] PubMed

   CURRENT NGC SUMMARY: Hyperglycemic crises in diabetes. (NGC-3428)

3. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. (NGC-5445)
   • American Diabetes Association. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2007 Jan;30 Suppl 1:S48-65. [119 references] PubMed

   CURRENT NGC SUMMARY: Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. (NGC-6285)

4. Pancreas transplantation for patients with type 1 diabetes. (NGC-2809)
   • Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2003 Jan;26 Suppl 1:S120. [1 reference] PubMed

   CURRENT NGC SUMMARY: Pancreas transplantation in type 1 diabetes. (NGC-3429)

5. Standards of medical care in diabetes. I. Classification and diagnosis. (NGC-5441)
   • American Diabetes Association (ADA). Standards of medical care in diabetes. I. Classification and diagnosis. Diabetes Care 2007 Jan;30(Suppl 1):S4-5.

   CURRENT NGC SUMMARY: Standards of medical care in diabetes. I. Classification and diagnosis. (NGC-6277)

6. Standards of medical care in diabetes. II. Screening for diabetes. (NGC-5442)
   • American Diabetes Association (ADA). Standards of medical care in diabetes. II. Screening for diabetes. Diabetes Care 2007 Jan;30(Suppl 1):S5-7.

   CURRENT NGC SUMMARY: Standards of medical care in diabetes. II. Testing for prediabetes and diabetes in asymptomatic patients. (NGC-6278)

7. Standards of medical care in diabetes. III. Detection and diagnosis of gestational diabetes mellitus (GDM). (NGC-5443)
   • American Diabetes Association (ADA). Standards of medical care in diabetes. III. Detection and diagnosis of GDM. Diabetes Care 2007 Jan;30(Suppl 1):S7.

   CURRENT NGC SUMMARY: Standards of medical care in diabetes. III. Detection and diagnosis of gestational diabetes mellitus (GDM). (NGC-6279)

8. Standards of medical care in diabetes. IV. Prevention/delay of type 2 diabetes. (NGC-5444)
   • American Diabetes Association (ADA). Standards of medical care in diabetes. IV. Prevention/delay of type 2 diabetes. Diabetes Care 2007 Jan;30(Suppl 1):S7-8.

   CURRENT NGC SUMMARY: Standards of medical care in diabetes. IV. Prevention/delay of type 2 diabetes. (NGC-6280)

9. Standards of medical care in diabetes. V. Diabetes care. (NGC-5446)
   • American Diabetes Association (ADA). Standards of medical care in diabetes. V. Diabetes care. Diabetes Care 2007 Jan;30(Suppl 1):S8-15.

   CURRENT NGC SUMMARY: Standards of medical care in diabetes. V. Diabetes care. (NGC-6281)

10. Standards of medical care in diabetes. VI. Prevention and management of diabetes complications. (NGC-5447)
    • American Diabetes Association (ADA). Standards of medical care in diabetes. VI. Prevention and management of diabetes complications. Diabetes Care 2007 Jan;30(Suppl 1):S15-24.

    CURRENT NGC SUMMARY: Standards of medical care in diabetes. VI. Prevention and management of diabetes complications. (NGC-6282)

11. Standards of medical care in diabetes. VII. Diabetes care in specific populations. (NGC-5448)
    • American Diabetes Association (ADA). Standards of medical care in diabetes. VII. Diabetes care in specific populations. Diabetes Care 2007 Jan;30(Suppl 1):S24-7.

    CURRENT NGC SUMMARY: Standards of medical care in diabetes. VII. Diabetes care in specific populations. (NGC-6283)

12. Standards of medical care in diabetes. VIII. Diabetes care in specific settings. (NGC-5449)
    • American Diabetes Association (ADA). Standards of medical care in diabetes. VIII. Diabetes care in specific settings. Diabetes Care 2007 Jan;30(Suppl 1):S27-33.

    CURRENT NGC SUMMARY: Standards of medical care in diabetes. VIII. Diabetes care in specific settings. (NGC-6284)

American Gastroenterological Association Institute

1. Colorectal cancer screening: clinical guidelines and rationale. (NGC-0045)
   • Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ. Colorectal cancer screening: clinical guidelines and rationale [published errata appear in Gastroenterology 1997 Mar;112(3):1060 and 1998 Mar;114(3):625]. Gastroenterology 1997 Feb;112(2):594-642. [220 references] PubMed

   CURRENT NGC SUMMARY: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. (NGC-2912)

2. Evaluation of dyspepsia. (NGC-0529)
   • American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998 Mar;114(3):579-81. [189 references] PubMed

   CURRENT NGC SUMMARY: American Gastroenterological Association medical position statement: evaluation of dyspepsia. (NGC-4711)

American Heart Association

1. Evidence-based guidelines for cardiovascular disease prevention in women. (NGC-3490)
   • Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004 Feb 10;109(5):672-93. [505 references] PubMed

   CURRENT NGC SUMMARY: Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (NGC-5565)

American Medical Directors Association

1. Altered mental states. (NGC-1030)
   • American Medical Directors Association (AMDA). Altered mental states. Columbia (MD): American Medical Directors Association (AMDA); 1998. 20 p. [17 references]

   CURRENT NGC SUMMARY: Delirium and acute problematic behavior in the long-term care setting. (NGC-6408)

2. Dementia. (NGC-1031)
   • American Medical Directors Association (AMDA). Dementia. Columbia (MD): American Medical Directors Association (AMDA); 1998. 32 p. [35 references]

   CURRENT NGC SUMMARY: Dementia. (NGC-4446)

3. Depression. (NGC-1032)
   • American Medical Directors Association (AMDA). Depression. Columbia (MD): American Medical Directors Association (AMDA); 1996. 20 p. [38 references]

   CURRENT NGC SUMMARY: Depression. (NGC-3520)

4. Falls and fall risk. (NGC-1034)
   • American Medical Directors Association (AMDA). Falls and fall risk. Columbia (MD): American Medical Directors Association (AMDA); 1998. 16 p. [23 references]

   CURRENT NGC SUMMARY: Falls and fall risk. (NGC-3521)

5. Heart failure. (NGC-1035)
   • American Medical Directors Association (AMDA). Heart failure. Columbia (MD): The American Medical Directors Association (AMDA); 1996. 12 p. [15 references]

   CURRENT NGC SUMMARY: Heart failure. (NGC-2529)

6. Managing diabetes in the long-term care setting. (NGC-2948)
   • American Medical Directors Association (AMDA). Managing diabetes in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2002. 51 p. [49 references]

   CURRENT NGC SUMMARY: Diabetes management in the long-term care setting. (NGC-6411)

7. Osteoporosis. (NGC-1036)
   • American Medical Directors Association (AMDA). Osteoporosis. Columbia (MD): American Medical Directors Association (AMDA); 1998. 16 p. [16 references]

   CURRENT NGC SUMMARY: Osteoporosis. (NGC-3523)

8. Pharmacotherapy companion to the depression clinical practice guideline. (NGC-1033)
   • Pharmacotherapy companion to the depression clinical practice guideline. Columbia (MD): American Medical Directors Association; 1998. 26 p. [28 references]

   CURRENT NGC SUMMARY: Pharmacotherapy companion to the depression. (NGC-4447)

9. Pressure ulcers. (NGC-1037)
   • American Medical Directors Association (AMDA). Pressure ulcers. Columbia (MD): American Medical Directors Association; 1996. 16 p.

   CURRENT NGC SUMMARY: Pressure ulcers in the long-term care setting. (NGC-6410)

American Optometric Association

1. Care of the patient with conjunctivitis. (NGC-1220)
   • American Optometric Association. Care of the patient with conjunctivitis. 2nd ed. St. Louis (MO): American Optometric Association; 1996. 54 p. (Optometric clinical practice guideline; no. 11). [54 references]

   CURRENT NGC SUMMARY: Care of the patient with conjunctivitis. 2nd edition. (NGC-3384)

2. Care of the patient with diabetes mellitus. 2nd edition. (NGC-1212)
   • American Optometric Association. Care of the patient with diabetes mellitus. 2nd ed. St. Louis (MO): American Optometric Association; 1998. 69 p. (Optometric clinical practice guideline; no. 3). [98 references]

   CURRENT NGC SUMMARY: Care of the patient with diabetes mellitus. 3rd edition. (NGC-3386)

3. Care of the patient with ocular surface disease. (NGC-1219)
   • American Optometric Association. Care of the patient with ocular surface disease. 2nd ed. St. Louis (MO): American Optometric Association; 1995. 58 p. (Optometric clinical practice guideline; no. 10). [88 references]

   CURRENT NGC SUMMARY: Care of the patient with ocular surface disorders. (NGC-2775)

4. Care of the patient with open angle glaucoma. (NGC-1218)
   • American Optometric Association. Care of the patient with open angle glaucoma. St. Louis (MO): American Optometric Association; 1995. 90 p. (Optometric clinical practice guideline; no. 9). [285 references]

   CURRENT NGC SUMMARY: Care of the patient with open angle glaucoma. 2nd edition. (NGC-3385)

5. Comprehensive adult eye and vision examination. (NGC-1210)
   • American Optometric Association (AOA). Comprehensive adult eye and vision examination: reference guide for clinicians. St. Louis (MO): American Optometric Association (AOA); 1994. 16 p. (Optometric clinical practice guideline; no. 1). [69 references]

   CURRENT NGC SUMMARY: Comprehensive adult eye and vision examination. (NGC-4725)

6. Pediatric eye and vision examination. (NGC-1211)
   • American Optometric Association. Pediatric eye and vision examination. 2nd ed. St. Louis (MO): American Optometric Association; 1994. 27 p. (Optometric clinical practice guideline; no. 2). [95 references]

   CURRENT NGC SUMMARY: Pediatric eye and vision examination. (NGC-2774)

American Psychiatric Association

1. Practice guideline for major depressive disorder in adults. (NGC-0662)
   • American Psychiatric Association (APA). Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993 Apr;150(4 Suppl):1-26. [169 references]
   
   
   
   • American Psychiatric Association (APA). Practice guideline for major depressive disorder in adults. Washington (DC): American Psychiatric Press, Inc; 1993. 51 p. (APA practice guidelines; no. 1993). [169 references]

   CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with major depressive disorder. (NGC-1831)

2. Practice guideline for psychiatric evaluation of adults. (NGC-0665)
   • American Psychiatric Association (APA). Practice guideline for psychiatric evaluation of adults. Washington (DC): American Psychiatric Press, Inc; 1995. 28 p. [58 references]
   
   
   
   • Practice guideline for psychiatric evaluation of adults. American Psychiatric Association (APA). Am J Psychiatry 1995 Nov;152(11 Suppl):63-80. [58 references] PubMed

   CURRENT NGC SUMMARY: Practice guideline for the psychiatric evaluation of adults. (NGC-4986)

3. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. (NGC-0668)
   • American Psychiatric Association (APA). Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997 May;154(5 Suppl):1-39. [243 references] PubMed
   
   
   
   • American Psychiatric Association (APA). Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. Washington (DC): American Psychiatric Press, Inc.; 1997 May. 93 p. [243 references]

   CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with Alzheimer's disease and other dementias. (NGC-5974)

4. Practice guideline for the treatment of patients with eating disorders. (NGC-1420)
   • American Psychiatric Association Work Group on Eating Disorders. Practice guideline for the treatment of patients with eating disorders (revision). Am J Psychiatry 2000 Jan;157(1 Suppl):1-39. [356 references]

   CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with eating disorders. (NGC-4987)

5. Practice guideline for the treatment of patients with schizophrenia. (NGC-0667)
   • American Psychiatric Association (APA). Practice guideline for the treatment of patients with schizophrenia. Washington (DC): American Psychiatric Press, Inc; 1997. 146 p. [581 references]
   
   
   
   • Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association (APA). Am J Psychiatry 1997 Apr;154(4 Suppl):1-63. [581 references] PubMed

   CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with schizophrenia. Second edition. (NGC-3572)

6. Practice guideline for treatment of patients with bipolar disorder. (NGC-0663)
   • American Psychiatric Association (APA). Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994 Dec;151(12 Suppl):1-36. [258 references] PubMed
   
   
   
   • American Psychiatric Association (APA). Practice guideline for treatment of patients with bipolar disorder. Washington (DC): American Psychiatric Press, Inc; 1995. 74 p. [258 references]

   CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with bipolar disorder (revision). (NGC-2528)

7. Practice guideline for treatment of patients with substance use disorders: alcohol, cocaine, opioids. (NGC-0664)
   • American Psychiatric Association (APA). Practice guideline for treatment of patients with substance abuse disorders: alcohol, cocaine, opioids. Washington (DC): American Psychiatric Press, Inc; 1995. 116 p. [481 references]
   
   
   
   • Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association (APA). Am J Psychiatry 1995 Nov;152(11 Suppl):1-59. [481 references] PubMed

   CURRENT NGC SUMMARY: Practice guideline for the treatment of patients with substance use disorders. (NGC-4985)

American Society for Gastrointestinal Endoscopy

1. Modifications in endoscopic practice for pediatric patients. (NGC-3821)
   • Eisen GM, Chutkan R, Goldstein JL, Petersen BT, Ryan ME, Sherman S, Vargo JJ 2nd, Wright RA, Young HS, Catalano MF, Denstman F, Smith CD, Walter V V. Modifications in endoscopic practice for pediatric patients. Gastrointest Endosc 2000 Dec;52(6 Pt 1):838-42. [27 references] PubMed

   CURRENT NGC SUMMARY: Modifications in endoscopic practice for pediatric patients. (NGC-6462)

2. The role of endoscopy in dyspepsia. (NGC-4064)
   • Eisen GM, Dominitz JA, Faigel DO, Goldstein JA, Kalloo AN, Petersen BT, Raddawi HM, Ryan ME, Vargo JJ 3rd, Young HS, Fanelli RD, Hyman NH, Wheeler-Harbaugh J. The role of endoscopy in dyspepsia. Gastrointest Endosc 2001 Dec;54(6):815-7. [24 references] PubMed

   CURRENT NGC SUMMARY: The role of endoscopy in dyspepsia. (NGC-6221)

American Society of Anesthesiologists

1. Practice guidelines for acute pain management in the perioperative setting. (NGC-0754)
   • Practice guidelines for acute pain management in the perioperative setting. A report by the American Society of Anesthesiologists Task Force on Pain Management, Acute Pain Section. Anesthesiology 1995 Apr;82(4):1071-81. [2 references] PubMed

   CURRENT NGC SUMMARY: Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. (NGC-4319)

2. Practice guidelines for management of the difficult airway. (NGC-0750)
   • Practice guidelines for management of the difficult airway. A report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 1993 Mar;78(3):597-602. PubMed

   CURRENT NGC SUMMARY: Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. (NGC-4318)

3. Practice guidelines for obstetrical anesthesia. (NGC-1079)
   • American Society of Anesthesiologists. Practice guidelines for obstetrical anesthesia: a report by the American Society of Anesthesiologists Task Force on Obstetrical Anesthesia. Anesthesiology 1999 Feb;90(2):600-11. [3 references] PubMed

   CURRENT NGC SUMMARY: Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. (NGC-5632)

4. Practice guidelines for pulmonary artery catheterization. (NGC-0753)
   • Practice guidelines for pulmonary artery catheterization. A report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. Anesthesiology 1993 Feb;78(2):380-94. [89 references] PubMed

   CURRENT NGC SUMMARY: Practice guidelines for pulmonary artery catheterization: an updated report by the American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization. (NGC-4317)

American Society of Clinical Oncology

1. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. (NGC-1972)
   • Bast RC, Ravdin P, Hayes DF, Bates S, Fritsche H, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 Mar 15;19(6):1865-78.

   CURRENT NGC SUMMARY: American Society of Clinical Oncology 2007 update recommendations for the use of tumor markers in breast cancer. (NGC-6050)

2. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. (NGC-2593)
   • American Society of Clinical Oncology Bisphosphonates Expert Panel. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002 Sep 1;20(17):1-19. [72 references]

   CURRENT NGC SUMMARY: American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. (NGC-5670)

3. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. (NGC-3620)
   • Loblaw DA, Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ, Taplin ME, Vogelzang NJ, Wade JL Jr, Bennett CL, Scher HI. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol 2004 Jul 15;22(14):2927-41. [59 references] PubMed

   CURRENT NGC SUMMARY: Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. (NGC-5633)

4. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. (NGC-2594)
   • Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2002 Aug 1;20(15):3317-27. [53 references] PubMed

   CURRENT NGC SUMMARY: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive breast cancer: status report 2004. (NGC-4267)

5. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. (NGC-0656)
   • Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997 Aug;15(8):2996-3018. [256 references] PubMed

   CURRENT NGC SUMMARY: American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. (NGC-3361)

6. Guideline on the role of bisphosphonates in breast cancer. (NGC-1588)
   • American Society of Clinical Oncology. Guideline on the role of bisphosphonates in breast cancer. J Clin Oncol 2000 Mar;18(6):1378-91. [68 references]

   CURRENT NGC SUMMARY: American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. (NGC-3355)

7. Recommended breast cancer surveillance guidelines. (NGC-0026)
   • American Society of Clinical Oncology. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999 Mar;17(3):1080-2. [5 references]
   
   
   
   • American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol 1997 May;15(5):2149-56. [38 references] PubMed

   CURRENT NGC SUMMARY: American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. (NGC-5304)

8. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. (NGC-1111)
   • Benson AB, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Smith TJ, Somerfield MR. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000 Oct 15;18(20):3586-8. [9 references]
   
   
   
   • Desch CE, Benson AB 3rd, Smith TJ, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Somerfield MR. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999 Apr;17(4):1312-21. [9 references]

   CURRENT NGC SUMMARY: Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. (NGC-4896)

9. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (NGC-2768)
   • Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 2002 Oct 1;100(7):2303-20. PubMed
   
   
   
   • Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 2002 Oct 1;20(19):4083-107. [67 references] PubMed

   CURRENT NGC SUMMARY: Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. (NGC-6051)

American Society of Colon and Rectal Surgeons

1. Practice parameters for ambulatory anorectal surgery. (NGC-1351)
   • American Society of Colon and Rectal Surgeons. Practice parameters for ambulatory anorectal surgery. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 3 p. [0 references]

   CURRENT NGC SUMMARY: Practice parameters for ambulatory anorectal surgery. (NGC-3797)

2. Practice parameters for the management of anal fissure. (NGC-1353)
   • American Society of Colon and Rectal Surgeons. Practice parameters for the management of anal fissure. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 4 p. [40 references]

   CURRENT NGC SUMMARY: Practice parameters for the management of anal fissures (revised). (NGC-4075)

3. Practice parameters for the prevention of venous thromboembolism. (NGC-1819)
   • Practice parameters for the prevention of venous thromboembolism. The Standards Task Force of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 2000 Aug;43(8):1037-47. [54 references]

   CURRENT NGC SUMMARY: Practice parameters for the prevention of venous thromboembolism. (NGC-5610)

4. Practice parameters for the treatment of hemorrhoids. (NGC-1352)
   • American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of hemorrhoids. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1993. 4 p. [0 references]

   CURRENT NGC SUMMARY: Practice parameters for the management of hemorrhoids (revised). (NGC-4337)

5. Practice parameters for the treatment of rectal carcinoma. (NGC-1354)
   • American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of rectal carcinoma. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 3 p. [0 references]

   CURRENT NGC SUMMARY: Practice parameters for the management of rectal cancer (revised). (NGC-4336)

6. Practice parameters for the treatment of sigmoid diverticulitis. (NGC-1822)
   • Practice parameters for the treatment of sigmoid diverticulitis. Standards Task Force. American Society of Colon and Rectal Surgeons. Dis Colon Rectum 2000 Mar;43(3):289. [83 references]

   CURRENT NGC SUMMARY: Practice parameters for sigmoid diverticulitis. (NGC-5611)

7. Practice parameters for treatment of fistula-in-ano. (NGC-1358)
   • Practice parameters for treatment of fistula-in-ano. The Standards Practice Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1996 Dec;39(12):1361-2. [1 reference] PubMed

   CURRENT NGC SUMMARY: Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). (NGC-4432)

8. Practice parameters for treatment of mucosal ulcerative colitis. (NGC-1359)
   • Wexner SD, Rosen L, Lowry A, Roberts PL, Burnstein M, Hicks T, Kerner B, Oliver GC, Robertson HD, Robertson WG, Ross TM, Senatore PJ, Simmang C, Smith C, Vernava AM, Wong WD. Practice parameters for the treatment of mucosal ulcerative colitis--supporting documentation. Standards Practice Task Force. American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1997 Nov;40(11):1277-85. [99 references] PubMed

   CURRENT NGC SUMMARY: Practice parameters for the surgical treatment of ulcerative colitis. (NGC-5612)

American Society of Interventional Pain Physicians

1. Interventional techniques in the management of chronic spinal pain: evidence-based practice guidelines. (NGC-4173)
   • Boswell MV, Shah RV, Everett CR, Sehgal N, Mckenzie-Brown AM, Abdi S, Bowman RC, Deer TR, Datta S, Colson JD, Spillane WF, Smith HS, Lucas LF, Burton AW, Chopra P, Staats PS, Wasserman RA, Manchikanti L. Interventional techniques in the management of chronic spinal pain: evidence-based practice guidelines. Pain Physician 2005;8(1):1-47. [764 references]

   CURRENT NGC SUMMARY: Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. (NGC-5510)

2. Opioid guidelines in the management of chronic non-cancer pain. (NGC-4853)
   • Trescot AM, Boswell MV, Atluri SL, Hansen NC, Deer TR, Abdi S, Jasper JF, Singh V, Jordan AE, Johnson BW, Cicala RS, Dunbar EE, Helm S II, Varley KG, Suchdev PK, Swicegood JR, Calodney AK, Ogoke BA, Minore WS, Manchikanti L. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9(1):1-39. [350 references]

   CURRENT NGC SUMMARY: Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) guidelines. (NGC-6445)

American Urological Association Education and Research, Inc.

1. Management of non-muscle-invasive bladder cancer. (NGC-1369)
   • American Urological Association, Inc. Report on the management of non-muscle-invasive bladder cancer. Baltimore (MD): American Urological Association, Inc.; 1999. 66 p. [108 references]

   CURRENT NGC SUMMARY: Guideline for the management of nonmuscle invasive bladder cancer: (stages Ta,T1, and Tis): 2007 update. (NGC-6069)

2. The management of clinically localized prostate cancer. (NGC-0793)
   • American Urological Association (AUA), Prostate Cancer Clinical Guidelines Panel. Report on the management of clinically localized prostate cancer. Baltimore (MD): American Urological Association, Inc; 1995. 49 p. (Clinical practice guidelines; no. 1/95).

   CURRENT NGC SUMMARY: Guideline for the management of clinically localized prostate cancer: 2007 update. (NGC-5951)

3. The management of erectile dysfunction: an update. (NGC-4323)
   • Erectile Dysfunction Guideline Update Panel. The management of erectile dysfunction: an update. Baltimore (MD): American Urological Association Education and Research, Inc.; 2005. Various p. [78 references]

   CURRENT NGC SUMMARY: (1) The management of erectile dysfunction: an update. (2) 2006 addendum. (NGC-5332)

4. The management of ureteral calculi. (NGC-0553)
   • American Urological Association (AUA), Ureteral Stones Guidelines Panel. Report on the management of ureteral calculi. Baltimore (MD): American Urological Association, Inc; 1997 Sep. 72 p. (Clinical practice guidelines; no. 9/97). [72 references]

   CURRENT NGC SUMMARY: 2007 guideline for the management of ureteral calculi. (NGC-6296)

Association of Coloproctology of Britain and Ireland

1. Guidelines for the management of colorectal cancer. (NGC-4282)
   • Association of Coloproctology of Great Britain and Ireland. Guidelines for the management of colorectal cancer. London (UK): Association of Coloproctology of Great Britain and Ireland; 2001. 87 p. [273 references]

   CURRENT NGC SUMMARY: Guidelines for the management of colorectal cancer. (NGC-5904)

Barts and the London, Queen Mary's School of Medicine and Dentistry

1. Guidelines for the prevention of falls in people over 65. (NGC-1798)
   • Feder G, Cryer C, Donovan S, Carter Y. Guidelines for the prevention of falls in people over 65. The Guidelines' Development Group. BMJ 2000 Oct 21;321(7267):1007-11. [33 references]

   CURRENT NGC SUMMARY: Clinical practice guideline for the assessment and prevention of falls in older people. (NGC-3968)

Brain Trauma Foundation

1. (1) Part I. Guidelines for the management of severe traumatic brain injury. In: Management and prognosis of severe traumatic brain injury. (2) Update notice. Guidelines for the management of severe traumatic brain injury: cerebral perfusion pressure. (NGC-3020)
   • Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury: cerebral perfusion pressure. New York (NY): Brain Trauma Foundation, Inc.; 2003 Mar 14. 14 p. [47 references]
   
   
   
   • Brain Trauma Foundation, Inc, American Association of Neurological Surgeons. Part 1: guidelines for the management of severe traumatic brain injury. New York (NY): Brain Trauma Foundation, Inc.; 2000. 165 p. [299 references]

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Blood pressure and oxygenation. (NGC-5769)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Hyperosmolar therapy. (NGC-5770)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Prophylactic hypothermia. (NGC-5771)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Infection prophylaxis. (NGC-5772)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Deep vein thrombosis prophylaxis. (NGC-5773)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Nutrition. (NGC-5780)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Cerebral perfusion thresholds. (NGC-5777)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Brain oxygen monitoring and thresholds. (NGC-5778)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Anesthetics, analgesics, and sedatives. (NGC-5779)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Antiseizure prophylaxis. (NGC-5781)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Hyperventilation. (NGC-5782)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Steroids. (NGC-5783)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Indications for intracranial pressure monitoring. (NGC-5774)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Intracranial pressure monitoring technology. (NGC-5775)

   CURRENT NGC SUMMARY: Guidelines for the management of severe traumatic brain injury. Intracranial pressure thresholds. (NGC-5776)

2. Guidelines for prehospital management of traumatic brain injury. (NGC-2514)
   • Brain Trauma Foundation. Guidelines for prehospital management of traumatic brain injury. New York (NY): Brain Trauma Foundation; 2000. 81 p. [165 references]

   CURRENT NGC SUMMARY: Assessment: oxygenation and blood pressure. In: Guidelines for the prehospital management of severe traumatic brain injury, second edition. (NGC-6383)

   CURRENT NGC SUMMARY: Assessment: Glasgow Coma Scale score. In: Guidelines for the prehospital management of severe traumatic brain injury, second edition. (NGC-6384)

   CURRENT NGC SUMMARY: Assessment: pupil examination. In: Guidelines for the prehospital management of severe traumatic brain injury, second edition. (NGC-6385)

   CURRENT NGC SUMMARY: Treatment: airway, ventilation, and oxygenation. In: Guidelines for the prehospital management of severe traumatic brain injury, second edition. (NGC-6386)

   CURRENT NGC SUMMARY: Treatment: fluid resuscitation. In: Guidelines for the prehospital management of severe traumatic brain injury, second edition. (NGC-6387)

   CURRENT NGC SUMMARY: Treatment: cerebral herniation. In: Guidelines for the prehospital management of severe traumatic brain injury, second edition. (NGC-6388)

   CURRENT NGC SUMMARY: Decision making within the EMS system: dispatch, scene, transportation, and destination. In: Guidelines for the prehospital management of severe traumatic brain injury, second edition. (NGC-6389)

British Association for Sexual Health and HIV

1. 2002 guidelines for the management of pelvic infection and perihepatitis. (NGC-2269)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guidelines for the management of pelvic infection and perihepatitis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [19 references]

   CURRENT NGC SUMMARY: United Kingdom national guideline for the management of pelvic inflammatory disease. (NGC-4512)

2. 2002 national guideline for the management of Chlamydia trachomatis genital tract infection. (NGC-2255)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of Chlamydia trachomatis genital tract infection. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [42 references]

   CURRENT NGC SUMMARY: 2006 UK national guideline for the management of genital tract infection with Chlamydia trachomatis. (NGC-5360)

3. 2002 national guideline for the management of anogenital warts. (NGC-2272)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of anogenital warts. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [43 references]

   CURRENT NGC SUMMARY: United Kingdom national guideline for the management of anogenital warts, 2007. (NGC-6017)

4. 2002 national guideline for the management of bacterial vaginosis. (NGC-2258)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of bacterial vaginosis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [27 references]

   CURRENT NGC SUMMARY: National guideline for the management of bacterial vaginosis (2006). (NGC-6014)

5. 2002 national guideline for the management of genital herpes. (NGC-2261)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of genital herpes. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [38 references]

   CURRENT NGC SUMMARY: 2007 national guideline for the management of genital herpes. (NGC-6299)

6. 2002 national guideline for the management of lymphogranuloma venereum. (NGC-2265)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of lymphogranuloma venereum. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [28 references]

   CURRENT NGC SUMMARY: 2006 national guideline for the management of lymphogranuloma venereum. (NGC-6016)

7. 2002 national guideline on the management of Phthirus pubis infestation. (NGC-2274)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of phthirus pubis infestation. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [4 references]

   CURRENT NGC SUMMARY: United Kingdom national guideline on the management of phthirus pubis infestation. (NGC-6363)

8. 2002 national guideline on the management of gonorrhoea in adults. (NGC-2257)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of gonorrhoea in adults. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [20 references]

   CURRENT NGC SUMMARY: National guideline on the diagnosis and treatment of gonorrhoea in adults 2005. (NGC-4511)

9. 2002 national guideline on the management of molluscum contagiosum. (NGC-2275)
   • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of molluscum contagiosum. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [8 references]

   CURRENT NGC SUMMARY: United Kingdom national guideline on the management of molluscum contagiosum. (NGC-6364)

10. 2002 national guideline on the management of scabies. (NGC-2273)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of scabies. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [7 references]

    CURRENT NGC SUMMARY: United Kingdom national guideline on the management of scabies infestation. (NGC-6362)

11. 2002 national guideline on the management of the viral hepatitides A, B, and C. (NGC-2680)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of the viral hepatitides A, B, and C. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [201 references]

    CURRENT NGC SUMMARY: United Kingdom national guideline on the management of the viral hepatitides A, B, and C 2005. (NGC-4513)

12. 2002 national guideline on the management of trichomonas vaginalis. (NGC-2260)
    • Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline on the management of trichomonas vaginalis. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002. Various p. [22 references]

    CURRENT NGC SUMMARY: United Kingdom national guideline on the management of trichomonas vaginalis (2007). (NGC-6015)

13. Clinical standards for the screening and management of acquired syphilis in HIV-positive adults. (NGC-2666)
    • Medical Society for the Study of Venereal Diseases (MSSVD). Clinical standards for the screening and management of acquired syphilis in HIV-positive adults. London (UK): Medical Society for the Study of Venereal Diseases (MSSVD); 2002 Feb 21. 9 p. [28 references]

    CURRENT NGC SUMMARY: 2006 United Kingdom national guideline on the sexual health of people with HIV: sexually transmitted infections. (NGC-5031)

California Diabetes Program

1. Basic guidelines for diabetes care. (NGC-3369)
   • Diabetes Coalition of California, California Diabetes Prevention and Control Program. Basic guidelines for diabetes care. Sacramento (CA): California Diabetes Prevention and Control Program, Department of Health Services; 2003. 26 p.

   CURRENT NGC SUMMARY: Basic guidelines for diabetes care. (NGC-4591)

Canadian Task Force on Preventive Health Care

1. Breast feeding. (NGC-1254)
   • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Breast feeding. p. 232-42. [33 references]

   CURRENT NGC SUMMARY: Interventions to promote breast-feeding: applying the evidence in clinical practice. (NGC-3651)

2. Screening for diabetes mellitus in the non-pregnant adult. (NGC-1282)
   • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for diabetes mellitus in the non-pregnant adult. p. 602-9. [19 references]

   CURRENT NGC SUMMARY: Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care. (NGC-4089)

Centers for Disease Control and Prevention

1. (1) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children.
   (2) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. (NGC-0060)
   • Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. MMWR Recomm Rep 1997 Mar 28;46(RR-7):1-25. [50 references]
   
   
   
   • Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2000 Nov 17;49(RR13):1-8. [17 references]

   CURRENT NGC SUMMARY: (1) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children.
   (2) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. (Addendum) (NGC-3288)

2. (1) Prevention and treatment of tuberculosis among patients with infected human immunodeficiency virus: Principles of therapy and revised recommendations.
   (2) Notice to readers: updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
   (3) Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patient (NGC-3404)
   • Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2004 Jan 20. 6 p. [30 references]
   
   
   
   • Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR Recomm Rep 1998 Oct 30;47(RR-20):1-58. [162 references] PubMed
   
   
   
   • Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitor. MMWR Morb Mortal Wkly Rep 2000 Mar 10;49(9):185-9. [10 references] PubMed

   CURRENT NGC SUMMARY: Managing drug interactions in the treatment of HIV-related tuberculosis. (NGC-6326)

3. (1) Targeted tuberculin testing and treatment of latent tuberculosis infection.
   (2) Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001. (NGC-1528)
   • Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000 Jun;49(RR-6):1-54. [169 references]
   
   
   
   • Update: fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States 2001. MMWR Recomm Rep 2001 Aug 31;50(34):733-5.

   CURRENT NGC SUMMARY: (1) Targeted tuberculin testing and treatment of latent tuberculosis infection.
   (2) Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
   (3) Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. (NGC-3134)

4. Cervical cancer screening for women who attend STD clinics or have a history of STDs. Sexually transmitted diseases treatment guidelines 2002. (NGC-2467)
   • Centers for Disease Control and Prevention. Cervical cancer screening for women who attend STD clinics or have a history of STDs. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):57-9.

   CURRENT NGC SUMMARY: Cervical cancer screening for women who attend STD clinics or have a history of STDs. Sexually transmitted diseases treatment guidelines 2006. (NGC-5192)

5. Clinical prevention guidelines. Sexually transmitted diseases treatment guidelines 2002. (NGC-2456)
   • Centers for Disease Control and Prevention. Clinical prevention guidelines. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):2-5.

   CURRENT NGC SUMMARY: Clinical prevention guidance. Sexually transmitted diseases treatment guidelines 2006. (NGC-5181)

6. Congenital syphilis. Sexually transmitted diseases treatment guidelines 2002. (NGC-2460)
   • Centers for Disease Control and Prevention. Congenital syphilis. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):26-8.

   CURRENT NGC SUMMARY: Congenital syphilis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5185)

7. Diagnosis and management of foodborne illnesses: a primer for physicians. (NGC-1933)
   • Diagnosis and management of foodborne illnesses: a primer for physicians. MMWR Recomm Rep 2001 Jan 26;50 (RR-2):1-69. [95 references]

   CURRENT NGC SUMMARY: Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. (NGC-3593)

8. Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines 2002. (NGC-2459)
   • Centers for Disease Control and Prevention. Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):11-25.

   CURRENT NGC SUMMARY: Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines 2006. (NGC-5184)

9. Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5187)
   • Centers for Disease Control and Prevention, Workowski KA, Berman SM. Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006 [published errata appear in MMWR Morb Mortal Wkly Rep 2006 Sep 15;55(36):997]. MMWR Morb Mortal Wkly Rep 2006 Aug 4;55(RR-11):35-49. [222 references]

   CURRENT NGC SUMMARY: (1) Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (2) Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. (NGC-5597)

10. Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines 2002. (NGC-2463)
    • Centers for Disease Control and Prevention. Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):42-8.

    CURRENT NGC SUMMARY: Diseases characterized by vaginal discharge. Sexually transmitted diseases treatment guidelines 2006. (NGC-5188)

11. Ectoparasitic infections. Sexually transmitted diseases treatment guidelines 2002. (NGC-2471)
    • Centers for Disease Control and Prevention. Ectoparasitic infections. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):67-9.

    CURRENT NGC SUMMARY: Ectoparasitic infections. Sexually transmitted diseases treatment guidelines 2006. (NGC-5196)

12. Epidemic/epizootic West Nile virus in the United States: Revised guidelines for surveillance, prevention, and control. (NGC-2011)
    • Epidemic/epizootic West Nile Virus in the United States: revised guidelines for surveillance, prevention, and control. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2001 Apr. 104 p. [55 references]

    CURRENT NGC SUMMARY: Epidemic/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control. (NGC-3165)

13. Epididymitis. Sexually transmitted diseases treatment guidelines 2002. (NGC-2465)
    • Centers for Disease Control and Prevention. Epididymitis. Sexually transmitted Diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):52-3.

    CURRENT NGC SUMMARY: Epididymitis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5190)

14. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-5379)
    • Kroger AT, Atkinson WL, Marcuse EK, Pickering LK, Advisory Committee on Immunization Practices (ACIP) Centers for Disease. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published errata appear in MMWR Morb Mortal Wkly Rep 2007 Mar 23;56(11):256]. MMWR Recomm Rep 2006 Dec 1;55(RR-15):1-48. [202 references] PubMed

    CURRENT NGC SUMMARY: 1) General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2) Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. (NGC-6390)

15. Guidelines for isolation precautions in hospitals. (NGC-0842)
    • Centers for Disease Control and Prevention (CDC), Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospital infection control advisory committee. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 1996 Jan 1. 38 p. (CDC prevention guidelines; no. 1/96). [97 references]

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Administrative responsibilities. (NGC-5763)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Education and training. (NGC-5764)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Surveillance. (NGC-5765)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Standard precautions. (NGC-5766)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Transmission-based precautions. (NGC-5767)

    CURRENT NGC SUMMARY: Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Protective environment. (NGC-5768)

16. Guidelines for prevention of nosocomial pneumonia. (NGC-0841)
    • Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Recomm Rep 1997 Jan 3;46(RR-1):1-79. [140 references] PubMed

    CURRENT NGC SUMMARY: Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. (NGC-3506)

17. Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-6332)
    • Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Bethesda (MD): U.S. Department of Health and Human Services; 2008 Feb 28. 134 p. [359 references]

    CURRENT NGC SUMMARY: Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-6652)

18. Guidelines for using the QuantiFERON®-TB test for diagnosing latent mycobacterium tuberculosis infection. (NGC-2844)
    • Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 Jan 31;52(RR-2):15-8. [6 references] PubMed

    CURRENT NGC SUMMARY: Guidelines for using the QuantiFERON®-TB gold test for detecting mycobacterium tuberculosis infection, United States. (NGC-4741)

19. Hepatitis C. Sexually transmitted diseases treatment guidelines 2002. (NGC-2469)
    • Centers for Disease Control and Prevention. Hepatitis C. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):64-6.

    CURRENT NGC SUMMARY: Hepatitis C. Sexually transmitted diseases treatment guidelines 2006. (NGC-5194)

20. HIV infection: detection, counseling, and referral. Sexually transmitted diseases treatment guidelines 2002. (NGC-2458)
    • Centers for Disease Control and Prevention. HIV infection: detection, counseling, and referral. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):7-11.

    CURRENT NGC SUMMARY: HIV infection: detection, counseling, and referral. Sexually transmitted diseases treatment guidelines 2006. (NGC-5183)

21. Human papillomavirus infection. Sexually transmitted diseases treatment guidelines 2002. (NGC-2466)
    • Centers for Disease Control and Prevention. Human papillomavirus infection. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):53-7.

    CURRENT NGC SUMMARY: HPV infection and genital warts. Sexually transmitted diseases treatment guidelines 2006. (NGC-5191)

22. Management of patients who have a history of penicillin allergy. Sexually transmitted diseases treatment guidelines 2002. (NGC-2461)
    • Centers for Disease Control and Prevention. Management of patients who have a history of penicillin allergy. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):28-30.

    CURRENT NGC SUMMARY: Management of patients who have a history of penicillin allergy. Sexually transmitted diseases treatment guidelines 2006. (NGC-5186)

23. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. (NGC-0906)
    • Centers for Disease Control and Prevention (CDC). Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998 Sep 25;47(RR-17):1-14. [56 references] PubMed

    CURRENT NGC SUMMARY: Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. (NGC-4049)

24. Pelvic inflammatory disease. Sexually transmitted diseases treatment guidelines 2002. (NGC-2464)
    • Centers for Disease Control and Prevention. Pelvic inflammatory disease. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):48-52.

    CURRENT NGC SUMMARY: Pelvic inflammatory disease. Sexually transmitted diseases treatment guidelines 2006. (NGC-5189)

25. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1794)
    • Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. MMWR Recomm Rep 2000 Oct 6;49(RR-9):1-38. [123 references]

    CURRENT NGC SUMMARY: (1) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2) Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24--59 months who are not completely vaccinated. (NGC-6419)

26. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. (NGC-5730)
    • Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Advisory Committee on Immunization Practices (ACIP), Centers for Disease. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007 Jul 13;56(RR-6):1-54. PubMed

    CURRENT NGC SUMMARY: Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. (NGC-6678)

27. Prevention and control of tuberculosis in correctional facilities: recommendations of the Advisory Council for the Elimination of Tuberculosis. (NGC-0102)
    • Centers for Disease Control and Prevention, Advisory Council for the Elimination of Tuberculosis. Prevention and control of tuberculosis in correctional facilities. MMWR Recomm Rep 1997 Jun 7;45(RR-8):1-27. [49 references]

    CURRENT NGC SUMMARY: Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. (NGC-5076)

28. Prevention of Hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1365)
    • Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999 Oct 1;48(RR-12):1-37. [161 references]

    CURRENT NGC SUMMARY: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-5008)

29. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-5727)
    • Marin M, Guris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 Jun 22;56(RR-4):1-40. [204 references] PubMed

    CURRENT NGC SUMMARY: 1) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2) Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. (NGC-6391)

30. Proctitis, proctocolitis, and enteritis. Sexually transmitted diseases treatment guidelines 2002. (NGC-2470)
    • Centers for Disease Control and Prevention. Proctitis, proctocolitis, and enteritis. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):66-7.

    CURRENT NGC SUMMARY: Proctitis, proctocolitis, and enteritis. Sexually transmitted diseases treatment guidelines 2006. (NGC-5195)

31. Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Version 2. Supplement E: managing international travel-related transmission risk. (NGC-3380)
    • Centers for Disease Control and Prevention (CDC). Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Version 2. Supplement E: managing international travel-related transmission risk. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2003 Dec 29. 14 p.

    CURRENT NGC SUMMARY: Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). Version 3. Supplement E: managing international travel-related transmission risk. (NGC-4176)

32. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. (NGC-6030)
    • Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Rockville (MD): U.S. Public Health Service; 2007 Nov 2. 96 p. [315 references]

    CURRENT NGC SUMMARY: Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. (NGC-6627)

33. Revised guidelines for HIV counseling, testing, and referral. (NGC-2278)
    • Centers for Disease Control and Prevention (CDC). Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001 Nov 9;50(RR-19):1-58. [151 references] PubMed

    CURRENT NGC SUMMARY: Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. (NGC-5246)

34. Revised recommendations for HIV screening of pregnant women. (NGC-2279)
    • Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep 2001 Nov 9;50(RR-19):59-86. [87 references] PubMed

    CURRENT NGC SUMMARY: Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. (NGC-5246)

35. Sexual assault and STDs. Sexually transmitted diseases treatment guidelines 2002. (NGC-2472)
    • Centers for Disease Control and Prevention. Sexual assault and STDs. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):69-74.

    CURRENT NGC SUMMARY: Sexual assault and STDs. Sexually transmitted diseases treatment guidelines 2006. (NGC-5197)

36. Special populations. Sexually transmitted diseases treatment guidelines 2002. (NGC-2457)
    • Centers for Disease Control and Prevention. Special populations. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):5-7.

    CURRENT NGC SUMMARY: Special populations. Sexually transmitted diseases treatment guidelines 2006. (NGC-5182)

37. Vaccine preventable STDs. Sexually transmitted diseases treatment guidelines 2002. (NGC-2468)
    • Centers for Disease Control and Prevention. Vaccine preventable STDs. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 May 10;51(RR-6):59-64.

    CURRENT NGC SUMMARY: Vaccine preventable STDs. Sexually transmitted diseases treatment guidelines 2006. (NGC-5193)

Cincinnati Children's Hospital Medical Center

1. Evidence based clinical care guideline for acute gastroenteritis (AGE) in children aged 2 months through 5 years. (NGC-4664)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical care guideline for acute gastroenteritis (AGE) in children aged 2 months through 5 years. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Oct 31. 15 p. [50 references]

   CURRENT NGC SUMMARY: Evidence-based clinical care guideline for acute gastroenteritis (AGE) in children aged 2 months through 5 years. (NGC-5079)

2. Evidence based clinical practice guideline for anesthesia, analgesia and sedation following arterial switch operation. (NGC-3172)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for anesthesia, analgesia and sedation following arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 22. 8 p. [14 references]

   CURRENT NGC SUMMARY: Evidence-based care guideline for anesthesia, analgesia and sedation following arterial switch operation. (NGC-5289)

3. Evidence based clinical practice guideline for children with acute bacterial sinusitis in children 1 to 18 years of age. (NGC-2344)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for children with acute bacterial sinusitis in children 1 to 18 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Apr 27. 17 p. [234 references]

   CURRENT NGC SUMMARY: Evidence-based care guideline for management of acute bacterial sinusitis in children 1 to 18 years of age. (NGC-5080)

4. Evidence based clinical practice guideline for children with hypertrophic pyloric stenosis. (NGC-2345)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for hypertrophic pyloric stenosis. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Aug 8. 16 p. [186 references]

   CURRENT NGC SUMMARY: Evidence based clinical practice guideline hypertrophic pyloric stenosis. (NGC-6224)

5. Evidence based clinical practice guideline for cytomegalovirus prophylaxis following solid organ, blood and marrow transplants. (NGC-3170)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for cytomegalovirus prophylaxis following solid organ, blood and marrow transplants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jun 7. 16 p. [145 references]

   CURRENT NGC SUMMARY: Evidence-based care guideline for cytomegalovirus prophylaxis following solid organ transplants. (NGC-6205)

6. Evidence based clinical practice guideline for inotropic support with phosphodiesterase inhibitors after repair of tetralogy of Fallot. (NGC-3649)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for inotropic support with phosphodiesterase inhibitors after repair of tetralogy of Fallot. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 25. 9 p. [16 references]

   CURRENT NGC SUMMARY: Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after repair of tetralogy of Fallot. (NGC-5205)

7. Evidence based clinical practice guideline for medical management of bronchiolitis in infants less than 1 year of age presenting with a first time episode. (NGC-4464)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of bronchiolitis in infants less than 1 year of age presenting with a first time episode. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Aug 15. 12 p. [85 references]

   CURRENT NGC SUMMARY: Evidence-based clinical practice guideline for medical management of bronchiolitis in infants less than 1 year of age presenting with a first time episode. (NGC-5078)

8. Evidence based clinical practice guideline for medical management of first time acute urinary tract infection in children 12 years of age or less. (NGC-4334)
   • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of first time acute urinary tract infection in children 12 years of age or less. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Apr 18. 20 p. [61 references]

   CURRENT NGC SUMMARY: Evidence-based care guideline for medical management of first urinary tract infection in children 12 years of age or less. (NGC-5348)

9. Evidence based clinical practice guideline for medical management of otitis media in children 2 months to 6 years of age. (NGC-1198)
   • Cincinnati Children's Hospital Medical Center. Evidence-based clinical practice guideline for medical management of otitis media in children 2 months to 6 years of age. Cincinnati (OH): Children's Hospital Medical Center (CHMC); 1999. 8 p.

   CURRENT NGC SUMMARY: Evidence based clinical practice guideline for medical management of otitis media with effusion in children 2 months to 13 years of age. (NGC-3957)

   CURRENT NGC SUMMARY: Evidence based clinical practice guideline for medical management of acute otitis media in children 2 months to 13 years of age. (NGC-3958)

10. Evidence based clinical practice guideline for prevention of thromboembolism after cavopulmonary anastomosis (bidirectional Glenn and Fontan operations). (NGC-3171)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for prevention of thromboembolism after cavopulmonary anastomosis (bidirectional Glenn and Fontan operations). Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 May 29. 10 p. [20 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for prevention of thromboembolism after cavopulmonary anastamosis (bidirectional Glenn and Fontan operations). (NGC-5291)

11. Evidence based clinical practice guideline of fever of uncertain source. Outpatient evaluation and management for children 2 months to 36 months of age. (NGC-1879)
    • Cincinnati Children's Hospital Medical Center. Evidence-based clinical practice guideline of fever of uncertain source. Outpatient evaluation and management for children 2 months to 36 months of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2000. 10 p. [36 references]

    CURRENT NGC SUMMARY: Evidence based clinical practice guideline for fever of uncertain source in children 2 to 36 months of age. (NGC-3783)

12. Evidence based clinical protocol guideline for fever of uncertain source in infants 60 days of age or less. (NGC-0659)
    • Cincinnati Children's Hospital Medical Center. Evidence based clinical protocol guideline for fever of uncertain source in infants 60 days of age or less. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 1998. 32 p. [51 references]

    CURRENT NGC SUMMARY: Evidence based clinical practice guideline for fever of uncertain source in infants 60 days of age or less. (NGC-3166)

13. Evidence-based care guideline for community acquired pneumonia in children 60 days through 17 years of age. (NGC-4743)
    • Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for community acquired pneumonia in children 60 days through 17 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Dec. 16 p. [80 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for community acquired pneumonia in children 60 days through 17 years of age. (NGC-5199)

14. Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after arterial switch operation. (NGC-5038)
    • Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2006 Jan 10. 8 p. [16 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for inotropic support with phosphodiesterase inhibitors after arterial switch operation. (NGC-5211)

15. Evidence-based care guideline for necrotizing enterocolitis (NEC) among very low birth weight infants. (NGC-4466)
    • Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for necrotizing enterocolitis (NEC) among very low birth weight infants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2005 Jul 14. 12 p. [91 references]

    CURRENT NGC SUMMARY: Evidence-based care guideline for necrotizing enterocolitis (NEC) among very low birth weight infants. (NGC-5522)

Consortium for Spinal Cord Medicine

1. Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. (NGC-0396)
   • Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. J Spinal Cord Med 1997 Jul;20(3):284-308. [88 references]

   CURRENT NGC SUMMARY: Acute management of autonomic dysreflexia: individuals with spinal cord injury presenting to health-care facilities. (NGC-2190)

2. Prevention of thromboembolism in spinal cord injury. (NGC-0395)
   • Prevention of thromboembolism in spinal cord injury. J Spinal Cord Med 1997 Jul;20(3):259-83. [60 references]

   CURRENT NGC SUMMARY: Prevention of thromboembolism in spinal cord injury. (NGC-2191)

Council on Chiropractic Practice

1. Vertebral subluxation in chiropractic practice. (NGC-0677)
   • Council on Chiropractic Practice. Vertebral subluxation in chiropractic practice. Chandler (AZ): Council on Chiropractic Practice; 1998. 120 p. (Clinical practice guideline; no. 1). [939 references]

   CURRENT NGC SUMMARY: Vertebral subluxation in chiropractic practice. (NGC-3438)

European Society of Cardiology

1. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. (NGC-3445)
   • 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 Jun;21(6):1011-53. [342 references] PubMed

   CURRENT NGC SUMMARY: 2007 guidelines for the management of arterial hypertension. (NGC-5732)

2. European guidelines on cardiovascular disease prevention in clinical practice. (NGC-3446)
   • European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003 Dec;10(Suppl 1):S1-78. [782 references]

   CURRENT NGC SUMMARY: European guidelines on cardiovascular disease prevention in clinical practice. (NGC-6457)

3. Guidelines for the diagnosis and treatment of chronic heart failure. (NGC-2202)
   • Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001 Sep;22(17):1527-60. [196 references] PubMed

   CURRENT NGC SUMMARY: Guidelines for the diagnosis and treatment of chronic heart failure (update 2005). (NGC-4345)

4. Guidelines on management (diagnosis and treatment) of syncope. (NGC-2200)
   • Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001 Aug;22(15):1256-306. [409 references]

   CURRENT NGC SUMMARY: Guidelines on management (diagnosis and treatment) of syncope - update 2004. (NGC-4059)

5. Management of acute coronary syndromes in patients presenting without persistent ST- segment elevation. (NGC-2744)
   • Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, De Feyter PJ, Specchia G, Ruzyllo W. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002 Dec;23(23):1809-40. [218 references] PubMed

   CURRENT NGC SUMMARY: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. (NGC-5733)

6. Management of stable angina pectoris. (NGC-1151)
   • Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997 Mar;18(3):394-413. [121 references] PubMed

   CURRENT NGC SUMMARY: Guidelines on the management of stable angina pectoris. (NGC-5042)

Faculty of Sexual and Reproductive Healthcare

1. Emergency contraception. (NGC-4271)
   • Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Emergency contraception. Aberdeen (Scotland): Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit; 2003 Jun. 7 p. [53 references]

   CURRENT NGC SUMMARY: Emergency contraception. (NGC-6303)

2. First prescription of the combined oral contraception. (NGC-4273)
   • First prescription of combined oral contraception. J Fam Plann Reprod Health Care 2003 Oct;29(4):209-22. [128 references] PubMed

   CURRENT NGC SUMMARY: First prescription of the combined oral contraception. (NGC-6302)

Finnish Medical Society Duodecim

1. Acne. (NGC-5503)
   • Finnish Medical Society Duodecim. Acne. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2007 Jan 4 [Various].

   CURRENT NGC SUMMARY: Acne. (NGC-5809)

2. Aortic aneurysm and dissection. (NGC-4359)
   • Finnish Medical Society Duodecim. Aortic aneurysm and dissection. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2004 Feb 26 [Various].

   CURRENT NGC SUMMARY: Aortic aneurysm and dissection. (NGC-6588)

3. Benign prostatic hyperplasia. (NGC-5282)
   • Finnish Medical Society Duodecim. Benign prostatic hyperplasia. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Sep 18 [Various].

   CURRENT NGC SUMMARY: Benign prostatic hyperplasia. (NGC-5810)

4. Blood transfusion: indications and administration. (NGC-5274)
   • Finnish Medical Society Duodecim. Blood transfusion: indications and administration. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Aug 8 [Various].

   CURRENT NGC SUMMARY: Blood transfusion: indications and administration. (NGC-6589)

5. Chlamydial urethritis and cervicitis. (NGC-4327)
   • Finnish Medical Society Duodecim. Chlamydial urethritis and cervicitis. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2005 Mar 30 [Various].

   CURRENT NGC SUMMARY: Chlamydial urethritis and cervicitis. (NGC-5276)

6. Chronic obstructive pulmonary disease (COPD). (NGC-4856)
   • Finnish Medical Society Duodecim. Chronic obstructive pulmonary disease (COPD). In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Mar 2 [Various]. [37 references]

   CURRENT NGC SUMMARY: Chronic obstructive pulmonary disease (COPD). (NGC-5811)

7. Coronary heart disease (CHD): symptoms, diagnosis and treatment. (NGC-5812)
   • Finnish Medical Society Duodecim. Coronary heart disease (CHD): symptoms, diagnosis and treatment. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2007 Apr 22 [Various].

   CURRENT NGC SUMMARY: Coronary heart disease (CHD): symptoms, diagnosis and treatment. (NGC-6590)

8. Deep venous thrombosis. (NGC-4098)
   • Finnish Medical Society Duodecim. Deep venous thrombosis. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2005 Feb 8 [Various].

   CURRENT NGC SUMMARY: Deep venous thrombosis. (NGC-4983)

9. Determining the volume of residual urine by ultrasonography. (NGC-2079)
   • Determining the volume of residual urine by ultrasonography. Helsinki, Finland: Duodecim Medical Publications Ltd; 2000 May 9. 4 p. [2 references]

   CURRENT NGC SUMMARY: Determining the volume of residual urine by ultrasonography. (NGC-4099)

10. Diagnosis and treatment of childhood hypercholesterolaemia. (NGC-4587)
    • Finnish Medical Society Duodecim. Diagnosis and treatment of childhood hypercholesterolaemia. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Mar 21 [Various].

    CURRENT NGC SUMMARY: Diagnosis and treatment of childhood hypercholesterolaemia. (NGC-5813)

11. Diagnostic coronary angiography. (NGC-4857)
    • Finnish Medical Society Duodecim. Diagnostic coronary angiography. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Jan 25 [Various]. [18 references]

    CURRENT NGC SUMMARY: Diagnostic coronary angiography. (NGC-6591)

12. Differential diagnosis of chest pain. (NGC-4100)
    • Finnish Medical Society Duodecim. Differential diagnosis of chest pain. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2004 Sep 14 [Various].

    CURRENT NGC SUMMARY: Differential diagnosis of chest pain. (NGC-6592)

13. Drug treatment for hyperlipidaemias. (NGC-3604)
    • Strandberg T, Vanhanen H. Drug treatment for hyperlipidaemias. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2004 Apr 22 [various]. [18 references]

    CURRENT NGC SUMMARY: Drug treatment for hyperlipidaemias. (NGC-6593)

14. Eating disorders among children and adolescents. (NGC-5277)
    • Finnish Medical Society Duodecim. Eating disorders among children and adolescents. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Feb 8 [Various].

    CURRENT NGC SUMMARY: Eating disorders among children and adolescents. (NGC-5814)

15. Food hypersensitivity and allergy. (NGC-5502)
    • Finnish Medical Society Duodecim. Food hypersensitivity and allergy. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Dec 13 [Various].

    CURRENT NGC SUMMARY: Paediatric food hypersensitivity and allergy. (NGC-6594)

16. Gynaecological ultrasound examination. (NGC-3605)
    • Palo P. Gynaecological ultrasound examination. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Apr 14 [Various]. [2 references]

    CURRENT NGC SUMMARY: Gynaecological ultrasound examination. (NGC-4597)

17. Haematuria. (NGC-4363)
    • Finnish Medical Society Duodecim. Haematuria. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2004 Aug 26 [Various].

    CURRENT NGC SUMMARY: Haematuria. (NGC-6595)

18. HIV infection. (NGC-4943)
    • Finnish Medical Society Duodecim. HIV infection. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Mar 24 [Various].

    CURRENT NGC SUMMARY: HIV infection. (NGC-5815)

19. Long-term management of asthma. (NGC-5154)
    • Keistinen T. Long-term management of asthma. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Apr 27 [various].

    CURRENT NGC SUMMARY: Long-term management of asthma. (NGC-5816)

20. Metabolic syndrome. (NGC-4588)
    • Finnish Medical Society Duodecim. Metabolic syndrome. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Sep 9 [Various].

    CURRENT NGC SUMMARY: Metabolic syndrome. (NGC-5817)

21. Multiple myeloma (MM). (NGC-4326)
    • Finnish Medical Society Duodecim. Multiple myeloma (MM). In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 May 1 [Various].

    CURRENT NGC SUMMARY: Multiple myeloma (MM). (NGC-5818)

22. Myocardial infarction. (NGC-5283)
    • Finnish Medical Society Duodecim. Myocardial infarction. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Apr 26 [Various].

    CURRENT NGC SUMMARY: Myocardial infarction. (NGC-6596)

23. Nephropathia epidemica (NE). (NGC-5155)
    • Makela S. Nephropathia epidemica (NE). In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 May 4 [various].

    CURRENT NGC SUMMARY: Nephropathia epidemica (NE). (NGC-5819)

24. Palliative treatment of cancer. (NGC-4598)
    • Finnish Medical Society Duodecim. Palliative treatment of cancer. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Jun 26 [Various].

    CURRENT NGC SUMMARY: Palliative treatment of cancer. (NGC-5820)

25. Physical activity in the prevention, treatment and rehabilitation of diseases. (NGC-5500)
    • Finnish Medical Society Duodecim. Physical activity in the prevention, treatment and rehabilitation of diseases. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Dec 22 [Various].

    CURRENT NGC SUMMARY: Physical activity in the prevention, treatment and rehabilitation of diseases. (NGC-6597)

26. Prevention and screening of colorectal cancer. (NGC-4324)
    • Finnish Medical Society Duodecim. Prevention and screening of colorectal cancer. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Feb 23 [Various].

    CURRENT NGC SUMMARY: Prevention and screening of colorectal cancer. (NGC-6598)

27. Prevention of venous thrombosis. (NGC-4367)
    • Finnish Medical Society Duodecim. Prevention of venous thrombosis. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Mar 6 [Various].

    CURRENT NGC SUMMARY: Prevention of venous thrombosis. (NGC-4984)

28. Prolonged cough in children. (NGC-2602)
    • Finnish Medical Society Duodecim. Prolonged cough in children. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2001 Nov 17. Various p.

    CURRENT NGC SUMMARY: Prolonged cough in children. (NGC-3807)

29. Psoriasis. (NGC-3808)
    • Snellman E. Psoriasis. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Jun 18 [various]. [74 references]

    CURRENT NGC SUMMARY: Psoriasis. (NGC-4599)

30. Rhabdomyolysis. (NGC-4368)
    • Finnish Medical Society Duodecim. Rhabdomyolysis. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2004 Jun 16 [Various].

    CURRENT NGC SUMMARY: Rhabdomyolysis. (NGC-5822)

31. Seborrhoeic dermatitis. (NGC-5504)
    • Finnish Medical Society Duodecim. Seborrhoeic dermatitis. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2007 Jan 17 [Various].

    CURRENT NGC SUMMARY: Seborrhoeic dermatitis. (NGC-5823)

32. Skin cancer. (NGC-4103)
    • Finnish Medical Society Duodecim. Skin cancer. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Aug 18 [Various].

    CURRENT NGC SUMMARY: Skin cancer. (NGC-4600)

33. Sore throat and tonsillitis. (NGC-4859)
    • Finnish Medical Society Duodecim. Sore throat and tonsillitis. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Dec 28 [Various]. [3 references]

    CURRENT NGC SUMMARY: Sore throat and tonsillitis. (NGC-5824)

34. Syphilis. (NGC-3812)
    • Reunala T. Syphilis. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Jun 19 [various]. [9 references]

    CURRENT NGC SUMMARY: Syphilis. (NGC-5275)

35. Systemic diseases in pregnancy. (NGC-5284)
    • Finnish Medical Society Duodecim. Systemic diseases in pregnancy. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Aug 30 [Various].

    CURRENT NGC SUMMARY: Systemic diseases in pregnancy. (NGC-5825)

36. Systemic lupus erythematosus (SLE). (NGC-5156)
    • Gripenberg-Gahmberg M. Systemic lupus erythematosus (SLE). In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 May 24 [various].

    CURRENT NGC SUMMARY: Systemic lupus erythematosus (SLE). (NGC-5826)

37. Thrombocytopenia. (NGC-4328)
    • Finnish Medical Society Duodecim. Thrombocytopenia. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Apr 17 [Various].

    CURRENT NGC SUMMARY: Thrombocytopenia. (NGC-5827)

38. Thrombolytic therapy and balloon angioplasty in acute ST elevation myocardial infarction (STEMI). (NGC-4594)
    • Finnish Medical Society Duodecim. Thrombolytic therapy and balloon angioplasty in acute ST elevation myocardial infarction (STEMI). In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2005 Sep 25 [Various].

    CURRENT NGC SUMMARY: Thrombolytic therapy and balloon angioplasty in acute ST elevation myocardial infarction (STEMI). (NGC-5157)

39. Tonsillitis and pharyngitis in children. (NGC-4861)
    • Finnish Medical Society Duodecim. Tonsillitis and pharyngitis in children. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Oct 30 [Various]. [1 reference]

    CURRENT NGC SUMMARY: Tonsillitis and pharyngitis in children. (NGC-5828)

40. Treatment of acute exacerbation of asthma. (NGC-4372)
    • Finnish Medical Society Duodecim. Treatment of acute exacerbation of asthma. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2004 Apr 8 [Various].

    CURRENT NGC SUMMARY: Treatment of acute exacerbation of asthma. (NGC-5829)

41. Treatment of hyperlipidaemia: aims and selection. (NGC-5158)
    • Strandberg T, Vanhanen H. Treatment of hyperlipidaemia: aims and selection. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2005 Jun 10 [various].

    CURRENT NGC SUMMARY: Treatment of hyperlipidaemia: aims and selection. (NGC-5830)

42. Treatment of obesity. (NGC-4373)
    • Finnish Medical Society Duodecim. Treatment of obesity. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Jun 22 [Various].

    CURRENT NGC SUMMARY: Treatment of obesity. (NGC-5278)

43. Tularaemia. (NGC-5279)
    • Finnish Medical Society Duodecim. Tularaemia. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2006 Jul 27 [Various].

    CURRENT NGC SUMMARY: Tularaemia. (NGC-5831)

44. Ultrasonographic examinations: indications and preparation of the patient. (NGC-4105)
    • Finnish Medical Society Duodecim. Ultrasonographic examinations: indications and preparation of the patient. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2005 Jan 2 [Various].

    CURRENT NGC SUMMARY: Ultrasonographic examinations: indications and preparation of the patient. (NGC-5501)

45. Ultrasound scanning during pregnancy. (NGC-3815)
    • Yla-Outinen A. Ultrasound scanning during pregnancy. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Apr 19 [various]. [27 references]

    CURRENT NGC SUMMARY: Ultrasound scanning during pregnancy. (NGC-4106)

46. Unstable angina pectoris. (NGC-4107)
    • Finnish Medical Society Duodecim. Unstable angina pectoris. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Sep 14 [Various].

    CURRENT NGC SUMMARY: Unstable angina pectoris. (NGC-4946)

47. Urinary incontinence in women. (NGC-4325)
    • Finnish Medical Society Duodecim. Urinary incontinence in women. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2005 Mar 31 [Various].

    CURRENT NGC SUMMARY: Urinary incontinence in women. (NGC-4539)

Fourth International Conference on the Mechanisms and Treatment of Neuropathic Pain

1. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. (NGC-3405)
   • Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003 Nov;60(11):1524-34. [70 references] PubMed

   CURRENT NGC SUMMARY: Pharmacologic management of neuropathic pain: evidence-based recommendations. (NGC-6049)

Global Initiative for Asthma

1. Global strategy for asthma management and prevention. (NGC-5354)
   • Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI). Global strategy for asthma management and prevention. Bethesda (MD): Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI); 2006. 92 p. [339 references]

   CURRENT NGC SUMMARY: Global strategy for asthma management and prevention. (NGC-6356)

Global Initiative for Chronic Obstructive Lung Disease

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (NGC-5361)
   • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda (MD): Global Initiative for Chronic Obstructive Lung Disease, World Health Organization, National Heart, Lung and Blood Institute; 2006. 88 p. [560 references]

   CURRENT NGC SUMMARY: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (NGC-6275)

Hartford Institute for Geriatric Nursing

1. Advance directives: protecting patient's rights. (NGC-2742)
   • Ramsey G, Mitty E. Advance directives: protecting patient's rights. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 265-91. [33 references]

   CURRENT NGC SUMMARY: Advance directives. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6348)

2. Assessing cognitive function. (NGC-2734)
   • Foreman MD, Fletcher K, Mion LC, Trygstad L. Assessing cognitive function. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 99-115. [6 references]

   CURRENT NGC SUMMARY: Assessing cognitive function. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6350)

3. Assessment of function: of critical importance to acute care of older adults. (NGC-2730)
   • Kresevic DM, Mezey M. Assessment of function. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 31-46. [18 references]

   CURRENT NGC SUMMARY: Assessment of function. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6343)

4. Delirium: strategies for assessing and treating. (NGC-2735)
   • Foreman MD, Mion LC, Trygstad L, Fletcher K. Delirium: strategies for assessing and treating. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 116-40. [20 references]

   CURRENT NGC SUMMARY: Delirium: prevention, early recognition, and treatment. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6345)

5. Depression in older adults. (NGC-2738)
   • Kurlowicz LH. Depression in older adults. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 185-206. [33 references]

   CURRENT NGC SUMMARY: Depression. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6344)

6. Evaluating excessive sleepiness in the older adult. (NGC-2731)
   • Umlauf MG, Chasens ER, Weaver TE. Excessive sleepiness. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 47-65. [35 references]

   CURRENT NGC SUMMARY: Excessive sleepiness. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6347)

7. Mealtime difficulties for older persons: assessment and management. (NGC-2732)
   • Amella EJ. Mealtime difficulties. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 66-82. [28 references]

   CURRENT NGC SUMMARY: Mealtime difficulties. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6351)

8. Medication in older adults. (NGC-2739)
   • Fulmer T, Foreman MD, Zwicker CD. Medication in older adults. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 207-28. [41 references]

   CURRENT NGC SUMMARY: Reducing adverse drug events. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6342)

9. Pain management. (NGC-2740)
   • Horgas AL, McLennon SM. Pain management. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 229-50. [46 references]

   CURRENT NGC SUMMARY: Pain management. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6352)

10. Preventing falls in acute care. (NGC-2736)
    • Resnick B. Preventing falls in acute care. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 141-64. [25 references]

    CURRENT NGC SUMMARY: Preventing falls in acute care. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6349)

11. Preventing pressure ulcers and skin tears. (NGC-2737)
    • Ayello EA. Preventing pressure ulcers and skin tears. In: Mezey M, Fulmer T, Abraham I, Zwicker DA, editor(s). Geriatric nursing protocols for best practice. 2nd ed. New York (NY): Springer Publishing Company, Inc.; 2003. p. 165-84. [45 references]

    CURRENT NGC SUMMARY: Preventing pressure ulcers and skin tears. In: Evidence-based geriatric nursing protocols for best practice. (NGC-6346)

Health Care Association of New Jersey

1. Fall management guidelines. (NGC-4178)
   • Health Care Association of New Jersey (HCANJ). Fall management guidelines. Hamilton (NJ): Health Care Association of New Jersey (HCANJ); 2005 Feb. 25 p.

   CURRENT NGC SUMMARY: Fall management guideline. (NGC-5216)

2. Pain management guidelines. (NGC-4177)
   • Health Care Association of New Jersey (HCANJ). Pain management guidelines. Hamilton (NJ): Health Care Association of New Jersey (HCANJ); 2005 Jan. 18 p.

   CURRENT NGC SUMMARY: Pain management guideline. (NGC-5217)

Health Care for the Homeless (HCH) Clinician's Network

1. Adapting your practice: treatment and recommendations for homeless patients with asthma. (NGC-3491)
   • Bonin E, Brammer S, Brehove T, Hale A, Hines L, Kline S, Kopydlowski MA, Misgen M, Obias ME, Olivet J, O'Sullivan A, Post P, Rabiner M, Reller C, Schulz B, Sherman P, Strehlow AJ, Yungman J. Adapting your practice: treatment and recommendations for homeless patients with asthma. Nashville (TN): Health Care for the Homeless Clinicians' Network, National Health Care for the Homeless Council, Inc.; 2003. 28 p. [11 references]

   CURRENT NGC SUMMARY: Adapting your practice: treatment and recommendations for homeless patients with asthma. (NGC-6355)

2. Adapting your practice: treatment and recommendations for homeless patients with diabetes mellitus. (NGC-3494)
   • Brehove T, Bloominger MJ, Gillis L, Meierbachtol DA, Richardson VJ, Strehlow AJ. Adapting your practice: treatment and recommendations for homeless patients with diabetes mellitus. Nashville (TN): Health Care for the Homeless Clinicians' Network, National Health Care for the Homeless Council, Inc.; 2002 Jun. 10 p. [6 references]

   CURRENT NGC SUMMARY: Adapting your practice: treatment and recommendations for homeless patients with diabetes mellitus. (NGC-5663)

Healthways

1. Inpatient management guidelines for people with diabetes. (NGC-2443)
   • American Healthways. Inpatient management guidelines for people with diabetes. Nashville (TN): American Healthways, Inc; 2002 Mar. 18 p. [48 references]

   CURRENT NGC SUMMARY: Inpatient management guidelines for people with diabetes. (NGC-3868)

Heart Failure Society of America, Inc

1. Heart Failure Society of America guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction: pharmacological approaches. (NGC-1962)
   • Heart Failure Society of America. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. J Card Fail 1999 Dec;5(4):357-82. [130 references]
   
   
   
   • HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America. Pharmacotherapy 2000 May;20(5):495-522. [130 references]

   CURRENT NGC SUMMARY: Prevention of ventricular remodeling, cardiac dysfunction, and heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4988)

   CURRENT NGC SUMMARY: Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4989)

   CURRENT NGC SUMMARY: Management of asymptomatic patients with reduced left ventricular ejection fraction: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4990)

   CURRENT NGC SUMMARY: Nonpharmacological management and health care maintenance of patients with chronic heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4991)

   CURRENT NGC SUMMARY: Heart failure in patients with left ventricular systolic dysfunction: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4992)

   CURRENT NGC SUMMARY: Managing patients with hypertension and heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4999)

   CURRENT NGC SUMMARY: Evaluation and management of patients with acute decompensated heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4997)

   CURRENT NGC SUMMARY: Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4998)

   CURRENT NGC SUMMARY: Management of heart failure in special populations: HFSA 2006 comprehensive heart failure practice guideline. (NGC-5000)

   CURRENT NGC SUMMARY: Myocarditis: current treatment: HFSA 2006 comprehensive heart failure practice guideline. (NGC-5001)

   CURRENT NGC SUMMARY: Disease management in heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4993)

   CURRENT NGC SUMMARY: Electrophysiologic testing and use of devices in heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4994)

   CURRENT NGC SUMMARY: Surgical approaches to the treatment of heart failure: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4995)

   CURRENT NGC SUMMARY: Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction: HFSA 2006 comprehensive heart failure practice guideline. (NGC-4996)

Infectious Diseases Society of America

1. Practice guidelines for community-based parenteral anti-infective therapy. (NGC-0694)
   • Practice guidelines for community-based parental anti-infective therapy. Clin Infect Dis 1997 Oct;25(4):787-801. [101 references]

   CURRENT NGC SUMMARY: Practice guidelines for outpatient parenteral antimicrobial therapy. (NGC-3615)

2. Practice guidelines for diseases caused by Aspergillus. (NGC-1893)
   • Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):696-709. [202 references]

   CURRENT NGC SUMMARY: Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. (NGC-5975)

3. Practice guidelines for the management of community-acquired pneumonia in adults. (NGC-1891)
   • Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000 Aug;31(2):347-82. [218 references] PubMed

   CURRENT NGC SUMMARY: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. (NGC-3360)

4. Practice guidelines for the management of patients with blastomycosis. (NGC-1895)
   • Chapman SW, Bradsher RW, Campbell GD, Pappas PG, Kauffman CA. Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):679-83. [21 references]

   CURRENT NGC SUMMARY: Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. (NGC-6497)

5. Practice guidelines for the management of patients with histoplasmosis. (NGC-1894)
   • Wheat J, Sarosi G, McKinsey D, Hamill R, Bradsher R, Johnson P, Loyd J, Kauffman C. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):688-95. [46 references]

   CURRENT NGC SUMMARY: Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. (NGC-5950)

6. Practice guidelines for the management of patients with sporotrichosis. (NGC-1899)
   • Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):684-7. [29 references]

   CURRENT NGC SUMMARY: Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America (IDSA). (NGC-5949)

7. Practice guidelines for the treatment of candidiasis. (NGC-1896)
   • Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):662-78. [185 references]

   CURRENT NGC SUMMARY: Guidelines for treatment of candidiasis. (NGC-3359)

8. Practice guidelines for the treatment of coccidioidomycosis. (NGC-1900)
   • Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL. Practice guidelines for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000 Apr;30(4):658-61. [32 references]

   CURRENT NGC SUMMARY: Coccidioidomycosis. (NGC-4563)

9. Practice guidelines for the treatment of Lyme disease. (NGC-1898)
   • Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, Rush TJ, Rahn DW, Coyle PK, Persing DH, Fish D, Luft BJ. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 2000 Jul;31(Suppl 1):1-14. [99 references]

   CURRENT NGC SUMMARY: Infectious Diseases Society of America practice guidelines for clinical assessment, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis. (NGC-5085)

10. Practice guidelines for the treatment of tuberculosis. (NGC-1889)
    • Horsburgh CR, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 2000 Sep;31(3):633-9. [28 references]

    CURRENT NGC SUMMARY: Treatment of tuberculosis. (NGC-3054)

Institute for Clinical Systems Improvement

1. (1) Immunizations. (2) Immunizations update. (NGC-5431)
   • Institute for Clinical Systems Improvement (ICSI). Immunizations update. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Sep. 4 p. [69 references]
   
   
   
   • Institute for Clinical Systems Improvement (ICSI). Immunizations. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Jun. 61 p. [69 references]
   
   
   
   • Institute for Clinical Systems Improvement (ICSI). Immunizations. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jan. 8 p.

   CURRENT NGC SUMMARY: 1) Immunizations. 2) Immunization update. (NGC-6222)

2. Acne management. (NGC-3189)
   • Institute for Clinical Systems Improvement (ICSI). Acne management. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Sep. 32 p. [54 references]

   CURRENT NGC SUMMARY: Acne management. (NGC-5014)

3. Adult low back pain. (NGC-4543)
   • Institute for Clinical Systems Improvement (ICSI). Adult low back pain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Sep. 64 p. [115 references]

   CURRENT NGC SUMMARY: Adult low back pain. (NGC-5287)

4. Ankle sprain. (NGC-3191)
   • Institute for Clinical Systems Improvement (ICSI). Ankle sprain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 26 p. [26 references]

   CURRENT NGC SUMMARY: Ankle sprain. (NGC-4870)

5. Anticoagulation therapy supplement. (NGC-4964)
   • Institute for Clinical Systems Improvement (ICSI). Anticoagulation therapy supplement. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Apr. 49 p. [91 references]

   CURRENT NGC SUMMARY: Antithrombotic therapy supplement. (NGC-5971)

6. Assessment and management of acute pain. (NGC-4884)
   • Institute for Clinical Systems Improvement (ICSI). Assessment and management of acute pain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Mar. 68 p. [118 references]

   CURRENT NGC SUMMARY: Assessment and management of acute pain. (NGC-6371)

7. Assessment and management of chronic pain. (NGC-4684)
   • Institute for Clinical Systems Improvement (ICSI). Assessment and management of chronic pain. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Nov. 77 p. [139 references]

   CURRENT NGC SUMMARY: Assessment and management of chronic pain. (NGC-5586)

8. Atrial fibrillation. (NGC-3973)
   • Institute for Clinical Systems Improvement (ICSI). Atrial fibrillation. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Nov. 60 p. [103 references]

   CURRENT NGC SUMMARY: Atrial fibrillation. (NGC-5585)

9. Cardiac stress test supplement. (NGC-3970)
   • Institute for Clinical Systems Improvement (ICSI). Cardiac stress test supplement. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Nov. 21 p. [21 references]

   CURRENT NGC SUMMARY: Cardiac stress test supplement. (NGC-5635)

10. Chronic obstructive pulmonary disease. (NGC-4744)
    • Institute for Clinical Systems Improvement (ICSI). Chronic obstructive pulmonary disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Dec. 66 p. [122 references]

    CURRENT NGC SUMMARY: Chronic obstructive pulmonary disease. (NGC-5563)

11. Colorectal cancer screening. (NGC-5066)
    • Institute for Clinical Systems Improvement (ICSI). Colorectal cancer screening. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Jun. 50 p. [71 references]

    CURRENT NGC SUMMARY: Colorectal cancer screening. (NGC-6580)

12. Community-acquired pneumonia in adults. (NGC-4383)
    • Institute for Clinical Systems Improvement (ICSI). Community-acquired pneumonia in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 May. 40 p. [29 references]

    CURRENT NGC SUMMARY: Community-acquired pneumonia in adults. (NGC-5034)

13. Diagnosis and initial treatment of ischemic stroke. (NGC-4874)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and initial treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Feb. 66 p. [119 references]

    CURRENT NGC SUMMARY: Diagnosis and initial treatment of ischemic stroke. (NGC-5842)

14. Diagnosis and management of attention deficit hyperactivity disorder in primary care for school age children and adolescents. (NGC-4071)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of attention deficit hyperactivity disorder in primary care for school age children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Jan. 69 p. [131 references]

    CURRENT NGC SUMMARY: Diagnosis and management of attention deficit hyperactivity disorder in primary care for school age children and adolescents. (NGC-5843)

15. Diagnosis and outpatient management of asthma. (NGC-4295)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and outpatient management of asthma. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Mar. 49 p. [31 references]

    CURRENT NGC SUMMARY: Diagnosis and management of asthma. (NGC-6368)

16. Diagnosis and treatment of adult degenerative joint disease (DJD) of the knee. (NGC-3972)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of adult degenerative joint disease (DJD) of the knee. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Nov. 43 p. [50 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of adult degenerative joint disease (DJD)/osteoarthritis (OA) of the knee. (NGC-5844)

17. Diagnosis and treatment of chest pain and acute coronary syndrome (ACS). (NGC-4683)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of chest pain and acute coronary syndrome (ACS). Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Oct. 78 p. [119 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of chest pain and acute coronary syndrome (ACS). (NGC-5390)

18. Diagnosis and treatment of headache. (NGC-4769)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of headache. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Jan. 70 p. [121 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of headache. (NGC-5845)

19. Diagnosis and treatment of obstructive sleep apnea in adults. (NGC-5634)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of obstructive sleep apnea in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Mar. 55 p. [115 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of obstructive sleep apnea in adults. (NGC-6582)

20. Diagnosis and treatment of osteoporosis. (NGC-4544)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of osteoporosis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Sep. 61 p. [162 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of osteoporosis. (NGC-5146)

21. Diagnosis and treatment of otitis media in children. (NGC-3727)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of otitis media in children. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 May. 27 p. [58 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of otitis media in children. (NGC-6367)

22. Diagnosis and treatment of respiratory illness in children and adults. (NGC-5564)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of respiratory illness in children and adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jan. 71 p. [176 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of respiratory illness in children and adults. (NGC-6369)

23. Diagnosis of breast disease. (NGC-4681)
    • Institute for Clinical Systems Improvement (ICSI). Diagnosis of breast disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Nov. 51 p. [86 references]

    CURRENT NGC SUMMARY: Diagnosis of breast disease. (NGC-6317)

24. Domestic violence. (NGC-3971)
    • Institute for Clinical Systems Improvement (ICSI). Domestic violence. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Nov. 51 p. [111 references]

    CURRENT NGC SUMMARY: Domestic violence. (NGC-5286)

25. Dyspepsia and GERD. (NGC-3792)
    • Institute for Clinical Systems Improvement (ICSI). Dyspepsia and GERD. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jul. 50 p. [102 references]

    CURRENT NGC SUMMARY: Initial management of dyspepsia and GERD. (NGC-5174)

26. Emergency and inpatient management of asthma. (NGC-4940)
    • Institute for Clinical Systems Improvement (ICSI). Emergency and inpatient management of asthma. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Mar. 40 p. [59 references]

    CURRENT NGC SUMMARY: Diagnosis and management of asthma. (NGC-6368)

27. Heart failure in adults. (NGC-5215)
    • Institute for Clinical Systems Improvement (ICSI). Heart failure in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Aug. 116 p. [204 references]

    CURRENT NGC SUMMARY: Heart failure in adults. (NGC-5972)

28. Hypertension diagnosis and treatment. (NGC-4658)
    • Institute for Clinical Systems Improvement (ICSI). Hypertension diagnosis and treatment. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Oct. 53 p. [97 references]

    CURRENT NGC SUMMARY: Hypertension diagnosis and treatment. (NGC-5388)

29. Lipid management in adults. (NGC-5091)
    • Institute for Clinical Systems Improvement (ICSI). Lipid management in adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Jun. 76 p. [128 references]

    CURRENT NGC SUMMARY: Lipid management in adults. (NGC-5886)

30. Major depression in adults in primary care. (NGC-5679)
    • Institute for Clinical Systems Improvement (ICSI). Major depression in adults in primary care. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 May. 87 p. [239 references]

    CURRENT NGC SUMMARY: Major depression in adults in primary care. (NGC-6525)

31. Management of initial abnormal Pap smear. (NGC-4659)
    • Institute for Clinical Systems Improvement (ICSI). Management of initial abnormal Pap smear. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Oct. 28 p. [56 references]

    CURRENT NGC SUMMARY: Initial management of abnormal cervical cytology (Pap smear) and HPV testing. (NGC-5341)

32. Management of labor. (NGC-4596)
    • Institute for Clinical Systems Improvement (ICSI). Management of labor. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Oct. 73 p. [129 references]

    CURRENT NGC SUMMARY: Management of labor. (NGC-5587)

33. Management of type 2 diabetes mellitus. (NGC-5391)
    • Institute for Clinical Systems Improvement (ICSI). Management of type 2 diabetes mellitus. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Nov. 82 p. [117 references]

    CURRENT NGC SUMMARY: Diagnosis and management of type 2 diabetes mellitus in adults. (NGC-6581)

34. Menopause and hormone therapy (HT): collaborative decision-making and management. (NGC-4497)
    • Institute for Clinical Systems Improvement (ICSI). Menopause and hormone therapy (HT): collaborative decision-making and management. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Aug. 64 p. [176 references]

    CURRENT NGC SUMMARY: Menopause and hormone therapy (HT): collaborative decision-making and management. (NGC-5338)

35. Palliative care. (NGC-5531)
    • Institute for Clinical Systems Improvement (ICSI). Palliative care. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jan. 49 p. [80 references]

    CURRENT NGC SUMMARY: Palliative care. (NGC-6526)

36. Preoperative evaluation. (NGC-3200)
    • Institute for Clinical Systems Improvement (ICSI). Preoperative evaluation. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Sep. 34 p. [46 references]

    CURRENT NGC SUMMARY: Preoperative evaluation. (NGC-5144)

37. Prevention and management of obesity (mature adolescents and adults). (NGC-4682)
    • Institute for Clinical Systems Improvement (ICSI). Prevention and management of obesity (mature adolescents and adults). Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005 Nov. 100 p. [209 references]

    CURRENT NGC SUMMARY: Prevention and management of obesity (mature adolescents and adults). (NGC-5389)

38. Preventive services for adults. (NGC-5340)
    • Institute for Clinical Systems Improvement (ICSI). Preventive services for adults. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Oct. 82 p. [152 references]

    CURRENT NGC SUMMARY: Preventive services for adults. (NGC-6046)

39. Preventive services for children and adolescents. (NGC-5339)
    • Institute for Clinical Systems Improvement (ICSI). Preventive services for children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Oct. 77 p. [153 references]

    CURRENT NGC SUMMARY: Preventive services for children and adolescents. (NGC-6047)

40. Routine prenatal care. (NGC-5285)
    • Institute for Clinical Systems Improvement (ICSI). Routine prenatal care. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Aug. 85 p. [255 references]

    CURRENT NGC SUMMARY: Routine prenatal care. (NGC-5973)

41. Stable coronary artery disease. (NGC-5012)
    • Institute for Clinical Systems Improvement (ICSI). Stable coronary artery disease. Bloomington (NM): Institute for Clinical Systems Improvement (ICSI); 2006 Apr. 45 p. [70 references]

    CURRENT NGC SUMMARY: Stable coronary artery disease. (NGC-5658)

42. Tobacco use prevention and cessation for adults and mature adolescents. (NGC-3206)
    • Institute for Clinical Systems Improvement (ICSI). Tobacco use prevention and cessation for adults and mature adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 36 p. [54 references]

    CURRENT NGC SUMMARY: Tobacco use prevention and cessation for adults and mature adolescents. (NGC-3731)

43. Tobacco use prevention and cessation for infants, children and adolescents. (NGC-3207)
    • Institute for Clinical Systems Improvement (ICSI). Tobacco use prevention and cessation for infants, children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Jul. 27 p. [22 references]

    CURRENT NGC SUMMARY: Tobacco use prevention and cessation for infants, children and adolescents. (NGC-3732)

44. Uncomplicated urinary tract infection in women. (NGC-3767)
    • Institute for Clinical Systems Improvement (ICSI). Uncomplicated urinary tract infection in women. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 Jul. 21 p. [38 references]

    CURRENT NGC SUMMARY: Uncomplicated urinary tract infection in women. (NGC-5173)

45. Venous thromboembolism prophylaxis. (NGC-5145)
    • Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism prophylaxis. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Jun. 51 p. [90 references]

    CURRENT NGC SUMMARY: Venous thromboembolism prophylaxis. (NGC-5887)

46. Venous thromboembolism. (NGC-4871)
    • Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2006 Feb. 91 p. [202 references]

    CURRENT NGC SUMMARY: Venous thromboembolism. (NGC-5885)

International Diabetes Center

1. Gestational diabetes practice guidelines. (NGC-1789)
   • Staged diabetes management: a systematic approach. Minneapolis (MN): Matrex, International Diabetes Center; 2000. Gestational diabetes practice guidelines. p. 173-205. [19 references]

   CURRENT NGC SUMMARY: Gestational diabetes practice guidelines. (NGC-3188)

2. Type 2 diabetes practice guidelines. (NGC-1788)
   • Staged diabetes management: a systematic approach. Minneapolis (MN): Matrex, International Diabetes Center; 2000. Type 2 diabetes practice guidelines. p. 63-131. [35 references]

   CURRENT NGC SUMMARY: Type 2 diabetes practice guidelines. (NGC-3187)

3. Type I diabetes practice guidelines. (NGC-1787)
   • International Diabetes Center, Institute for Research and Education. Staged diabetes management: a systematic approach. Minneapolis (MN): Matrex, International Diabetes Center; 2000 . Type 1 diabetes practice guidelines. p. 133-71. [14 references]

   CURRENT NGC SUMMARY: Type I diabetes practice guidelines. (NGC-3186)

International Lactation Consultant Association

1. Evidence-based guidelines for breastfeeding management during the first fourteen days. (NGC-1335)
   • International Lactation Consultant Association. Evidence-based guidelines for breastfeeding management during the first fourteen days. Raleigh (NC): International Lactation Consultant Association; 1999 Apr. 31 p. [109 references]

   CURRENT NGC SUMMARY: Clinical guidelines for the establishment of exclusive breastfeeding. (NGC-4461)

Joint Council of Allergy, Asthma and Immunology

1. Disease management of atopic dermatitis: a practice parameter. (NGC-0670)
   • Joint Council of Allergy, Asthma and Immunology. Disease management of atopic dermatitis: a practice parameter. Ann Allergy Asthma Immunol 1997 Sep;79(3):197-211. [107 references]

   CURRENT NGC SUMMARY: Disease management of atopic dermatitis: an updated practice parameter. (NGC-4210)

2. Practice parameters for allergen immunotherapy. (NGC-0671)
   • Joint Council of Allergy, Asthma and Immunology. Practice parameters for allergen immunotherapy. J Allergy Clin Immunol 1996 Dec;98(6 Pt 1):1001-11. [66 references]

   CURRENT NGC SUMMARY: Allergen immunotherapy: a practice parameter. (NGC-2847)

3. Practice parameters for the diagnosis and management of immunodeficiency. (NGC-0672)
   • Joint Council of Allergy, Asthma and Immunology. Practice parameters for the diagnosis and management of immunodeficiency. Ann Allergy Asthma Immunol 1996 Mar;76(3):282-94. [47 references]

   CURRENT NGC SUMMARY: Practice parameter for the diagnosis and management of primary immunodeficiency. (NGC-4445)

4. Practice parameters for the diagnosis and treatment of asthma. (NGC-0675)
   • Joint Council of Allergy, Asthma and Immunology. Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol 1995 Nov;96(5 Pt 2):707-870. [1195 references]

   CURRENT NGC SUMMARY: Attaining optimal asthma control: a practice parameter. (NGC-4702)

Kaiser Permanente Care Management Institute

1. Adult diabetes clinical practice guidelines. (NGC-3597)
   • Kaiser Permanente Care Management Institute. Adult diabetes clinical practice guidelines. Oakland (CA): Kaiser Permanente Care Management Institute; 2004 Mar. 167 p. [119 references]

   CURRENT NGC SUMMARY: Adult diabetes clinical practice guidelines. (NGC-5175)

Massachusetts Department of Public Health, Bureau of Family and Community Health, Diabetes Control Program

1. Massachusetts guidelines for adult diabetes care. (NGC-2655)
   • Massachusetts Department of Public Health: Diabetes Control Program, Diabetes Guidelines Work Group. Massachusetts guidelines for adult diabetes care. Boston (MA): Massachusetts Department of Public Health; 2001 Jun. Various p.

   CURRENT NGC SUMMARY: Massachusetts guidelines for adult diabetes care. (NGC-4571)

Michigan Quality Improvement Consortium

1. Acute pharyngitis in children. (NGC-4557)
   • Michigan Quality Improvement Consortium. Acute pharyngitis in children. Southfield (MI): Michigan Quality Improvement Consortium; 2004 Apr. 1 p.

   CURRENT NGC SUMMARY: Acute pharyngitis in children. (NGC-5682)

2. Adult preventive services (ages 18 – 49). (NGC-4554)
   • Michigan Quality Improvement Consortium. Adult preventive services (ages 18-49). Southfield (MI): Michigan Quality Improvement Consortium; 2005 Jul. 1 p.

   CURRENT NGC SUMMARY: Adult preventive services (ages 18 - 49). (NGC-5238)

3. Adult preventive services (ages 50 – 65+). (NGC-4555)
   • Michigan Quality Improvement Consortium. Adult preventive services (ages 50-65+). Southfield (MI): Michigan Quality Improvement Consortium; 2005 Jul. 1 p.

   CURRENT NGC SUMMARY: Adult preventive services (ages 50 - 65+). (NGC-5239)

4. Identification, evaluation, and treatment of overweight and obesity in the adult. (NGC-4556)
   • Michigan Quality Improvement Consortium. Identification, evaluation, and treatment of overweight and obesity in the adult. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Mar. 1 p.

   CURRENT NGC SUMMARY: Management of overweight and obesity in the adult. (NGC-5683)

5. Management and prevention of osteoporosis. (NGC-5237)
   • Michigan Quality Improvement Consortium. Management and prevention of osteoporosis. Southfield (MI): Michigan Quality Improvement Consortium; 2006 Jan. 1 p.

   CURRENT NGC SUMMARY: Management and prevention of osteoporosis. (NGC-6329)

6. Management of adults with major depression. (NGC-6328)
   • Michigan Quality Improvement Consortium. Management of adults with major depression. Southfield (MI): Michigan Quality Improvement Consortium; 2008 Jan. 1 p.

   CURRENT NGC SUMMARY: Management of adults with major depression. (NGC-6531)

7. Management of diabetes mellitus. (NGC-3952)
   • Michigan Quality Improvement Consortium. Management of diabetes mellitus. Southfield (MI): Michigan Quality Improvement Consortium; 2004 Jul. 1 p.

   CURRENT NGC SUMMARY: Management of diabetes mellitus. (NGC-5235)

8. Management of persistent asthma. (NGC-3953)
   • Michigan Quality Improvement Consortium. Management of persistent asthma. Southfield (MI): Michigan Quality Improvement Consortium; 2004 Aug. 1 p.

   CURRENT NGC SUMMARY: Management of persistent asthma in adults and children older than 5 years of age. (NGC-5236)

9. Medical management of adults with hypertension. (NGC-4550)
   • Michigan Quality Improvement Consortium. Medical management of adults with hypertension. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Aug. 1 p.

   CURRENT NGC SUMMARY: Medical management of adults with hypertension. (NGC-5980)

10. Medical management of adults with osteoarthritis. (NGC-4551)
    • Michigan Quality Improvement Consortium. Medical management of adults with osteoarthritis. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Aug. 1 p.

    CURRENT NGC SUMMARY: Medical management of adults with osteoarthritis. (NGC-5981)

11. Outpatient management of uncomplicated deep venous thrombosis. (NGC-4552)
    • Michigan Quality Improvement Consortium. Outpatient management of uncomplicated deep vein thrombosis. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Aug. 1 p.

    CURRENT NGC SUMMARY: Outpatient management of uncomplicated deep venous thrombosis. (NGC-5982)

12. Screening and management of hyperlipidemia. (NGC-4549)
    • Michigan Quality Improvement Consortium. Screening and management of hyperlipidemia. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Aug. 1 p.

    CURRENT NGC SUMMARY: Screening and management of hyperlipidemia. (NGC-5979)

13. Screening and management of substance use disorders. (NGC-4548)
    • Michigan Quality Improvement Consortium. Screening and management of substance use disorders. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Aug. 1 p.

    CURRENT NGC SUMMARY: Screening, diagnosis and referral for substance use disorders. (NGC-5978)

14. Tobacco control. (NGC-4553)
    • Michigan Quality Improvement Consortium. Tobacco control. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Sep. 1 p.

    CURRENT NGC SUMMARY: Tobacco control. (NGC-5983)

National Abortion Federation

1. Clinical policy guidelines. (NGC-5572)
   • National Abortion Federation (NAF). Clinical policy guidelines. Washington (DC): National Abortion Federation (NAF); 2007. 48 p. [68 references]

   CURRENT NGC SUMMARY: Clinical policy guidelines. (NGC-6446)

National Academy of Clinical Biochemistry

1. Recommendations for the use of cardiac markers in coronary artery diseases. (NGC-2745)
   • Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999 Jul;45(7):1104-21. [119 references] PubMed

   CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. (NGC-6039)

   CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry and IFCC Committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: Analytical issues for biochemical markers of acute coronary syndromes. (NGC-6040)

   CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. (NGC-6041)

   CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry and IFCC Committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: Analytical issues for biomarkers of heart failure. (NGC-6042)

   CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Point of care testing, oversight and administration of cardiac biomarkers for acute coronary syndromes. (NGC-6043)

   CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type Natriuretic Peptide for Etiologies other than acute coronary syndromes and heart failure. (NGC-6044)

National Heart, Lung, and Blood Institute (U.S.)

1. Expert Panel Report: guidelines for the diagnosis and management of asthma. Update on selected topics. (NGC-2721)
   • National Asthma Education and Prevention Program Expert Panel Report: guidelines for the diagnosis and management of asthma update on selected topics-2002. J Allergy Clin Immunol 2002 Nov;110(5 pt 2):S141-219.

   CURRENT NGC SUMMARY: Measures of asthma assessment and monitoring: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-5905)

   CURRENT NGC SUMMARY: Education for a partnership in asthma care: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6021)

   CURRENT NGC SUMMARY: Control of environmental factors and comorbid conditions that affect asthma: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6022)

   CURRENT NGC SUMMARY: Medications: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6023)

   CURRENT NGC SUMMARY: Managing asthma long term in children 0-4 years of age and 5-11 years of age: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6024)

   CURRENT NGC SUMMARY: Managing asthma long term in youths >12 years of age and Adults: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6025)

   CURRENT NGC SUMMARY: Managing asthma long term-special situations: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6026)

   CURRENT NGC SUMMARY: Managing exacerbations of asthma: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6027)

2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-2970)
   • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003 May 21;289(19):2560-71. [81 references] PubMed

   CURRENT NGC SUMMARY: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-3450)

3. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (NGC-2195)
   • National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute; 2001 May. Various p. [1274 references]

   CURRENT NGC SUMMARY: (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2)Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (NGC-3746)

National Institute for Health and Clinical Excellence (NICE)

1. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease. (NGC-5408)
   • National Institute for Health and Clinical Excellence (NICE). Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Nov. 64 p. (Technology appraisal guidance; no. 111).

   CURRENT NGC SUMMARY: (1) Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (2) 2007 addendum. (NGC-5956)

National Kidney Foundation

1. NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2000. (NGC-2007)
   • NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2000. Am J Kidney Dis 2001 Jan;37(1 Suppl 1):S7-S64. [259 references]

   CURRENT NGC SUMMARY: NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2006. (NGC-5329)

2. NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. (NGC-2008)
   • NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis 2001 Jan;37(1 Suppl 1):S65-S136. [143 references]

   CURRENT NGC SUMMARY: NKF-KDOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2006. (NGC-5330)

3. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. (NGC-2009)
   • NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001 Jan;37(1 Suppl 1):S137-81. [209 references]

   CURRENT NGC SUMMARY: NKF-KDOQI clinical practice guidelines for vascular access: update 2006. (NGC-5331)

National Osteoporosis Foundation

1. Physician's guide to prevention and treatment of osteoporosis. (NGC-1377)
   • National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Belle Mead (NJ): Excerpta Medica, Inc.; 1999. 28 p.

   CURRENT NGC SUMMARY: Physician's guide to prevention and treatment of osteoporosis. (NGC-3073)

National Society of Genetic Counselors

1. Genetic counseling for fragile X syndrome: recommendations of the National Society of Genetic Counselors. (NGC-1772)
   • McIntosh N, Gane LW, McConkie-Rosell A, Bennett RL. Genetic counseling for fragile X syndrome: recommendations of the National Society of Genetic Counselors. J Genet Counsel 2000;9(4):303-25.

   CURRENT NGC SUMMARY: Genetic counseling for fragile X syndrome: updated recommendations of the National Society of Genetic Counselors. (NGC-4730)

New York State Department of Health

1. Antiretroviral therapy. (NGC-5881)
   • New York State Department of Health. Antiretroviral therapy. New York (NY): New York State Department of Health; 2007 Aug. 50 p. [18 references]

   CURRENT NGC SUMMARY: Antiretroviral therapy. (NGC-6653)

2. Anxiety disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4157)
   • Anxiety disorders in patients with HIV/AIDS. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 59-68.

   CURRENT NGC SUMMARY: Anxiety disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4888)

3. Cognitive disorders and HIV/AIDS: HIV-associated dementia and delirium. (NGC-4558)
   • New York State Department of Health. Cognitive disorders and HIV/AIDS: HIV-associated dementia and delirium. New York (NY): New York State Department of Health; 2005 Oct. 7 p. [6 references]

   CURRENT NGC SUMMARY: Cognitive disorders and HIV/AIDS: HIV-associated dementia and delirium. (NGC-6469)

4. Depression and mania in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4155)
   • Depression and mania in patients with HIV/AIDS (updated online 2005 Mar). In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 1-20.

   CURRENT NGC SUMMARY: Depression and mania in patients with HIV/AIDS. (NGC-6613)

5. Diagnostic, prognostic, and resistance tests for HIV. (NGC-3936)
   • New York State Department of Health. Diagnostic, prognostic, and resistance tests for HIV. New York (NY): New York State Department of Health; 2004. 18 p.

   CURRENT NGC SUMMARY: Diagnostic, monitoring, and resistance tests for HIV. (NGC-4378)

6. Drug-drug interactions between HAART, medications used in substance use treatment, and recreational drugs. (NGC-4452)
   • New York State Department of Health. Drug-drug interactions between HAART, medications used in substance use treatment, and recreational drugs. New York (NY): New York State Department of Health; 2005 Jul. 22 p. [57 references]

   CURRENT NGC SUMMARY: Drug-drug interactions between HAART, medications used in substance use treatment, and recreational drugs. (NGC-6471)

7. Growth, body composition, and metabolism. (NGC-3930)
   • New York State Department of Health. Growth, body composition, and metabolism. New York (NY): New York State Department of Health; 2004. 25 p. [24 references]

   CURRENT NGC SUMMARY: Growth, body composition, and metabolism. (NGC-6474)

8. Hepatitis A virus. (NGC-5758)
   • New York State Department of Health. Hepatitis A virus. New York (NY): New York State Department of Health; 2006 Apr. 4 p. [10 references]

   CURRENT NGC SUMMARY: Hepatitis A. (NGC-6466)

9. Hepatitis B virus. (NGC-4534)
   • New York State Department of Health. Hepatitis B virus. New York (NY): New York State Department of Health; 2004 Sep. 12 p.

   CURRENT NGC SUMMARY: Hepatitis B virus. (NGC-6614)

10. Hepatitis C virus. (NGC-3941)
    • New York State Department of Health. Hepatitis C virus. New York (NY): New York State Department of Health; 2003. 15 p. [14 references]

    CURRENT NGC SUMMARY: Hepatitis C virus. (NGC-4533)

11. HIV drug - drug interactions. (NGC-5756)
    • New York State Department of Health. HIV drug-drug interactions. New York (NY): New York State Department of Health; 2007 Feb. 44 p. [34 references]

    CURRENT NGC SUMMARY: HIV drug - drug interactions. (NGC-6467)

12. HIV post-exposure prophylaxis for children beyond the perinatal period. (NGC-3050)
    • New York State Department of Health. HIV post-exposure prophylaxis for children beyond the perinatal period. New York (NY): New York State Department of Health; 2002 Mar. 26 p. [36 references]

    CURRENT NGC SUMMARY: HIV post-exposure prophylaxis for children beyond the perinatal period. (NGC-3943)

13. HIV prophylaxis following non-occupational exposure including sexual assault. (NGC-5745)
    • New York State Department of Health. HIV prophylaxis following non-occupational exposure including sexual assault. New York (NY): New York State Department of Health; 2005 Dec. 46 p. [31 references]

    CURRENT NGC SUMMARY: HIV prophylaxis following non-occupational exposure including sexual assault. (NGC-6475)

14. HIV prophylaxis following occupational exposure. (NGC-5760)
    • New York State Department of Health. HIV prophylaxis following occupational exposure. New York (NY): New York State Department of Health; 2005 Dec. 44 p. [17 references]

    CURRENT NGC SUMMARY: HIV prophylaxis following occupational exposure. (NGC-6476)

15. Identification and ambulatory care of HIV-exposed and -infected adolescents. (NGC-3942)
    • New York State Department of Health. Identification and ambulatory care of HIV-exposed and -infected adolescents . New York (NY): New York State Department of Health; 2003. 21 p. [22 references]

    CURRENT NGC SUMMARY: Identification and ambulatory care of HIV-exposed and -infected adolescents. (NGC-5759)

16. Infectious complications associated with HIV infection: mycobacterial infections. (NGC-5747)
    • New York State Department of Health. Infectious complications associated with HIV infection: mycobacterial infections. New York (NY): New York State Department of Health; 2005 May. 20 p. [11 references]

    CURRENT NGC SUMMARY: Mycobacterial infections. (NGC-6468)

17. Long-term complications of antiretroviral therapy. (NGC-3933)
    • New York State Department of Health. Long-term complications of antiretroviral therapy. New York (NY): New York State Department of Health; 2004. 17 p. [39 references]

    CURRENT NGC SUMMARY: Long-term complications of antiretroviral therapy. (NGC-5755)

18. Oral health management of children and adolescents with HIV infections. (NGC-3035)
    • New York State Department of Health. Oral health management of children and adolescents with HIV infection. New York (NY): New York State Department of Health; 2003. 10 p. [6 references]

    CURRENT NGC SUMMARY: Oral health management of children and adolescents with HIV infections. (NGC-3891)

19. Primary care approach to the HIV-infected patient. (NGC-3935)
    • New York State Department of Health. Primary care approach to the HIV-infected patient. New York (NY): New York State Department of Health; 2004. 18 p. [9 references]

    CURRENT NGC SUMMARY: Primary care approach to the HIV-infected patient. (NGC-5757)

20. Smoking cessation in HIV-infected patients. (NGC-4450)
    • New York State Department of Health. Smoking cessation in HIV-infected patients. New York (NY): New York State Department of Health; 2005 Jun. 8 p. [17 references]

    CURRENT NGC SUMMARY: Smoking cessation in HIV-infected patients. (NGC-6472)

21. Substance use treatment modalities for HIV-infected persons. (NGC-5753)
    • New York State Department of Health. Substance use treatment modalities for HIV-infected persons. New York (NY): New York State Department of Health; 2005 Jul. 11 p. [21 references]

    CURRENT NGC SUMMARY: Substance use treatment modalities for HIV-infected persons. (NGC-6473)

22. Suicidality in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4156)
    • Suicidality in patients with HIV/AIDS. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 53-8.

    CURRENT NGC SUMMARY: Suicidality and violence in patients with HIV/AIDS. (NGC-5459)

23. Trauma and post-traumatic stress disorder in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4158)
    • Trauma and post-traumatic stress disorder in patients with HIV/AIDS (updated online 2004 Sep). In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 69-75.

    CURRENT NGC SUMMARY: Trauma and post-traumatic stress disorder in patients with HIV/AIDS. (NGC-6470)

24. Working with patients' personalities and styles. Mental health care for people with HIV infection. (NGC-4152)
    • Working with patients' personalities and styles. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 19-23.

    CURRENT NGC SUMMARY: Personality disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-5002)

New Zealand Guidelines Group

1. Primary care guidelines for the management of core aspects of diabetes care. (NGC-2336)
   • New Zealand Guidelines Group. Primary care guidelines for the management of core aspects of diabetes care. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2000 Jun. 19 p. [41 references]

   CURRENT NGC SUMMARY: Management of type 2 diabetes. (NGC-3363)

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

1. Constipation in infants and children: evaluation and treatment. (NGC-2821)
   • Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, Nurko S. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999 Nov;29(5):612-26. [77 references] PubMed

   CURRENT NGC SUMMARY: Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. (NGC-5245)

North American Spine Society

1. North American Spine Society Phase III: clinical guidelines for multidisciplinary spine care specialists. Spinal stenosis version 1.0. (NGC-2835)
   • North American Spine Society (NASS). Phase III clinical guidelines for multidisciplinary spine care specialists. Spinal stenosis version 1.0. LaGrange (IL): North American Spine Society (NASS); 2002. 91 p. [197 references]

   CURRENT NGC SUMMARY: Diagnosis and treatment of degenerative lumbar spinal stenosis. (NGC-5896)

Oncology Nursing Society

1. Access device guidelines: recommendations for nursing practice and education. (NGC-0909)
   • Oncology Nursing Society (ONS). Access device guidelines: recommendations for nursing practice and education. Pittsburgh (PA): Oncology Nursing Society; 1996. 83 p. [326 references]

   CURRENT NGC SUMMARY: Access device guidelines: recommendations for nursing practice and education. (NGC-4666)

Philippine Academy of Ophthalmology

1. Clinical practice guideline for the management of cataract among adults. (NGC-2189)
   • Philippine Academy of Ophthalmology. Clinical practice guideline for the management of cataract among adults. Philippines: Philippine Academy of Ophthalmology; 2001. 27 p. [73 references]

   CURRENT NGC SUMMARY: (1) Clinical practice guideline for the management of cataract among adults. (2) Updated recommendation #14. (NGC-4559)

Program in Evidence-based Care

1. Adjuvant systemic chemotherapy, following surgery and external beam radiotherapy, for adults with newly diagnosed malignant glioma. (NGC-3654)
   • Neuro-Oncology Disease Site Group. Perry J, Zuraw L. Adjuvant systemic chemotherapy, following surgery and external beam radiotherapy, for adults with newly diagnosed malignant glioma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Jun [online update]. 14 p. (Practice guideline report; no. 9-2). [32 references]

   CURRENT NGC SUMMARY: Adjuvant systemic chemotherapy, following surgery and external beam radiotherapy, for adults with newly diagnosed malignant glioma: a clinical practice guideline. (NGC-5092)

2. Adjuvant systemic therapy for node-negative breast cancer. (NGC-2506)
   • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Adjuvant systemic therapy for node-negative breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Feb. Various p. (Practice guideline; no. 1-8). [50 references]

   CURRENT NGC SUMMARY: Adjuvant systemic therapy for node-negative breast cancer. (NGC-3346)

3. Adjuvant therapy for stage II colon cancer following complete resection. (NGC-3462)
   • Gastrointestinal Disease Site Group. Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S. Adjuvant therapy for stage II colon cancer following complete resection [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Dec [online update]. 30 p. (Practice guideline report; no. 2-1). [70 references]

   CURRENT NGC SUMMARY: Adjuvant systemic chemotherapy for stage II and III colon cancer following complete resection: guideline recommendations. (NGC-6528)

4. Adjuvant therapy for stage III colon cancer following complete resection. (NGC-3463)
   • Gastrointestinal Cancer Disease Site Group. Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S. Adjuvant therapy for stage III colon cancer following complete resection [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Dec [online update]. 34 p. (Practice guideline report; no. 2-2). [81 references]

   CURRENT NGC SUMMARY: Adjuvant systemic chemotherapy for stage II and III colon cancer following complete resection: guideline recommendations. (NGC-6528)

5. Baseline staging tests in primary breast cancer. (NGC-2441)
   • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Baseline staging tests in primary breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Feb. Various p. (Practice guideline; no. 1-14).
   
   
   
   • Myers RE, Johnston M, Pritchard K, Levine M, Oliver T, Breast Cancer Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Baseline staging tests in primary breast cancer: a practice guideline. CMAJ 2001 May 15;164(10):1439-44. [34 references] PubMed

   CURRENT NGC SUMMARY: Baseline staging tests in primary breast cancer. (NGC-3345)

6. Chemotherapy in stage IV (metastatic) non-small cell lung cancer. (NGC-2422)
   • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Chemotherapy in stage IV (metastatic) non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Jan [online update]. Various p. (Practice guideline; no. 7-2). [28 references]

   CURRENT NGC SUMMARY: Chemotherapy in stage IV (metastatic) non-small cell lung cancer. (NGC-5093)

7. Combined modality radiotherapy and chemotherapy in the non-surgical management of localized carcinoma of the esophagus. (NGC-3264)
   • Gastrointestinal Cancer Disease Site Group. Wong RK, Malthaner RA, Zuraw L, Rumble RB. Combined modality radiotherapy and chemotherapy in the non-surgical management of localized carcinoma of the esophagus [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Aug 18 [online update]. 22 p. (Practice guideline; no. 2-12). [49 references]

   CURRENT NGC SUMMARY: Combined modality radiotherapy and chemotherapy in the non-surgical management of localized carcinoma of the esophagus. (NGC-4572)

8. Epirubicin, as a single agent or in combination, for metastatic breast cancer. (NGC-2424)
   • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Epirubicin, as a single agent or in combination, for metastatic breast cancer [full report]. Toronto (ON): CCOPGI; 2002 Feb [online update]. Various p. (Practice guideline report; no. 1-6). [14 references]

   CURRENT NGC SUMMARY: Epirubicin, as a single agent or in combination, for metastatic breast cancer. (NGC-3344)

9. First-line chemotherapy for postoperative patients with stage II, III or IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (NGC-3458)
   • Gynecology Disease Site Group. Covens A, Carey M, Bryson P, Verma S, Fung Kee Fung M. First-line chemotherapy for postoperative patients with stage II, III or IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Jan [online update]. 37 p. (Practice guideline report; no. 4-1-2). [64 references]

   CURRENT NGC SUMMARY: First-line chemotherapy for postoperative patients with stage II, III or IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. (NGC-3772)

10. Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2218)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Nov. Various p. (Practice guideline; no. 5-6b). [19 references]
    
    
    
    • Mackenzie RG, Hodson DI, Browman GP, Zuraw L, Head and Neck Cancer Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Curr Oncol 2001;8:6-15. [19 references]

    CURRENT NGC SUMMARY: Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2827)

11. Management of ductal carcinoma in situ of the breast. (NGC-2927)
    • Breast Cancer Disease Site Group. Management of ductal carcinoma in situ of the breast [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan [online update]. 18 p. (Practice guideline; no. 1-10). [46 references]

    CURRENT NGC SUMMARY: Management of ductal carcinoma in situ of the breast: a clinical practice guideline. (NGC-5344)

12. Management of single brain metastases. (NGC-3843)
    • Neuro-oncology Disease Site Group. Mintz AP, Perry J, Cairncross G, Chambers A. Management of single brain metastases [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Aug 17. 25 p. (Practice guideline report; no. 9-1). [50 references]

    CURRENT NGC SUMMARY: Management of single brain metastases: a clinical practice guideline. (NGC-5651)

13. Neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx). (NGC-2225)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx) [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul [online update]. Various p. (Practice guideline; no. 5-1). [36 references]

    CURRENT NGC SUMMARY: The role of neoadjuvant chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN) (excluding nasopharynx). (NGC-2925)

14. Neoadjuvant or adjuvant therapy for resectable esophageal cancer. (NGC-3466)
    • Gastrointestinal Cancer Disease Site Group. Malthaner R, Wong RK, Rumble RB, Zuraw L. Neoadjuvant or adjuvant therapy for resectable esophageal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Apr 16. 28 p. (Practice guideline report; no. 2-11). [51 references]

    CURRENT NGC SUMMARY: Neoadjuvant or adjuvant therapy for resectable esophageal cancer. (NGC-4436)

15. Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support. (NGC-2438)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Apr [online update]. Various p. (Practice guideline; no. 6-6). [90 references]
    
    
    
    • Imrie K, Esmail R, Meyer RM. The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines Initiative. Ann Intern Med 2002 Apr 16;136(8):619-29. [44 references] PubMed

    CURRENT NGC SUMMARY: Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support. (NGC-3539)

16. Oral capecitabine (Xeloda™) in the first-line treatment of metastatic colorectal cancer. (NGC-3465)
    • Gastrointestinal Cancer Disease Site Group. Kocha W, Maroun J, Jonker D, Rumble RB, Zuraw L. Oral capecitabine (Xeloda) in the first-line treatment of metastatic colorectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Dec 5. 19 p. (Practice guideline report; no. 2-15). [26 references]

    CURRENT NGC SUMMARY: Oral capecitabine (Xeloda) in the first-line treatment of metastatic colorectal cancer: a clinical practice guideline. (NGC-5094)

17. Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer. (NGC-3262)
    • Lung Cancer Disease Site Group. Okawara G, Ung YC, Markman BR, Mackay JA, Evans WK. Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Aug [online update]. 15 p. (Practice guideline; no. 7-1-1). [14 references]

    CURRENT NGC SUMMARY: Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer. (NGC-4124)

18. Primary treatment for locally advanced cervical cancer: concurrent platinum-based chemotherapy and radiation. (NGC-3088)
    • Gynecology Cancer Disease Site Group. Lukka H, Hirte H, Fyles A, Thomas G, Fung Kee Fung M. Primary treatment for locally advanced cervical cancer: concurrent platinum-based chemotherapy and radiation [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jun [online update]. 25 p. (Practice guideline; no. 4-5). [25 references]

    CURRENT NGC SUMMARY: Primary treatment for locally advanced cervical cancer: concurrent platinum-based chemotherapy and radiation. (NGC-3773)

19. Prophylactic cranial irradiation in small cell lung cancer. (NGC-2685)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI), Lung Cancer Disease Site Group. Kotalik J, Yu E, Markman BR, Gagliardi A, Evans WK. Prophylactic cranial irradiation in small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 July [online update]. 14 p. (Practice guideline; no. 7-13-2). [14 references]

    CURRENT NGC SUMMARY: Prophylactic cranial irradiation in small cell lung cancer. (NGC-3347)

20. Radiotherapy for newly diagnosed malignant glioma in adults. (NGC-3775)
    • Neuro-oncology Disease Site Group. Laperriere N, Perry J, Zuraw L. Radiotherapy for newly diagnosed malignant glioma in adults [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Jun [online update]. 27 p. (Practice guideline report; no. 9-3). [80 references]

    CURRENT NGC SUMMARY: Radiotherapy for newly diagnosed malignant glioma in adults: a clinical practice guideline. (NGC-4954)

21. Rituximab in lymphoma and chronic lymphocytic leukemia: a clinical guideline (NGC-4353)
    • Hematology Disease Site Group. Imrie K, Stevens A, Meyer R. Rituximab in lymphoma and chronic lymphocytic leukemia: a clinical practice guideline. Toronto (ON): Cancer Care Ontario (CCO); 2005 Feb 17. 43 p. (Evidence-based series; no. 6-8). [51 references]

    CURRENT NGC SUMMARY: Rituximab in lymphoma and chronic lymphocytic leukemia: a clinical practice guideline. (NGC-5095)

22. Screening for skin cancer: a clinical practice guideline. (NGC-5025)
    • From L, Marrett L, Johnston M, Mai V, Fong J, Rosen C, Bak K, Sibbald G, Skin Cancer Screening Guideline Panel. Screening for skin cancer: a clinical practice guideline. Toronto (ON): Cancer Care Ontario (CCO); 2006 Mar 15. 32 p. (Evidence-based series; no. 15-1). [70 references]

    CURRENT NGC SUMMARY: Screening for skin cancer: a clinical practice guideline. (NGC-5888)

23. Surgical management of early stage invasive breast cancer (stage I and II). (NGC-2425)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Surgical management of early stage invasive breast cancer (stage I and II) [full report]. Toronto (ON): CCOPGI; 2002 Jan [online update]. Various p. (Practice guideline report; no. 1-1). [20 references]

    CURRENT NGC SUMMARY: Surgical management of early stage invasive breast cancer. (NGC-2932)

24. Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients. (NGC-2760)
    • Hodson DI, Haines T, Berry M, Johnston M, Head and Neck Cancer Disease Site Group. Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct [online update]. 15 p. (Practice guideline; no. 5-5). [28 references]

    CURRENT NGC SUMMARY: Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients. (NGC-3526)

25. Systemic adjuvant therapy for patients at high risk for recurrent melanoma. (NGC-3774)
    • Melanoma Disease Site Group. Systemic adjuvant therapy for patients at high risk for recurrent melanoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Jun 30. 33 p. (Practice guideline report; no. 8-1). [59 references]

    CURRENT NGC SUMMARY: Systemic adjuvant therapy for patients at high risk for recurrent melanoma: a clinical practice guideline. (NGC-5020)

26. The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: a clinical practice. (NGC-4716)
    • Eisen A, Trudeau M, Sinclair S, Breast Cancer Disease Site Group. The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: a clinical practice guideline. Toronto (ON): Cancer Care Ontario (CCO); 2005 Oct 25. Various p. (Evidence-based series; no. 1-18). [42 references]

    CURRENT NGC SUMMARY: The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: guideline recommendations. (NGC-6433)

27. The role of Bevacizumab (Avastin™) combined with chemotherapy in the treatment of patients with advanced colorectal cancer: a clinical practice guideline. (NGC-4866)
    • Welch S, Kocha W, Rumble RB, Spithoff K, Maroun J, Gastrointestinal Cancer Disease Site Group. The role of bevacizumab (Avastin) combined with chemotherapy in the treatment of patients with advanced colorectal cancer. Toronto (ON): Cancer Care Ontario (CCO); 2005 Dec 12. 23 p. (Evidence-based series; no. 2-25). [18 references]

    CURRENT NGC SUMMARY: The role of Bevacizumab (Avastin®) combined with chemotherapy in the treatment of patients with advanced colorectal cancer: a clinical practice guideline. (NGC-6314)

28. The role of chemotherapy with radiotherapy in the management of patients with newly diagnosed locally advanced squamous cell or undifferentiated nasopharyngeal cancer. (NGC-3527)
    • Head and Neck Cancer Disease Site Group. Thephamongkhol K, Browman G, Hodson I, Oliver T, Zuraw L. The role of chemotherapy with radiotherapy in the management of patients with newly diagnosed locally advanced squamous cell or undifferentiated nasopharyngeal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Mar [online update]. 20 p. (Practice guideline report; no. 5-7). [25 references]

    CURRENT NGC SUMMARY: Chemotherapy with radiotherapy for nasopharyngeal cancer. (NGC-4357)

29. The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy. (NGC-2969)
    • Systematic Treatment Disease Site Group. The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Mar [online update]. 25 p. (Practice guideline; no. 12-1). [55 references]

    CURRENT NGC SUMMARY: The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy. (NGC-4311)

30. The role of gemcitabine in the management of metastatic breast cancer: a clinical practice guideline. (NGC-5099)
    • Dent S, Messersmith H, Trudeau M, Breast Cancer Disease Site Group. The role of gemcitabine in the management of metastatic breast cancer: a clinical practice guideline. Toronto (ON): Cancer Care Ontario (CCO); 2006 Jun 27. 36 p. (Evidence-based series; no. 1-12). [148 references]

    CURRENT NGC SUMMARY: The role of gemcitabine in the management of metastatic breast cancer: a clinical practice guideline. (NGC-5583)

31. The role of octreotide in the management of patients with cancer. (NGC-3260)
    • Systemic Treatment Disease Site Group. Major P, Figueredo A, Tandan V, Bramwell V, Charette M, Oliver T. The role of octreotide in the management of patients with cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May 7. 27 p. (Practice guideline; no. 12-7). [51 references]

    CURRENT NGC SUMMARY: The role of octreotide in the management of patients with cancer. (NGC-4042)

32. The role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first and second-line treatment of advanced colorectal cancer: a clinical practice guideline. (NGC-5345)
    • Jonker D, Rumble RB, Maroun J, Gastrointestinal Cancer Disease Site Group. The role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first and second-line treatment of advanced colorectal cancer: a clinical practice guideline. Toronto (ON): Cancer Care Ontario (CCO); 2005 Jun 2. 27 p. (Evidence-based series; no. 2-22). [36 references]

    CURRENT NGC SUMMARY: The role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first and second-line treatment of advanced colorectal cancer: a clinical practice guideline. (NGC-6242)

33. The role of single-agent docetaxel (Taxotere®) as a second-line treatment for advanced non-small-cell lung cancer. (NGC-4435)
    • Lung Cancer Disease Site Group. The role of single-agent docetaxel (Taxotere) as a second-line treatment for advanced non-small-cell lung cancer. Toronto (ON): Cancer Care Ontario (CCO); 2005 Jan. 14 p. (Practice guideline report; no. 7-7-2). [16 references]

    CURRENT NGC SUMMARY: Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a clinical practice guideline. (NGC-4953)

34. The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer. (NGC-2222)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Oct [online update]. Various p. (Practice guideline; no. 7-13-3). [24 references]
    
    
    
    • Okawara G, Gagliardi A, Evans WK, Lung Cancer Disease Site Group, Cancer Care Ontario Practice Guideline Initiative (CCOPGI). The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small-cell lung cancer. Curr Oncol 2000;7(3):162-72. [21 references]

    CURRENT NGC SUMMARY: The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer. (NGC-2991)

35. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer. (NGC-2935)
    • Gastrointestinal Cancer Disease Site Group. Figueredo A, Zuraw L, Wong RK, Agboola O, Tandan V. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Dec [online update]. 23 p. (Practice guideline; no. 2-13). [47 references]

    CURRENT NGC SUMMARY: The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer. (NGC-3461)

36. Unresected stage III non-small cell lung cancer. (NGC-2928)
    • Lung Cancer Disease Site Group. Unresected stage III non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jan [online update]. 22 p. (Practice guideline; no. 7-3). [52 references]

    CURRENT NGC SUMMARY: Management of unresected stage III non-small cell lung cancer: a clinical practice guideline. (NGC-5650)

37. Use of 5-HT₃ receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. (NGC-2420)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul. Various p. (Practice guideline; no. 12-3). [0 references]
    
    
    
    • Warr D, Bramwell V, Anderson D, Charette M, Systemic Treatment Disease Site Group. Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. Curr Oncol 2001;8(2):69-82. [41 references]

    CURRENT NGC SUMMARY: Use of 5-HT₃ receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. (NGC-2972)

38. Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder. (NGC-2833)
    • Genitourinary Cancer Disease Site Group. Segal R, Winquist E, Lukka H, Chin L, Brundage M, Markman BR. Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct [online update]. 12 p. (Practice guideline report; no. 3-2-1). [19 references]

    CURRENT NGC SUMMARY: Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder. (NGC-3263)

39. Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. (NGC-2226)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul [online update]. Various p. (Practice guideline; no. 12-6). [23 references]
    
    
    
    • Cancer Care Ontario Practice Guideline Initiative. Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. Curr Oncol 2000;7(3):149-61. [23 references]

    CURRENT NGC SUMMARY: Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer. (NGC-2929)

40. Use of bisphosphonates in women with breast cancer. (NGC-2931)
    • Breast Cancer Disease Site Group. Use of bisphosphonates in patients with breast cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Dec [online update]. 23 p. (Practice guideline; no. 1-11). [59 references]

    CURRENT NGC SUMMARY: Use of bisphosphonates in women with breast cancer. (NGC-3770)

41. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. (NGC-2584)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Jun [online update]. Various p. (Practice guideline; no. 12-5). [23 references]

    CURRENT NGC SUMMARY: Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. (NGC-3488)

42. Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma. (NGC-3348)
    • Gastrointestinal Cancer Disease Site Group. Germond C, Maroun J, Moore M, Zwaal C, Wong S. Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 Jun 24 [online update]. 15 p. (Practice guideline report; no. 2-10). [19 references]

    CURRENT NGC SUMMARY: Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma. (NGC-5096)

43. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. (NGC-2763)
    • Rusthoven J, Bramwell V, Stephenson B, Provincial Systemic Treatment Disease Site Group. Use of granulocyte colony stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Nov [online update]. 16 p. (Practice guideline; no. 12-2). [76 references]

    CURRENT NGC SUMMARY: The role of colony-stimulating factor (CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. (NGC-3460)

44. Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first line therapy for metastatic colorectal cancer. (NGC-2419)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of irinotecan (Camptosar, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first line therapy for metastatic colorectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Oct. Various p. (Practice guideline; no. 2-16b). [13 references]
    
    
    
    • Jonker D, Earle C, Kocha W, Moore M, Maroun J, Zuraw L, Gastrointestinal Cancer Disease Site Group. Use of irinotecan combined with 5-fluorouracil and leucovorin as first-line therapy for metastatic colorectal cancer. Curr Oncol 2001;8(2):60-8. [13 references]

    CURRENT NGC SUMMARY: Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer. (NGC-2989)

45. Use of irinotecan in the treatment of metastatic colorectal carcinoma. (NGC-3464)
    • Gastrointestinal Cancer Disease Site Group. Figueredo A, Moore M, Germond C, Kocha W, Maroun J, Zwaal C. Use of irinotecan in the treatment of metastatic colorectal carcinoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Dec [online update]. 15 p. (Practice guideline report; no. 2-16). [20 references]

    CURRENT NGC SUMMARY: Use of irinotecan in the second-line treatment of metastatic colorectal carcinoma. (NGC-4358)

46. Use of raltitrexed (Tomudex) in the management of metastatic colorectal carcinoma. (NGC-2926)
    • Gastrointestinal Cancer Disease Site Group. Use of raltitrexed (Tomudex) in the management of metastatic colorectal cancer. Toronto (ON): Cancer Care Ontario (CCO); 2003 Feb [online update]. 16 p. (Practice guideline; no. 2-17). [22 references]

    CURRENT NGC SUMMARY: Use of raltitrexed (Tomudex) in the management of metastatic colorectal cancer. (NGC-4434)

Public Health Service (U.S.)

1. Treating tobacco use and dependence. A clinical practice guideline. (NGC-1586)
   • U.S. Department of Health and Human Services, Public Health Service. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical practice guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 2000 Jun. 197 p. [311 references]

   CURRENT NGC SUMMARY: Treating tobacco use and dependence: 2008 update. (NGC-6444)

Reflex Sympathetic Dystrophy Syndrome Association

1. Clinical practice guideline (second edition) for the diagnosis, treatment, and management of reflex sympathetic dystrophy/complex regional pain syndrome (RSD/CRPS). (NGC-2430)
   • Reflex Sympathetic Dystrophy Syndrome Association (RSDSA). Clinical practice guidelines (second edition) for the diagnosis, treatment, and management of reflex sympathetic dystrophy/complex regional pain syndrome (RSD/CRPS). Milford (CT): Reflex Sympathetic Dystrophy Syndrome Association (RSDSA); 2002 Feb. 46 p. [47 references]

   CURRENT NGC SUMMARY: Complex regional pain syndrome: treatment guidelines (third edition). (NGC-5233)

Registered Nurses Association of Ontario

1. Adult asthma care guidelines for nurses: promoting control of asthma. (NGC-3631)
   • Registered Nurses Association of Ontario (RNAO). Adult asthma care guidelines for nurses: promoting control of asthma. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2004 Mar. 104 p. [119 references]

   CURRENT NGC SUMMARY: Adult asthma care guidelines for nurses: promoting control of asthma. (NGC-5958)

2. Assessment and management of pain. (NGC-2946)
   • Registered Nurses Association of Ontario (RNAO). Assessment and management of pain. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Nov. 142 p. [109 references]

   CURRENT NGC SUMMARY: Assessment and management of pain. (NGC-5960)

3. Assessment and management of stage I to IV pressure ulcers. (NGC-2945)
   • Registered Nurses Association of Ontario (RNAO). Assessment and management of stage I to IV pressure ulcers. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Aug. 104 p. [70 references]

   CURRENT NGC SUMMARY: Assessment and management of stage I to IV pressure ulcers. (NGC-5793)

4. Assessment and management of venous leg ulcers. (NGC-3632)
   • Registered Nurses Association of Ontario (RNAO). Assessment and management of venous leg ulcers. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2004 Mar. 112 p. [64 references]

   CURRENT NGC SUMMARY: Assessment and management of venous leg ulcers. (NGC-5961)

5. Breastfeeding best practice guidelines for nurses. (NGC-3633)
   • Registered Nurses Association of Ontario (RNAO). Breastfeeding best practice guidelines for nurses. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2003 Sep. 120 p. [175 references]

   CURRENT NGC SUMMARY: Breastfeeding best practice guidelines for nurses. (NGC-5959)

6. Client centred care. (NGC-2943)
   • Registered Nurses Association of Ontario (RNAO). Client centred care. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jul. 70 p. [63 references]

   CURRENT NGC SUMMARY: (1) Client centred care. (2) Client centred care 2006 supplement. (NGC-4949)

7. Crisis intervention. (NGC-2944)
   • Registered Nurses Association of Ontario (RNAO). Crisis intervention. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Aug. 55 p. [46 references]

   CURRENT NGC SUMMARY: (1) Crisis intervention. (2) Crisis intervention 2006 supplement. (NGC-4950)

8. Establishing therapeutic relationships. (NGC-2942)
   • Registered Nurses Association of Ontario (RNAO). Establishing therapeutic relationships. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jul. 54 p. [66 references]

   CURRENT NGC SUMMARY: (1) Establishing therapeutic relationships. (2) Establishing therapeutic relationships 2006 supplement. (NGC-4948)

9. Integrating smoking cessation into daily nursing practice. (NGC-3634)
   • Registered Nurses Association of Ontario (RNAO). Integrating smoking cessation into daily nursing practice. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2003 Oct. 80 p. [59 references]

   CURRENT NGC SUMMARY: Integrating smoking cessation into daily nursing practice. (NGC-5957)

10. Prevention of constipation in the older adult population. (NGC-2936)
    • Registered Nurses Association of Ontario (RNAO). Prevention of constipation in the older adult population. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jan. 38 p. [44 references]

    CURRENT NGC SUMMARY: Prevention of constipation in the older adult population. (NGC-4213)

11. Prevention of fall injuries in the older adult. (NGC-2938)
    • Registered Nurses Association of Ontario (RNAO). Prevention of falls and fall injuries in the older adult. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jan. 57 p. [95 references]

    CURRENT NGC SUMMARY: Prevention of falls and fall injuries in the older adult. (NGC-4264)

12. Promoting continence using prompted voiding. (NGC-2937)
    • Registered Nurses Association of Ontario (RNAO). Promoting continence using prompted voiding. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jan. 40 p. [23 references]

    CURRENT NGC SUMMARY: Promoting continence using prompted voiding. (NGC-4214)

13. Risk assessment and prevention of pressure ulcers. (NGC-2939)
    • Registered Nurses Association of Ontario (RNAO). Risk assessment and prevention of pressure ulcers. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jan. 56 p. [44 references]

    CURRENT NGC SUMMARY: Risk assessment & prevention of pressure ulcers. (NGC-4215)

14. Supporting and strengthening families through expected and unexpected life events. (NGC-2941)
    • Registered Nurses Association of Ontario (RNAO). Supporting and strengthening families through expected and unexpected life events. Toronto (ON): Registered Nurses Association of Ontario (RNAO); 2002 Jul. 48 p. [77 references]

    CURRENT NGC SUMMARY: (1) Supporting and strengthening families through expected and unexpected life events. (2) Supporting and strengthening families through expected and unexpected life events 2006 supplement. (NGC-4947)

Royal College of Obstetricians and Gynaecologists

1. Male and female sterilisation. (NGC-1783)
   • Royal College of Obstetricians and Gynaecologists (RCOG). Male and female sterilisation. London: RCOG Press; 1999 Apr. 86 p. (Evidence-based clinical guidelines; no. 4). [275 references]

   CURRENT NGC SUMMARY: Male and female sterilisation. (NGC-4468)

2. The care of women requesting induced abortion. (NGC-1780)
   • Royal College of Obstetricians & Gynaecologists. The care of women requesting induced abortion. London: RCOG Press; 2000. 70 p. (Evidence-based clinical guidelines; no. 7). [176 references]

   CURRENT NGC SUMMARY: The care of women requesting induced abortion. (NGC-4467)

3. The initial investigation and management of the infertile couple. (NGC-1779)
   • Royal College of Obstetricians and Gynaecologists. The initial investigation and management of the infertile couple. London: RCOG Press; 1998 Feb. 82 p. (Evidence-based clinical guidelines; no. 2). [390 references]

   CURRENT NGC SUMMARY: Fertility: assessment and treatment for people with fertility problems. (NGC-3469)

4. The management of infertility in secondary care. (NGC-1778)
   • Royal College of Obstetricians and Gynaecologists. The management of infertility in secondary care. London: RCOG Press; 1998 Feb. 148 p. (Evidence-based clinical guidelines; no. 3). [677 references]

   CURRENT NGC SUMMARY: Fertility: assessment and treatment for people with fertility problems. (NGC-3469)

5. The management of infertility in tertiary care. (NGC-1781)
   • Royal College of Obstetricians and Gynaecologists. The management of infertility in tertiary care. London: RCOG Press; 2000 Jan. 121 p. (Evidence-based clinical guidelines; no. 6). [543 references]

   CURRENT NGC SUMMARY: Fertility: assessment and treatment for people with fertility problems. (NGC-3469)

Scottish Intercollegiate Guidelines Network

1. Breast cancer in women. A national clinical guideline. (NGC-1066)
   • Scottish Intercollegiate Guidelines Network (SIGN). Breast cancer in women. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN), Scottish Cancer Therapy Network; 1998 Oct. 64 p. (SIGN publication; no. 29). [216 references]

   CURRENT NGC SUMMARY: Management of breast cancer in women. A national clinical guideline. (NGC-4745)

2. British guideline on the management of asthma. A clinical national guideline. (NGC-5864)
   • Scottish Intercollegiate Guidelines Network (SIGN), British Thoracic Society. British guideline on the management of asthma. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2007 Jul. 94 p. [680 references]

   CURRENT NGC SUMMARY: British guideline on the management of asthma. A national clinical guideline. (NGC-6484)

3. Coronary revascularisation in the management of stable angina pectoris. A national clinical guideline. (NGC-2131)
   • Coronary revascularisation in the management of stable angina pectoris. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998. 42 p. (SIGN publication; no. 32). [170 references]

   CURRENT NGC SUMMARY: Management of stable angina. A national clinical guideline. (NGC-5526)

4. Diagnosis and management of epilepsy in adults. A national clinical guideline. (NGC-2963)
   • Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of epilepsy in adults. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2003 Apr. 49 p. (SIGN publication; no. 70). [295 references]

   CURRENT NGC SUMMARY: (1) Diagnosis and management of epilepsy in adults. A national clinical guideline. (2) Diagnosis and management of epilepsy in adults. Update to printed guideline. (NGC-3832)

5. Diagnosis and treatment of heart failure due to left ventricular systolic dysfunction. A national clinical guideline. (NGC-2132)
   • Diagnosis and treatment of heart failure due to left ventricular systolic dysfunction. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1999. 68 p. (SIGN publication; no. 35). [214 references]

   CURRENT NGC SUMMARY: Management of chronic heart failure. A national clinical guideline. (NGC-5529)

6. Interventions in the management of behavioural and psychological aspects of dementia. A national clinical guideline. (NGC-2124)
   • Interventions in the management of behavioural and psychological aspects of dementia. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Feb. 26 p. (SIGN publication; no. 22). [76 references]

   CURRENT NGC SUMMARY: Management of patients with dementia. A national clinical guideline. (NGC-4855)

7. Lipids and the primary prevention of coronary heart disease. A national clinical guideline. (NGC-2135)
   • Lipids and the primary prevention of coronary heart disease. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1999. 60 p. (SIGN publication; no. 40). [234 references]

   CURRENT NGC SUMMARY: Risk estimation and the prevention of cardiovascular disease. A national clinical guideline. (NGC-5530)

8. Management of lung cancer. A national clinical guideline. (NGC-2125)
   • Management of lung cancer. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 1998 Feb. 53 p. (SIGN publication; no. 23). [134 references]

   CURRENT NGC SUMMARY: Management of patients with lung cancer. A national clinical guideline. (NGC-4159)

9. Management of stable angina. A national clinical guideline. (NGC-2142)
   • Management of stable angina. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2001. 26 p. (SIGN publication; no. 51). [172 references]

   CURRENT NGC SUMMARY: Management of stable angina. A national clinical guideline. (NGC-5526)

10. Perioperative blood transfusion for elective surgery. A national clinical guideline. (NGC-2303)
    • Scottish Intercollegiate Guidelines Network (SIGN). Perioperative blood transfusion for elective surgery. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2001 Oct. 34 p. (SIGN publication; no. 54). [173 references]

    CURRENT NGC SUMMARY: (1) Perioperative blood transfusion for elective surgery. A national clinical guideline. (2) Perioperative blood transfusion for elective surgery. Update to printed guideline. (NGC-3831)

11. Safe sedation of children undergoing diagnostic and therapeutic procedures. A national clinical guideline. (NGC-2412)
    • Scottish Intercollegiate Guidelines Network (SIGN). Safe sedation of children undergoing diagnostic and therapeutic procedures. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2002 Feb. 28 p. (SIGN publication; no. 58). [175 references]

    CURRENT NGC SUMMARY: Safe sedation of children undergoing diagnostic and therapeutic procedures. A national clinical guideline. (NGC-3833)

12. Secondary prevention of coronary heart disease following myocardial infarction. A national clinical guideline. (NGC-1529)
    • Scottish Intercollegiate Guidelines Network. Secondary prevention of coronary heart disease following myocardial infarction. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2000 Jan. 26 p. (SIGN publication; no. 41). [97 references]

    CURRENT NGC SUMMARY: Risk estimation and the prevention of cardiovascular disease. A national clinical guideline. (NGC-5530)

Singapore Ministry of Health

1. Diagnosis and management of headache. (NGC-2064)
   • Singapore Ministry of Health. Diagnosis and management of headache. Singapore: Singapore Ministry of Health; 2000 Nov. 25 p. [15 references]

   CURRENT NGC SUMMARY: Diagnosis and management of headache. (NGC-6048)

2. Glomerulonephritis. (NGC-2197)
   • Singapore Ministry of Health. Glomerulonephritis. Singapore: Singapore Ministry of Health; 2001 Oct. 132 p. [259 references]

   CURRENT NGC SUMMARY: Glomerulonephritis. (NGC-5660)

3. Hypertension. (NGC-2063)
   • Singapore Ministry of Health. Hypertension. Singapore: Singapore Ministry of Health; 2000 Dec. 42 p. [21 references]

   CURRENT NGC SUMMARY: Hypertension. (NGC-4457)

4. Lipids. (NGC-2301)
   • Singapore Ministry of Health. Lipids. Singapore: Singapore Ministry of Health; 2001 Jul. 52 p. [19 references]

   CURRENT NGC SUMMARY: Lipids. (NGC-5072)

5. Management of asthma. (NGC-2501)
   • Singapore Ministry of Health. Management of asthma. Singapore: Singapore Ministry of Health; 2002 Jan. 58 p. [53 references]

   CURRENT NGC SUMMARY: Management of asthma. (NGC-6366)

Siskin Hospital for Physical Rehabilitation (Chattanooga, TN)

1. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: An evidence-based approach. (NGC-2038)
   • Sanders SH, Harden N, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: an evidence-based approach. J Back Musculoskeletal Rehabil 1999 Jan 1;13:47-58. [65 references]

   CURRENT NGC SUMMARY: Evidence-based clinical practice guidelines for interdisciplinary rehabilitation of chronic non-malignant pain syndrome patients. (NGC-4500)

Smith and Nephew, Ltd.

1. Guidelines for the management of leg ulcers in Ireland. (NGC-2842)
   • Smith & Nephew Ltd. Grace P, editor(s). Guidelines for the management of leg ulcers in Ireland. Dublin (Ireland): Smith & Nephew Ltd; 2002. 44 p.

   CURRENT NGC SUMMARY: Leg ulcer guidelines: a pocket guide for practice. (NGC-5254)

Society for Surgery of the Alimentary Tract, Inc

1. Achalasia. (NGC-1401)
   • Society for Surgery of the Alimentary Tract. Achalasia. Manchester (MA): Society for Surgery of the Alimentary Tract (SSAT); 1996-2000. 4 p. [6 references]

   CURRENT NGC SUMMARY: Esophageal achalasia. (NGC-3747)

2. Indications for splenectomy. (NGC-1400)
   • Society for Surgery of the Alimentary Tract. Indications for splenectomy. Manchester (MA): Society for Surgery of the Alimentary Tract; 2000. 4 p. [5 references]

   CURRENT NGC SUMMARY: Indications for splenectomy. (NGC-3748)

3. Operative treatment for chronic pancreatitis. (NGC-1393)
   • Society for Surgery of the Alimentary Tract. Operative treatment for chronic pancreatitis. Manchester (MA): Society for Surgery of the Alimentary Tract; 2000. 3 p. [2 references]

   CURRENT NGC SUMMARY: Operative treatment for chronic pancreatitis. (NGC-3749)

4. Surgical management of hemorrhoids. (NGC-1397)
   • Society for Surgery of the Alimentary Tract. Surgical management of hemorrhoids. Manchester (MA): Society for Surgery of the Alimentary Tract; 2000. 3 p. [1 reference]

   CURRENT NGC SUMMARY: Surgical management of hemorrhoids. (NGC-3750)

5. Surgical repair of groin hernias. (NGC-1398)
   • Society for Surgery of the Alimentary Tract. Surgical repair of groin hernias. Manchester (MA): Society for Surgery of the Alimentary Tract; 2000. 3 p. [4 references]

   CURRENT NGC SUMMARY: Surgical repair of groin hernias. (NGC-3751)

6. Surgical treatment of diverticulitis. (NGC-1395)
   • Society for Surgery of the Alimentary Tract. Surgical treatment of diverticulitis. Manchester (MA): Society for Surgery of the Alimentary Tract; 2000. 4 p. [3 references]

   CURRENT NGC SUMMARY: Surgical treatment of diverticulitis. (NGC-3752)

7. Surgical treatment of pancreatic cancer. (NGC-1399)
   • Society for Surgery of the Alimentary Tract. Surgical treatment of pancreatic cancer. Manchester (MA): Society for Surgery of the Alimentary Tract; 2000. 3 p. [5 references]

   CURRENT NGC SUMMARY: Surgical treatment of pancreatic cancer. (NGC-3753)

8. Treatment of acute pancreatitis. (NGC-1392)
   • Society for Surgery of the Alimentary Tract. Treatment of acute pancreatitis. Manchester (MA): Society for Surgery of the Alimentary Tract; 2000. 3 p. [5 references]

   CURRENT NGC SUMMARY: Treatment of acute pancreatitis. (NGC-3755)

9. Treatment of gallstone and gallbladder disease. (NGC-0930)
   • Society for Surgery of the Ailmentary Tract, Inc. Treatment of gallstone and gallbladder disease. J Gastrointest Surg 1998 Sep-Oct;2(5):485-6. [12 references] PubMed

   CURRENT NGC SUMMARY: Treatment of gallstone and gallbladder disease. (NGC-3756)

Society of American Gastrointestinal and Endoscopic Surgeons

1. Global statement on deep venous thrombosis prophylaxis during laparoscopic surgery. (NGC-1084)
   • Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Global statement on deep venous thrombosis prophylaxis during laparoscopic surgery.SAGES position statement. Surg Endosc 1999 Feb;13(2):200. [6 references] PubMed

   CURRENT NGC SUMMARY: Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery. (NGC-5677)

2. SAGES guidelines for laparoscopic surgery during pregnancy. (NGC-2372)
   • Society of American Gastrointestinal Endoscopic Surgeons (SAGES). SAGES guidelines for laparoscopic surgery during pregnancy. Santa Monica (CA): Society of American Gastrointestinal Endoscopic Surgeons (SAGES); 2000 Oct. 4 p. [31 references]

   CURRENT NGC SUMMARY: Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. (NGC-5977)

Society of Critical Care Medicine

1. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. (NGC-3508)
   • Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004 Mar;32(3):858-73. [135 references] PubMed

   CURRENT NGC SUMMARY: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. (NGC-6316)

Society of Interventional Radiology

1. Guidelines regarding HIV and other bloodborne pathogens in vascular/interventional radiology. (NGC-1146)
   • Hansen ME, SCVIR Technology Assessment Committee, Bakal CW, Dixon GD, Eschelman DJ, Horton KM, Katz M, Olcott EW, Sacks D. Guidelines regarding HIV and other bloodborne pathogens in vascular/interventional radiology. J Vasc Interv Radiol 1997 Jul-Aug;8(4):667-76. [60 references] PubMed

   CURRENT NGC SUMMARY: Guidelines regarding HIV and other bloodborne pathogens in vascular/interventional radiology. (NGC-3694)

Society of Nuclear Medicine, Inc

1. Procedure guideline for bone pain treatment. (NGC-0620)
   • Society of Nuclear Medicine. Procedure guideline for bone pain treatment, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 26 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0). [5 references]

   CURRENT NGC SUMMARY: Procedure guideline for palliative treatment of painful bone metastases. (NGC-3584)

2. Procedure guideline for bone scintigraphy. (NGC-0601)
   • Society of Nuclear Medicine. Procedure guideline for bone scintigraphy, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 25 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0). [5 references]

   CURRENT NGC SUMMARY: Procedure guideline for bone scintigraphy. (NGC-3578)

3. Procedure guideline for breast scintigraphy. (NGC-0975)
   • Procedure guideline for breast scintigraphy, 1.0. J Nucl Med 1999 Jul;40(7):1233-5. [9 references]

   CURRENT NGC SUMMARY: Procedure guideline for breast scintigraphy. (NGC-4262)

4. Procedure guideline for diagnosis of renovascular hypertension. (NGC-0617)
   • Society of Nuclear Medicine. Procedure guideline for diagnosis of renovascular hypertension, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 21 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

   CURRENT NGC SUMMARY: Procedure guideline for diagnosis of renovascular hypertension. (NGC-3585)

5. Procedure guideline for gallium scintigraphy in inflammation. (NGC-0607)
   • Society of Nuclear Medicine. Procedure guideline for gallium scintigraphy in inflammation, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 21 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

   CURRENT NGC SUMMARY: Procedure guideline for gallium scintigraphy in inflammation. (NGC-4259)

6. Procedure guideline for gastric emptying and motility. (NGC-0972)
   • Procedure guideline for gastric emptying and motility, 1.0. J Nucl Med 1999 Jul;40(7):1236-9. [8 references]

   CURRENT NGC SUMMARY: Procedure guideline for gastric emptying and motility. (NGC-4257)

7. Procedure guideline for general imaging. (NGC-0606)
   • Society of Nuclear Medicine. Procedure guideline for general imaging, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 36 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

   CURRENT NGC SUMMARY: Procedure guideline for general imaging. (NGC-4258)

8. Procedure guideline for hepatic and splenic imaging. (NGC-0605)
   • Society of Nuclear Medicine. Procedure guideline for hepatic and splenic imaging, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 16 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

   CURRENT NGC SUMMARY: Procedure guideline for hepatic and splenic imaging 3.0. (NGC-3579)

9. Procedure guideline for In-111 leukocyte scintigraphy for suspected infection/inflammation. (NGC-0608)
   • Society of Nuclear Medicine. Procedure guideline for In-111 leukocyte scintigraphy for suspected infection/inflammation, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 22 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

   CURRENT NGC SUMMARY: Procedure guideline for 111in-leukocyte scintigraphy for suspected infection/inflammation. (NGC-4261)

10. Procedure guideline for lung scintigraphy. (NGC-0610)
    • Society of Nuclear Medicine. Procedure guideline for lung scintigraphy, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 24 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    CURRENT NGC SUMMARY: Procedure guideline for lung scintigraphy. (NGC-4263)

11. Procedure guideline for parathyroid scintigraphy. (NGC-0612)
    • Society of Nuclear Medicine. Procedure guideline for parathyroid scintigraphy, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 19 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    CURRENT NGC SUMMARY: Procedure guideline for parathyroid scintigraphy. (NGC-4256)

12. Procedure guideline for pediatric sedation in nuclear medicine. (NGC-0616)
    • Society of Nuclear Medicine. Procedure guideline for pediatric sedation in nuclear medicine, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 15 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    CURRENT NGC SUMMARY: Procedure guideline for pediatric sedation in nuclear medicine. (NGC-3582)

13. Procedure guideline for radionuclide cystography in children. (NGC-0614)
    • Society of Nuclear Medicine. Procedure guideline for radionuclide cystography in children, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 18 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    CURRENT NGC SUMMARY: Procedure guideline for radionuclide cystography in children. (NGC-3581)

14. Procedure guideline for Tc-99m exametazime (HMPAO) labeled leukocyte scintigraphy for suspected infection/inflammation. (NGC-0609)
    • Society of Nuclear Medicine. Procedure guideline for Tc-99m exametazime (HMPAO) labeled leukocyte scintigraphy for suspected infection/inflammation, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 22 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

    CURRENT NGC SUMMARY: Procedure guideline for 99m Tc-Exametazime (HMPAO)-labeled leukocyte scintigraphy for suspected infection/inflammation. (NGC-4260)

The North American Menopause Society

1. Management of postmenopausal osteoporosis: position statement of The North American Menopause Society. (NGC-2405)
   • Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause 2002 Mar-Apr;9(2):84-101. [129 references] PubMed

   CURRENT NGC SUMMARY: Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. (NGC-5035)

2. The role of calcium in peri- and postmenopausal women: consensus opinion of The North American Menopause Society. (NGC-1966)
   • The role of calcium in peri- and postmenopausal women: consensus opinion of the North American Menopause Society. Menopause 2001 Mar-Apr;8(2):84-95. [104 references]

   CURRENT NGC SUMMARY: The role of calcium in peri- and postmenopausal women: 2006 position statement of The North American Menopause Society. (NGC-5350)

United States Preventive Services Task Force

1. Counseling to prevent dental and periodontal disease (NGC-0205)
   • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 61, Counseling to prevent dental and periodontal disease. p. 711-22. [97 references]

   CURRENT NGC SUMMARY: Prevention of dental caries in preschool children: recommendations and rationale. (NGC-3184)

2. Counseling to prevent HIV infection and other sexually transmitted diseases. (NGC-0206)
   • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 62, Counseling to prevent HIV infection and other sexually transmitted diseases. p. 723-37. [111 references]

   CURRENT NGC SUMMARY: Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement. (NGC-6686)

3. Counseling to prevent low back pain. (NGC-0204)
   • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 60, Counseling to prevent low back pain. p. 699-710. [87 references]

   CURRENT NGC SUMMARY: Primary care interventions to prevent low back pain in adults: recommendation statement. (NGC-3451)

4. Counseling to prevent motor vehicle injuries (NGC-0201)
   • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 57, Counseling to prevent motor vehicle injuries. p. 643-58. [201 references]

   CURRENT NGC SUMMARY: Counseling about proper use of motor vehicle occupant restraints and avoidance of alcohol use while driving. (NGC-5453)

5. Counseling to prevent tobacco use (NGC-0198)
   • U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Counseling to prevent tobacco use. p. 597-609. [123 references]

   CURRENT NGC SUMMARY: Counseling to prevent tobacco use and tobacco-caused disease: recommendation statement. (NGC-3268)

6. Counseling to promote a healthy diet. (NGC-0200)
   • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 56, Counseling to promote a healthy diet. p. 625-42. [204 references]

   CURRENT NGC SUMMARY: Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale. (NGC-2720)

7. Newborn hearing screening: recommendations and rationale. (NGC-2205)
   • Newborn hearing screening: recommendations and rationale. Am Fam Physician 2001 Dec 15;64(12):1995-9. [20 references]

   CURRENT NGC SUMMARY: Universal screening for hearing loss in newborns: U.S. Preventive Services Task Force recommendation statement. (NGC-6548)

8. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale. (NGC-2681)
   • Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med 2002 Nov 19;137(10):834-9. PubMed

   CURRENT NGC SUMMARY: Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendation statement. (NGC-4276)

9. Screening for abdominal aortic aneurysm. (NGC-0150)
   • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 6, Screening for abdominal aortic aneurysm. p. 67-72. [25 references]

   CURRENT NGC SUMMARY: Screening for abdominal aortic aneurysms: recommendation statement. (NGC-3960)

10. Screening for adolescent idiopathic scoliosis. (NGC-0191)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 47, Screening for adolescent idiopathic scoliosis. p. 517-29. [100 references]

    CURRENT NGC SUMMARY: Screening for idiopathic scoliosis in adolescents: recommendation statement. (NGC-3625)

11. Screening for asymptomatic bacteriuria: recommendation statement. (NGC-3452)
    • U.S. Preventive Services Task Force (USPSTF). Screening for asymptomatic bacteriuria: recommendation statement. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2004 Feb. 5 p. [4 references]

    CURRENT NGC SUMMARY: Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. (NGC-6527)

12. Screening for asymptomatic carotid artery stenosis. (NGC-0149)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 4, Screening for asymptomatic carotid artery stenosis. p. 53-61. [58 references]

    CURRENT NGC SUMMARY: Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. (NGC-5970)

13. Screening for asymptomatic coronary artery disease. (NGC-0146)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 1, Screening for asymptomatic coronary artery disease. p. 3-14. [85 references]

    CURRENT NGC SUMMARY: Screening for coronary heart disease: recommendation statement. (NGC-3367)

14. Screening for bacterial vaginosis in pregnancy: recommendations and rationale. (NGC-1885)
    • Berg AO. Screening for bacterial vaginosis in pregnancy. Recommendations and rationale. Am J Prev Med 2001 Apr;20(3 Suppl):59-61. [5 references]

    CURRENT NGC SUMMARY: Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. Preventive Services Task Force Recommendation Statement. (NGC-6227)

15. Screening for bladder cancer. (NGC-0161)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 17, Screening for bladder cancer. p. 181-6. [29 references]

    CURRENT NGC SUMMARY: Screening for bladder cancer in adults: recommendation statement. (NGC-3595)

16. Screening for cervical cancer. (NGC-0153)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 9, Screening for cervical cancer. p. 105-17. [113 references]

    CURRENT NGC SUMMARY: Screening for cervical cancer: recommendations and rationale. (NGC-2758)

17. Screening for chlamydial infection: recommendations and rationale. (NGC-1886)
    • Berg AO. Screening for chlamydial infection. Recommendations and rationale. Am J Prev Med 2001 Apr;20(3 Suppl):90-4. [7 references]

    CURRENT NGC SUMMARY: Screening for chlamydial infection: recommendation statement. (NGC-5454)

18. Screening for congenital hypothyroidism (NGC-0189)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 45, Screening for congenital hypothyroidism. p. 503-507. [39 references]

    CURRENT NGC SUMMARY: Screening for congenital hypothyroidism: U.S. Preventive Services Task Force reaffirmation recommendation statement. (NGC-6354)

19. Screening for D (Rh) incompatibility. (NGC-0182)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 38, Screening for D (Rh) incompatibility. p. 425-432. [61 references]

    CURRENT NGC SUMMARY: Screening for Rh(D) incompatibility: recommendation statement. (NGC-3455)

20. Screening for dementia and other diseases. (NGC-0192)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 48, Screening for dementia and other diseases. p. 531-40. [68 references]

    CURRENT NGC SUMMARY: Screening for dementia: recommendations and rationale. (NGC-2916)

21. Screening for drug abuse (NGC-0197)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 53, Screening for drug abuse. p. 583-95. [80 references]

    CURRENT NGC SUMMARY: Screening for illicit drug use: U.S. Preventive Services Task Force recommendation statement. (NGC-6245)

22. Screening for elevated lead levels in childhood and pregnancy. (NGC-0167)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 23, Screening for elevated lead levels in childhood and pregnancy. p. 247-67. [152 references]

    CURRENT NGC SUMMARY: Screening for elevated blood lead levels in children and pregnant women: recommendation statement. (NGC-5433)

23. Screening for family violence. (NGC-0195)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 51, Screening for family violence. p. 555-65.

    CURRENT NGC SUMMARY: Screening for family and intimate partner violence: recommendation statement. (NGC-3341)

24. Screening for genital herpes simplex. (NGC-0174)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 30, Screening for genital herpes simplex. p. 335-46. [68 references]

    CURRENT NGC SUMMARY: Screening for genital herpes: recommendation statement. (NGC-4067)

25. Screening for gestational diabetes mellitus: recommendations and rationale. (NGC-2719)
    • U.S. Preventive Services Task Force (USPSTF). Screening for gestational diabetes mellitus: recommendations and rationale. Obstet Gynecol 2003 Feb;101(2):393-5. [50 references]

    CURRENT NGC SUMMARY: Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. (NGC-6437)

26. Screening for glaucoma. (NGC-0178)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 34, Screening for glaucoma. p. 383-92. [41 references]

    CURRENT NGC SUMMARY: Screening for glaucoma: recommendation statement. (NGC-3990)

27. Screening for gonorrhea - including ocular prophylaxis in newborns. (NGC-0171)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 27, Screening for gonorrhea - including ocular prophylaxis in newborns. p. 293-302. [52 references]

    CURRENT NGC SUMMARY: Screening for gonorrhea: recommendation statement. (NGC-4290)

28. Screening for hemoglobinopathies. (NGC-0187)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 43, Screening for hemoglobinopathies. p. 485-94. [53 references]

    CURRENT NGC SUMMARY: Screening for sickle cell disease in newborns: U.S. Preventive Services Task Force recommendation statement. (NGC-5908)

29. Screening for hepatitis B virus infection. (NGC-0168)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 24, Screening for hepatitis B virus infection. p. 269-76. [56 references]

    CURRENT NGC SUMMARY: Screening for hepatitis B virus infection: recommendation statement. (NGC-3453)

30. Screening for high blood pressure: recommendations and rationale. (NGC-3068)
    • U.S. Preventive Services Task Force (USPSTF). Screening for high blood pressure: recommendations and rationale. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2003 Jul 14. 12 p. [46 references]

    CURRENT NGC SUMMARY: Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. (NGC-5952)

31. Screening for human immunodeficiency virus. (NGC-0172)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 28, Screening for human immunodeficiency virus infection. p. 303-24. [159 references]

    CURRENT NGC SUMMARY: Screening for HIV: recommendation statement. (NGC-4292)

32. Screening for iron deficiency anemia - including iron prophylaxis. (NGC-0166)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 22, Screening for iron deficiency anemia--including iron prophylaxis. p. 231-46.

    CURRENT NGC SUMMARY: Screening for iron deficiency anemia - including iron supplementation for children and pregnant women. (NGC-4965)

33. Screening for lipid disorders in adults: recommendations and rationale. (NGC-1887)
    • Berg AO. Screening adults for lipid disorders. Recommendations and rationale. Am J Prev Med 2001 Apr;20(3 Suppl):73-6. [12 references]

    CURRENT NGC SUMMARY: Screening for lipid disorders in adults: U.S. Preventive Services Task Force recommendation statement. (NGC-6542)

34. Screening for lung cancer. (NGC-0155)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Screening for lung cancer. p. 135-9. [34 references]

    CURRENT NGC SUMMARY: Lung cancer screening: recommendation statement. (NGC-3370)

35. Screening for obesity. (NGC-0165)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 21, Screening for obesity. p. 219-29. [134 references]

    CURRENT NGC SUMMARY: Screening for obesity in adults: recommendations and rationale. (NGC-3163)

36. Screening for oral cancer. (NGC-0160)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 16, Screening for oral cancer. p. 175-80. [27 references]

    CURRENT NGC SUMMARY: Screening for oral cancer: recommendation statement. (NGC-3454)

37. Screening for ovarian cancer. (NGC-0158)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 14, Screening for ovarian cancer. p. 159-66. [58 references]

    CURRENT NGC SUMMARY: Screening for ovarian cancer: recommendation statement. (NGC-3498)

38. Screening for pancreatic cancer. (NGC-0159)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 15, Screening for pancreatic cancer. p. 167-73. [60 references]

    CURRENT NGC SUMMARY: Screening for pancreatic cancer: recommendation statement. (NGC-3468)

39. Screening for peripheral arterial disease. (NGC-0393)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 5, Screening for peripheral arterial disease. p. 63-6. [16 references]

    CURRENT NGC SUMMARY: Screening for peripheral arterial disease. (NGC-4291)

40. Screening for phenylketonuria. (NGC-0188)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 44, Screening for phenylketonuria. p. 495-502. [56 references]

    CURRENT NGC SUMMARY: Screening for phenylketonuria (PKU): U.S. Preventive Services Task Force reaffirmation recommendation statement. (NGC-6353)

41. Screening for postmenopausal osteoporosis. (NGC-0190)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 46, Screening for postmenopausal osteoporosis. p. 509-16. [52 references]

    CURRENT NGC SUMMARY: Screening for osteoporosis in postmenopausal women: recommendations and rationale. (NGC-2643)

42. Screening for problem drinking. (NGC-0196)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 52, Screening for problem drinking. p. 567-82. [116 references]

    CURRENT NGC SUMMARY: Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. (NGC-3399)

43. Screening for prostate cancer: recommendations and rationale. (NGC-2630)
    • Berg AO. Screening for prostate cancer: recommendations and rationale. Am J Nurs 2003 Mar;103(3):107-10. PubMed
    
    
    
    • Screening for prostate cancer: recommendations and rationale. Ann Intern Med 2002 Dec 3;137(11):915-6. [8 references] PubMed

    CURRENT NGC SUMMARY: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. (NGC-6629)

44. Screening for skin cancer-including counseling to prevent skin cancer. (NGC-0156)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 12, Screening for skin cancer - including counseling to prevent skin cancer. p. 141-52. [90 references]

    CURRENT NGC SUMMARY: Counseling to prevent skin cancer: recommendations and rationale. (NGC-2954)

45. Screening for suicide risk. (NGC-0194)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 50, Screening for suicide risk. p. 547-54. [52 references]

    CURRENT NGC SUMMARY: Screening for suicide risk: recommendation statement. (NGC-3457)

46. Screening for syphilis. (NGC-0170)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 26, Screening for syphilis. p. 287-92. [31 references]

    CURRENT NGC SUMMARY: Screening for syphilis infection: recommendation statement. (NGC-3592)

47. Screening for testicular cancer. (NGC-0157)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 13, Screening for testicular cancer. p. 153-7. [23 references]

    CURRENT NGC SUMMARY: Screening for testicular cancer: recommendation statement. (NGC-3456)

48. Screening for thyroid disease. (NGC-0164)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 20, Screening for thyroid disease. p. 209-18. [102 references]

    CURRENT NGC SUMMARY: Screening for thyroid disease: recommendation statement. (NGC-3266)

49. Screening for type 2 diabetes mellitus in adults: recommendations and rationale. (NGC-2749)
    • Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med 2003 Feb 4;138(3):212-4. [3 references] PubMed

    CURRENT NGC SUMMARY: Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. (NGC-6485)

50. Screening for visual impairment. (NGC-0177)
    • U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 33, Screening for visual impairment. p. 373-82. [63 references]

    CURRENT NGC SUMMARY: Screening for visual impairment in children younger than age 5 years: recommendation statement. (NGC-3477)

University of Iowa Gerontological Nursing Interventions Research Center, Research Translation and Dissemination Core

1. Alzheimer's disease and chronic dementing illnesses. (NGC-0546)
   • Gerontological Nursing Interventions Research Center (University of Iowa), Research Development and Dissemination Core. Alzheimer's disease and chronic dementing illnesses. Iowa City (IA): University of Iowa; 1996. 65 p. (Research-based protocol; no. 1996). [24 references]

   CURRENT NGC SUMMARY: Non-pharmacologic management of agitated behaviors in persons with Alzheimer disease and other chronic dementing illnesses. (NGC-3992)

2. Bathing persons with dementia. (NGC-0544)
   • Gerontological Nursing Interventions Research Center (University of Iowa), Research Development and Dissemination Core. Bathing persons with dementia. Iowa City (IA): University of Iowa; 1998 Apr. 17 p. (Research-based protocol; no. 1998). [14 references]

   CURRENT NGC SUMMARY: Bathing persons with dementia. (NGC-3991)

3. Detection of depression in the cognitively intact older adult. (NGC-0729)
   • Piven MLS. Detection of depression in the cognitively intact older adult evidence-based protocol. In: Titler MG, editor(s). Series on evidence-based practice for older adults. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. p. 25 . [92 references]

   CURRENT NGC SUMMARY: Detection of depression in the cognitively intact older adult. (NGC-4519)

4. Evidence-based protocol. Exercise promotion: walking in elders. (NGC-2300)
   • Jitramontree N. Evidence-based protocol. Excercise promotion: walking in elders. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 2001 Feb. 53 p. [81 references]

   CURRENT NGC SUMMARY: Evidence-based practice guideline. Exercise promotion: walking in elders. (NGC-5728)

5. Evidence-based protocol. Individualized music. (NGC-2299)
   • Gerdner L. Evidence-based protocol. Individualized music. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 2001 Feb. 35 p. [43 references]

   CURRENT NGC SUMMARY: Individualized music for elders with dementia. (NGC-5605)

6. Hydration management. (NGC-0685)
   • The Iowa Veterans Affairs Nursing Research Consotium. Mentes JC. Hydration management. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. 34 p. [76 references]

   CURRENT NGC SUMMARY: Hydration management. (NGC-3479)

7. Prevention of deep vein thrombosis. (NGC-1193)
   • Blondin M. Prevention of deep vein thrombosis. Iowa City (IA): University of Iowa Gerontological Nursing Research Center, Research Dissemination Core; 1999. 31 p. [56 references]

   CURRENT NGC SUMMARY: Prevention of deep vein thrombosis. (NGC-4960)

8. Prevention of falls. (NGC-0542)
   • Gerontological Nursing Interventions Research Center (University of Iowa), Research Development and Dissemination Core. Prevention of falls. Iowa City (IA): University of Iowa; 1996. 37 p. (Research-based protocol; no. 1996). [67 references]

   CURRENT NGC SUMMARY: Fall prevention for older adults. (NGC-3480)

9. Progressive resistance training. (NGC-0537)
   • Mobily K, Mobily P. Progressive resistance training. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1998. 25 p. [24 references]

   CURRENT NGC SUMMARY: Progressive resistance training. (NGC-3478)

10. Restraints. (NGC-0545)
    • Ledford L, Mentes J. Restraints research-based protocol. In: Titler MG, editor(s). Series on evidence-based practice for older adults. Iowa City (IA): University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; 1997 Sep. p. 83. [55 references]

    CURRENT NGC SUMMARY: Changing the practice of physical restraint use in acute care. (NGC-4806)

University of Michigan Health System

1. Acute rhinosinusitis in adults. (NGC-4208)
   • University of Michigan Health System. Acute rhinosinusitis in adults. Ann Arbor (MI): University of Michigan Health System; 2005 Feb. 8 p. [6 references]

   CURRENT NGC SUMMARY: Acute rhinosinusitis in adults. (NGC-6570)

2. Adult preventive health care: immunizations. (NGC-5676)
   • University of Michigan Health System. Adult preventive health care: immunizations. Ann Arbor (MI): University of Michigan Health System; 2007 Mar. 9 p. [4 references]

   CURRENT NGC SUMMARY: Adult preventive health care: immunizations. (NGC-6487)

3. Allergic rhinitis. (NGC-2599)
   • University of Michigan Health System. Allergic rhinitis. Ann Arbor (MI): University of Michigan Health System; 2002 Jul. 12 p. [3 references]

   CURRENT NGC SUMMARY: Allergic rhinitis. (NGC-6031)

4. Asthma. (NGC-3903)
   • University of Michigan Health System. Asthma. Ann Arbor (MI): University of Michigan Health System; 2004 Sep. 15 p. [13 references]

   CURRENT NGC SUMMARY: Asthma. (NGC-4879)

5. Depression. (NGC-3787)
   • University of Michigan Health System. Depression. Ann Arbor (MI): University of Michigan Health System; 2004 May. 21 p. [3 references]

   CURRENT NGC SUMMARY: Depression. (NGC-4662)

6. Essential hypertension. (NGC-2765)
   • University of Michigan Health System. Essential hypertension. Ann Arbor (MI): University of Michigan Health System; 2002 Aug. 14 p. [7 references]

   CURRENT NGC SUMMARY: Essential hypertension. (NGC-4462)

7. Heart failure - systolic dysfunction. (NGC-1508)
   • University of Michigan Health System. Heart failure - systolic dysfunction. Ann Arbor (MI): University of Michigan Health System; 1999 Aug. 12 p. [9 references]

   CURRENT NGC SUMMARY: Heart failure - systolic dysfunction. (NGC-5363)

8. Knee pain or swelling: acute or chronic. (NGC-2766)
   • University of Michigan Health System. Knee pain or swelling: acute or chronic. Ann Arbor (MI): University of Michigan Health System; 2002 Aug [rev. 2004 Oct]. 13 p. [8 references]

   CURRENT NGC SUMMARY: Knee pain or swelling: acute or chronic. (NGC-4491)

9. Management of gastroesophageal reflux disease (GERD). (NGC-2598)
   • University of Michigan Health System. Management of gastroesophageal reflux disease (GERD). Ann Arbor (MI): University of Michigan Health System; 2002 Mar. 9 p. [4 references]

   CURRENT NGC SUMMARY: Gastroesophageal reflux disease (GERD). (NGC-5568)

10. Management of type 2 diabetes mellitus. (NGC-3788)
    • University of Michigan Health System. Management of type 2 diabetes mellitus. Ann Arbor (MI): University of Michigan Health System; 2004 Jul. 18 p. [4 references]

    CURRENT NGC SUMMARY: Management of type 2 diabetes mellitus. (NGC-6273)

11. Osteoporosis: prevention and treatment. (NGC-2767)
    • University of Michigan Health System. Osteoporosis: prevention and treatment. Ann Arbor (MI): University of Michigan Health System; 2002 Mar. 12 p. [3 references]

    CURRENT NGC SUMMARY: Osteoporosis: prevention and treatment. (NGC-4492)

12. Otitis media. (NGC-2597)
    • University of Michigan Health System. Otitis media. Ann Arbor (MI): University of Michigan Health System; 2002 May. 12 p. [7 references]

    CURRENT NGC SUMMARY: Otitis media. (NGC-6032)

13. Peptic ulcer disease. (NGC-1512)
    • University of Michigan Health System. UMHS peptic ulcer guideline. Ann Arbor (MI): University of Michigan Health System; 1999 May. 6 p. [7 references]

    CURRENT NGC SUMMARY: Peptic ulcer disease. (NGC-4376)

14. Pharyngitis. (NGC-2183)
    • Pharyngitis. Guidelines for clinical care. Ann Arbor (MI): University of Michigan Health System; 2000 Dec. 8 p. [8 references]

    CURRENT NGC SUMMARY: Pharyngitis. (NGC-5567)

15. Smoking cessation. (NGC-2184)
    • Smoking cessation. Guidelines for clinical care. Ann Arbor (MI): University of Michigan Health System; 2001 Feb. 9 p. [1 reference]

    CURRENT NGC SUMMARY: Smoking cessation. (NGC-5247)

16. Urinary tract infection. (NGC-1510)
    • University of Michigan Health System. UMHS urinary tract infection guideline. Ann Arbor (MI): University of Michigan Health System; 1999 Jun. 7 p. [6 references]

    CURRENT NGC SUMMARY: Urinary tract infection. (NGC-4377)

University of Texas Medical Branch Correctional Managed Care

1. Chronic COPD. (NGC-2702)
   • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Chronic COPD. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2002 Apr. 3 p. [2 references]

   CURRENT NGC SUMMARY: Chronic COPD. (NGC-3305)

2. Hypertension. (NGC-2701)
   • Texas Tech University Managed Health Care Network Pharmacy & Therapeutics Committee. Hypertension. Conroe (TX): University of Texas Medical Branch Correctional Managed Care; 2002 Apr. 6 p. [1 reference]

   CURRENT NGC SUMMARY: Hypertension. (NGC-3304)

Veterans Health Administration

1. Diagnosis and management of hypertension in the primary care setting. (NGC-1805)
   • Diagnosis and management of hypertension in the primary care setting. Washington (DC): Department of Veterans Affairs (U.S.); 1999 May. Various p. [39 references]

   CURRENT NGC SUMMARY: VHA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting. (NGC-4198)

2. The management of diabetes mellitus in the primary care setting. (NGC-1809)
   • Management of diabetes mellitus in the primary care setting. Washington (DC): Department of Veterans Affairs (U.S.); 1999 Dec. 147 p. [185 references]

   CURRENT NGC SUMMARY: VA/DoD clinical practice guideline for the management of diabetes mellitus. (NGC-3567)

3. The pharmacologic management of chronic heart failure. (NGC-2253)
   • The pharmacologic management of chronic heart failure. Washington (DC): Department of Veterans Affairs (U.S.), Veterans Health Administration (VHA); 2001 Feb. 42 p. [159 references]

   CURRENT NGC SUMMARY: The pharmacologic management of chronic heart failure. (NGC-3566)

4. Tobacco use cessation in the primary care setting. (NGC-1802)
   • Tobacco use cessation in the primary care setting. Department of Veterans Affairs (U.S.); 1999 May. Various p. [45 references]

   CURRENT NGC SUMMARY: VA/DoD clinical practice guideline for the management of tobacco use. (NGC-3962)

5. VHA/DoD clinical practice guideline for the management of dyslipidemia in primary care. (NGC-2413)
   • Veterans Health Administration, Department of Defense. VHA/DoD clinical practice guideline for the management of dyslipidemia in primary care. Washington (DC): Veterans Health Administration, Department of Defense; 2001 Dec. Various p. [115 references]

   CURRENT NGC SUMMARY: VA/DoD clinical practice guideline for the management of dyslipidemia. (NGC-5303)

Washington State Department of Labor and Industries

1. Criteria for cervical surgery related to entrapment of a single cervical nerve root. (NGC-3213)
   • Washington State Department of Labor and Industries. Criteria for cervical surgery related to entrapment of a single cervical nerve root. Olympia (WA): Washington State Department of Labor and Industries; 2002 Aug. 1 p.

   CURRENT NGC SUMMARY: Review criteria for cervical surgery for entrapment of a single nerve root. (NGC-3856)

2. Criteria for knee surgery. (NGC-1119)
   • Washington State Department of Labor and Industries. Criteria for knee surgery. Olympia (WA): Washington State Department of Labor and Industries; 1999 Jun. 1 p. [1 reference]

   CURRENT NGC SUMMARY: Review criteria for knee surgery. (NGC-3482)

3. Guideline for the use of Neurontin® in the management of neuropathic pain. (NGC-2776)
   • Washington Department of Labor and Industries, Washington State Medical Association. Guideline for the use of Neurontin in the management of neuropathic pain. Seattle (WA): Washington Department of Labor and Industries, Washington State Medical Association; 2002. 5 p. [12 references]

   CURRENT NGC SUMMARY: Antiepileptic drugs guideline for chronic pain. (NGC-4707)

4. Guideline on facet neurotomy. (NGC-3181)
   • Washington State Department of Labor and Industries. Guideline on facet neurotomy. Provider Bull 2003 Sep;(PB 03-11):1-6. [6 references]

   CURRENT NGC SUMMARY: Guideline on diagnostic facet medial nerve branch blocks and facet neurotomy. (NGC-4706)

5. Guidelines for psychiatric and psychological evaluation of injured or chronically disabled workers. (NGC-3221)
   • Washington State Department of Labor and Industries. Guidelines for psychiatric and psychological evaluation of injured or chronically disabled workers. Olympia (WA): Washington State Department of Labor and Industries; 2002 Aug. 10 p.

   CURRENT NGC SUMMARY: Guideline for the evaluation and treatment of injured workers with psychiatric conditions. (NGC-3857)

Work Loss Data Institute

1. Ankle & foot (acute & chronic). (NGC-5460)
   • Work Loss Data Institute. Ankle & foot (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 140 p. [172 references]

   CURRENT NGC SUMMARY: Ankle & foot (acute & chronic). (NGC-5794)

2. Burns. (NGC-5461)
   • Work Loss Data Institute. Burns. Corpus Christi (TX): Work Loss Data Institute; 2006. 43 p. [60 references]

   CURRENT NGC SUMMARY: Burns. (NGC-5795)

3. Carpal tunnel syndrome (acute & chronic). (NGC-5462)
   • Work Loss Data Institute. Carpal tunnel syndrome (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 198 p. [270 references]

   CURRENT NGC SUMMARY: Carpal tunnel syndrome (acute & chronic). (NGC-5796)

4. Elbow (acute & chronic). (NGC-5463)
   • Work Loss Data Institute. Elbow (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 141 p. [292 references]

   CURRENT NGC SUMMARY: Elbow (acute & chronic). (NGC-5797)

5. Eye. (NGC-5464)
   • Work Loss Data Institute. Eye. Corpus Christi (TX): Work Loss Data Institute; 2006. 57 p. [83 references]

   CURRENT NGC SUMMARY: Eye. (NGC-5798)

6. Fitness for duty. (NGC-4699)
   • Work Loss Data Institute. Fitness for duty. Corpus Christi (TX): Work Loss Data Institute; 2005. 72 p. [92 references]

   CURRENT NGC SUMMARY: Fitness for duty. (NGC-5465)

7. Forearm, wrist, & hand (acute & chronic), not including carpal tunnel syndrome. (NGC-5466)
   • Work Loss Data Institute. Forearm, wrist, & hand (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 80 p. [91 references]

   CURRENT NGC SUMMARY: Forearm, wrist, & hand (acute & chronic), not including carpal tunnel syndrome. (NGC-5799)

8. Head (trauma, headaches, etc., not including stress & mental disorders). (NGC-5467)
   • Work Loss Data Institute. Head (trauma, headaches, etc., not including stress & mental disorders). Corpus Christi (TX): Work Loss Data Institute; 2006. 143 p. [166 references]

   CURRENT NGC SUMMARY: Head (trauma, headaches, etc., not including stress & mental disorders). (NGC-5800)

9. Hernia. (NGC-5468)
   • Work Loss Data Institute. Hernia. Corpus Christi (TX): Work Loss Data Institute; 2006. 42 p. [38 references]

   CURRENT NGC SUMMARY: Hernia. (NGC-5801)

10. Hip & pelvis (acute & chronic). (NGC-5469)
    • Work Loss Data Institute. Hip & pelvis (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 147 p. [158 references]

    CURRENT NGC SUMMARY: Hip & pelvis (acute & chronic). (NGC-5802)

11. Knee & leg (acute & chronic). (NGC-5470)
    • Work Loss Data Institute. Knee & leg (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 216 p. [222 references]

    CURRENT NGC SUMMARY: Knee & leg (acute & chronic). (NGC-5803)

12. Low back - lumbar & thoracic (acute & chronic). (NGC-5471)
    • Work Loss Data Institute. Low back - lumbar & thoracic (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 431 p. [514 references]

    CURRENT NGC SUMMARY: Low back - lumbar & thoracic (acute & chronic). (NGC-5804)

13. Neck and upper back (acute & chronic). (NGC-5472)
    • Work Loss Data Institute. Neck and upper back (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 248 p. [288 references]

    CURRENT NGC SUMMARY: Neck and upper back (acute & chronic). (NGC-5805)

14. Pain (chronic). (NGC-5473)
    • Work Loss Data Institute. Pain (chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 303 p. [371 references]

    CURRENT NGC SUMMARY: Pain (chronic). (NGC-5806)

15. Shoulder (acute & chronic). (NGC-5475)
    • Work Loss Data Institute. Shoulder (acute & chronic). Corpus Christi (TX): Work Loss Data Institute; 2006. 176 p. [185 references]

    CURRENT NGC SUMMARY: Shoulder (acute & chronic). (NGC-5808)

16. Stress related conditions and other mental disorders. (NGC-5474)
    • Work Loss Data Institute. Stress related conditions and other mental disorders. Corpus Christi (TX): Work Loss Data Institute; 2006. 152 p. [202 references]

    CURRENT NGC SUMMARY: Stress related conditions and other mental disorders. (NGC-5807)

Wound, Ostomy, and Continence Nurses Society

1. Guideline for management of wounds in patients with lower-extremity arterial disease. (NGC-2516)
   • Wound Ostomy and Continence Nurses Society (WOCN). Guideline for management of wounds in patients with lower-extremity arterial disease. Glenview (IL): Wound Ostomy and Continence Nurses Society (WOCN); 2002 Jun. 44 p. (WOCN clinical practice guideline series; no. 1). [131 references]

   CURRENT NGC SUMMARY: Guideline for management of wounds in patients with lower-extremity arterial disease. (NGC-6521)